'en:stillbirth'
(id=6890779 ; fe=en:stillbirth ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=62065 creation date=2017-06-25 touchdate=2025-08-27 17:13:54.000) ≈ 1110 relations sortantes
- en:stillbirth --
r_associated #0: 93 / 1 ->
mort à la naissance
n1=en:stillbirth | n2=mort à la naissance | rel=r_associated | relid=0 | w=93
- en:stillbirth --
r_associated #0: 90 / 0.968 ->
mort in utéro
n1=en:stillbirth | n2=mort in utéro | rel=r_associated | relid=0 | w=90
- en:stillbirth --
r_associated #0: 90 / 0.968 ->
mort intra-utérine
n1=en:stillbirth | n2=mort intra-utérine | rel=r_associated | relid=0 | w=90
- en:stillbirth --
r_associated #0: 90 / 0.968 ->
mort-né
n1=en:stillbirth | n2=mort-né | rel=r_associated | relid=0 | w=90
- en:stillbirth --
r_associated #0: 90 / 0.968 ->
mortinatalité
n1=en:stillbirth | n2=mortinatalité | rel=r_associated | relid=0 | w=90
- en:stillbirth --
r_associated #0: 90 / 0.968 ->
naissance sans vie
n1=en:stillbirth | n2=naissance sans vie | rel=r_associated | relid=0 | w=90
- en:stillbirth --
r_associated #0: 75 / 0.806 ->
processus pathologique
n1=en:stillbirth | n2=processus pathologique | rel=r_associated | relid=0 | w=75
- en:stillbirth --
r_associated #0: 70 / 0.753 ->
mortinaissance
n1=en:stillbirth | n2=mortinaissance | rel=r_associated | relid=0 | w=70
- en:stillbirth --
r_associated #0: 65 / 0.699 ->
mort prénatale
n1=en:stillbirth | n2=mort prénatale | rel=r_associated | relid=0 | w=65
- en:stillbirth --
r_associated #0: 63 / 0.677 ->
naissance d'un enfant mort-né
n1=en:stillbirth | n2=naissance d'un enfant mort-né | rel=r_associated | relid=0 | w=63
- en:stillbirth --
r_associated #0: 55 / 0.591 ->
enfant
n1=en:stillbirth | n2=enfant | rel=r_associated | relid=0 | w=55
- en:stillbirth --
r_associated #0: 55 / 0.591 ->
mise au monde d'un enfant mort-né
n1=en:stillbirth | n2=mise au monde d'un enfant mort-né | rel=r_associated | relid=0 | w=55
- en:stillbirth --
r_associated #0: 42 / 0.452 ->
état d'un enfant mort-né
n1=en:stillbirth | n2=état d'un enfant mort-né | rel=r_associated | relid=0 | w=42
- en:stillbirth --
r_associated #0: 40 / 0.43 ->
en:spontaneous abortion
n1=en:stillbirth | n2=en:spontaneous abortion | rel=r_associated | relid=0 | w=40
- en:stillbirth --
r_associated #0: 35 / 0.376 ->
en:miscarriage
n1=en:stillbirth | n2=en:miscarriage | rel=r_associated | relid=0 | w=35
- en:stillbirth --
r_associated #0: 33 / 0.355 ->
naissance
n1=en:stillbirth | n2=naissance | rel=r_associated | relid=0 | w=33
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
22 semaines de gestation
n1=en:stillbirth | n2=22 semaines de gestation | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
décès
n1=en:stillbirth | n2=décès | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:arthralgia
n1=en:stillbirth | n2=en:arthralgia | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:death by electrocution
n1=en:stillbirth | n2=en:death by electrocution | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:premature aging syndrome
n1=en:stillbirth | n2=en:premature aging syndrome | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:presentation in children - diarrhea, constipation (rarely), short stature, pubertal delay, rickets, iron and folate deficiency with anemia
n1=en:stillbirth | n2=en:presentation in children - diarrhea, constipation (rarely), short stature, pubertal delay, rickets, iron and folate deficiency with anemia | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:prevalence estimated at 1 in 50,000
n1=en:stillbirth | n2=en:prevalence estimated at 1 in 50,000 | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:prevalent among the amish
n1=en:stillbirth | n2=en:prevalent among the amish | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:quadruplet pregnancy with fetal loss and retention of one or more fetus(es), delivered, with or without mention of antepartum condition
n1=en:stillbirth | n2=en:quadruplet pregnancy with fetal loss and retention of one or more fetus(es), delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:quadruplet pregnancy with fetal loss and retention of one or more fetus(es), unspecified as to episode of care or not applicable
n1=en:stillbirth | n2=en:quadruplet pregnancy with fetal loss and retention of one or more fetus(es), unspecified as to episode of care or not applicable | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:skeletal and facial features are variable
n1=en:stillbirth | n2=en:skeletal and facial features are variable | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:small placenta
n1=en:stillbirth | n2=en:small placenta | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:some patients may show a favorable response to oral coenzyme q10 supplementation
n1=en:stillbirth | n2=en:some patients may show a favorable response to oral coenzyme q10 supplementation | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:some patients with advanced loss of vision have normal eog
n1=en:stillbirth | n2=en:some patients with advanced loss of vision have normal eog | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:variable expression
n1=en:stillbirth | n2=en:variable expression | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
en:visual impairment is present at birth and is progressive
n1=en:stillbirth | n2=en:visual impairment is present at birth and is progressive | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
épidémiologie
n1=en:stillbirth | n2=épidémiologie | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
expulsion
n1=en:stillbirth | n2=expulsion | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
expulsion du foetus
n1=en:stillbirth | n2=expulsion du foetus | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
foetus
n1=en:stillbirth | n2=foetus | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
interruption médicale de grossesse
n1=en:stillbirth | n2=interruption médicale de grossesse | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
maladies
n1=en:stillbirth | n2=maladies | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
médecine
n1=en:stillbirth | n2=médecine | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
médecine spécialisée
n1=en:stillbirth | n2=médecine spécialisée | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
médecine
(science)
n1=en:stillbirth | n2=médecine (science) | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
mort
n1=en:stillbirth | n2=mort | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
mort-nés
n1=en:stillbirth | n2=mort-nés | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
mortalité
n1=en:stillbirth | n2=mortalité | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
mortalité néonatale
n1=en:stillbirth | n2=mortalité néonatale | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
obstétrique
n1=en:stillbirth | n2=obstétrique | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
pédiatrie
n1=en:stillbirth | n2=pédiatrie | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
sociologie
n1=en:stillbirth | n2=sociologie | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
spécialités médicales
n1=en:stillbirth | n2=spécialités médicales | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 30 / 0.323 ->
taux
n1=en:stillbirth | n2=taux | rel=r_associated | relid=0 | w=30
- en:stillbirth --
r_associated #0: 29 / 0.312 ->
en:pregnancy test false positive
n1=en:stillbirth | n2=en:pregnancy test false positive | rel=r_associated | relid=0 | w=29
- en:stillbirth --
r_associated #0: 29 / 0.312 ->
en:recurrent bacterial infection
n1=en:stillbirth | n2=en:recurrent bacterial infection | rel=r_associated | relid=0 | w=29
- en:stillbirth --
r_associated #0: 29 / 0.312 ->
en:some patients show a favorable response to sulfonylurea treatment
n1=en:stillbirth | n2=en:some patients show a favorable response to sulfonylurea treatment | rel=r_associated | relid=0 | w=29
- en:stillbirth --
r_associated #0: 29 / 0.312 ->
en:twin pregnancy with fetal loss and retention of one fetus, antepartum condition or complication
n1=en:stillbirth | n2=en:twin pregnancy with fetal loss and retention of one fetus, antepartum condition or complication | rel=r_associated | relid=0 | w=29
- en:stillbirth --
r_associated #0: 29 / 0.312 ->
en:variable age at onset (late childhood to adult)
n1=en:stillbirth | n2=en:variable age at onset (late childhood to adult) | rel=r_associated | relid=0 | w=29
- en:stillbirth --
r_associated #0: 28 / 0.301 ->
accouchement d'un enfant mort-né
n1=en:stillbirth | n2=accouchement d'un enfant mort-né | rel=r_associated | relid=0 | w=28
- en:stillbirth --
r_associated #0: 28 / 0.301 ->
anomalie congénitale
n1=en:stillbirth | n2=anomalie congénitale | rel=r_associated | relid=0 | w=28
- en:stillbirth --
r_associated #0: 28 / 0.301 ->
en:ethnologic
n1=en:stillbirth | n2=en:ethnologic | rel=r_associated | relid=0 | w=28
- en:stillbirth --
r_associated #0: 28 / 0.301 ->
en:pediatric adverse events terminology
n1=en:stillbirth | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=28
- en:stillbirth --
r_associated #0: 28 / 0.301 ->
en:precipitated by fever
n1=en:stillbirth | n2=en:precipitated by fever | rel=r_associated | relid=0 | w=28
- en:stillbirth --
r_associated #0: 28 / 0.301 ->
en:progressive clinical course with onset in childhood
n1=en:stillbirth | n2=en:progressive clinical course with onset in childhood | rel=r_associated | relid=0 | w=28
- en:stillbirth --
r_associated #0: 28 / 0.301 ->
en:short survival (less than 10 years after onset)
n1=en:stillbirth | n2=en:short survival (less than 10 years after onset) | rel=r_associated | relid=0 | w=28
- en:stillbirth --
r_associated #0: 28 / 0.301 ->
en:subset of patients have leigh syndrome (256000)
n1=en:stillbirth | n2=en:subset of patients have leigh syndrome (256000) | rel=r_associated | relid=0 | w=28
- en:stillbirth --
r_associated #0: 28 / 0.301 ->
en:triplet pregnancy with fetal loss and retention of one or more fetus(es), delivered, with or without mention of antepartum condition
n1=en:stillbirth | n2=en:triplet pregnancy with fetal loss and retention of one or more fetus(es), delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=28
- en:stillbirth --
r_associated #0: 28 / 0.301 ->
en:variable features present
n1=en:stillbirth | n2=en:variable features present | rel=r_associated | relid=0 | w=28
- en:stillbirth --
r_associated #0: 27 / 0.29 ->
bébé mort à la naissance
n1=en:stillbirth | n2=bébé mort à la naissance | rel=r_associated | relid=0 | w=27
- en:stillbirth --
r_associated #0: 27 / 0.29 ->
en:osteoporosis
n1=en:stillbirth | n2=en:osteoporosis | rel=r_associated | relid=0 | w=27
- en:stillbirth --
r_associated #0: 27 / 0.29 ->
en:poor response to l-dopa
n1=en:stillbirth | n2=en:poor response to l-dopa | rel=r_associated | relid=0 | w=27
- en:stillbirth --
r_associated #0: 27 / 0.29 ->
en:prevalence of true hypoprothrombinemia is 1 in 2 million
n1=en:stillbirth | n2=en:prevalence of true hypoprothrombinemia is 1 in 2 million | rel=r_associated | relid=0 | w=27
- en:stillbirth --
r_associated #0: 27 / 0.29 ->
en:psychology qualifier
n1=en:stillbirth | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=27
- en:stillbirth --
r_associated #0: 27 / 0.29 ->
en:some patients may lose independent ambulation
n1=en:stillbirth | n2=en:some patients may lose independent ambulation | rel=r_associated | relid=0 | w=27
- en:stillbirth --
r_associated #0: 27 / 0.29 ->
en:some patients may not present until adulthood
n1=en:stillbirth | n2=en:some patients may not present until adulthood | rel=r_associated | relid=0 | w=27
- en:stillbirth --
r_associated #0: 27 / 0.29 ->
en:some patients never gain ambulation or become wheelchair-bound
n1=en:stillbirth | n2=en:some patients never gain ambulation or become wheelchair-bound | rel=r_associated | relid=0 | w=27
- en:stillbirth --
r_associated #0: 27 / 0.29 ->
en:stein-leventhal syndrome
n1=en:stillbirth | n2=en:stein-leventhal syndrome | rel=r_associated | relid=0 | w=27
- en:stillbirth --
r_associated #0: 27 / 0.29 ->
en:sudden infant death syndrome
n1=en:stillbirth | n2=en:sudden infant death syndrome | rel=r_associated | relid=0 | w=27
- en:stillbirth --
r_associated #0: 27 / 0.29 ->
en:twin preg with fetal loss and retention of one fetus,delivered, with or w/o mention of antepart cond
n1=en:stillbirth | n2=en:twin preg with fetal loss and retention of one fetus,delivered, with or w/o mention of antepart cond | rel=r_associated | relid=0 | w=27
- en:stillbirth --
r_associated #0: 27 / 0.29 ->
maladie des ovaires
n1=en:stillbirth | n2=maladie des ovaires | rel=r_associated | relid=0 | w=27
- en:stillbirth --
r_associated #0: 26 / 0.28 ->
accouchement
n1=en:stillbirth | n2=accouchement | rel=r_associated | relid=0 | w=26
- en:stillbirth --
r_associated #0: 26 / 0.28 ->
en:brain death
n1=en:stillbirth | n2=en:brain death | rel=r_associated | relid=0 | w=26
- en:stillbirth --
r_associated #0: 26 / 0.28 ->
en:fetal death from asphyxia and/or anoxia, not clear if noted before or after onset of labor
n1=en:stillbirth | n2=en:fetal death from asphyxia and/or anoxia, not clear if noted before or after onset of labor | rel=r_associated | relid=0 | w=26
- en:stillbirth --
r_associated #0: 26 / 0.28 ->
en:malignant vaginal neoplasm
n1=en:stillbirth | n2=en:malignant vaginal neoplasm | rel=r_associated | relid=0 | w=26
- en:stillbirth --
r_associated #0: 26 / 0.28 ->
en:precipitated by fatigue or alcohol
n1=en:stillbirth | n2=en:precipitated by fatigue or alcohol | rel=r_associated | relid=0 | w=26
- en:stillbirth --
r_associated #0: 26 / 0.28 ->
en:severe ambulatory restriction
n1=en:stillbirth | n2=en:severe ambulatory restriction | rel=r_associated | relid=0 | w=26
- en:stillbirth --
r_associated #0: 26 / 0.28 ->
en:stillbirth rate
n1=en:stillbirth | n2=en:stillbirth rate | rel=r_associated | relid=0 | w=26
- en:stillbirth --
r_associated #0: 26 / 0.28 ->
en:sudden death within first days of life
n1=en:stillbirth | n2=en:sudden death within first days of life | rel=r_associated | relid=0 | w=26
- en:stillbirth --
r_associated #0: 26 / 0.28 ->
en:triplet pregnancy with fetal loss and retention of one or more fetus(es), unspecified as to episode of care or not applicable
n1=en:stillbirth | n2=en:triplet pregnancy with fetal loss and retention of one or more fetus(es), unspecified as to episode of care or not applicable | rel=r_associated | relid=0 | w=26
- en:stillbirth --
r_associated #0: 26 / 0.28 ->
en:two unrelated families have been reported (last curated may 2013)
n1=en:stillbirth | n2=en:two unrelated families have been reported (last curated may 2013) | rel=r_associated | relid=0 | w=26
- en:stillbirth --
r_associated #0: 26 / 0.28 ->
infertilité féminine
n1=en:stillbirth | n2=infertilité féminine | rel=r_associated | relid=0 | w=26
- en:stillbirth --
r_associated #0: 26 / 0.28 ->
mise
n1=en:stillbirth | n2=mise | rel=r_associated | relid=0 | w=26
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
en:accidental death
n1=en:stillbirth | n2=en:accidental death | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
en:endometriosis
n1=en:stillbirth | n2=en:endometriosis | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
en:female infertility
n1=en:stillbirth | n2=en:female infertility | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
en:ovarian disorder
n1=en:stillbirth | n2=en:ovarian disorder | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
en:pediatric terminology
n1=en:stillbirth | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
en:presence of additional features is variable
n1=en:stillbirth | n2=en:presence of additional features is variable | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
en:six patients have been reported (as of october 2011)
n1=en:stillbirth | n2=en:six patients have been reported (as of october 2011) | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
en:some patients have resolution of symptoms in first year of life
n1=en:stillbirth | n2=en:some patients have resolution of symptoms in first year of life | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
en:sudden unexplained death in epilepsy
n1=en:stillbirth | n2=en:sudden unexplained death in epilepsy | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
en:therapeutic abortion procedure
n1=en:stillbirth | n2=en:therapeutic abortion procedure | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
en:twin pregnancy with fetal loss and retention of one fetus, unspecified as to episode of care or not applicable
n1=en:stillbirth | n2=en:twin pregnancy with fetal loss and retention of one fetus, unspecified as to episode of care or not applicable | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
en:variable age of onset (range 4 months to 45 years)
n1=en:stillbirth | n2=en:variable age of onset (range 4 months to 45 years) | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
mise au monde
n1=en:stillbirth | n2=mise au monde | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 25 / 0.269 ->
morts-nés
n1=en:stillbirth | n2=morts-nés | rel=r_associated | relid=0 | w=25
- en:stillbirth --
r_associated #0: 24 / 0.258 ->
en:epidemiologic
n1=en:stillbirth | n2=en:epidemiologic | rel=r_associated | relid=0 | w=24
- en:stillbirth --
r_associated #0: 24 / 0.258 ->
en:sensorineural hearing loss may be presenting feature
n1=en:stillbirth | n2=en:sensorineural hearing loss may be presenting feature | rel=r_associated | relid=0 | w=24
- en:stillbirth --
r_associated #0: 24 / 0.258 ->
en:some patients may present with myopathic features
n1=en:stillbirth | n2=en:some patients may present with myopathic features | rel=r_associated | relid=0 | w=24
- en:stillbirth --
r_associated #0: 24 / 0.258 ->
en:usually symptomatic in adulthood with history of weakness since infancy or childhood
n1=en:stillbirth | n2=en:usually symptomatic in adulthood with history of weakness since infancy or childhood | rel=r_associated | relid=0 | w=24
- en:stillbirth --
r_associated #0: 24 / 0.258 ->
en:variable age at onset, first to second decades
n1=en:stillbirth | n2=en:variable age at onset, first to second decades | rel=r_associated | relid=0 | w=24
- en:stillbirth --
r_associated #0: 24 / 0.258 ->
en:variable age of onset (7-59 years)
n1=en:stillbirth | n2=en:variable age of onset (7-59 years) | rel=r_associated | relid=0 | w=24
- en:stillbirth --
r_associated #0: 24 / 0.258 ->
en:variable phenotype, particularly with regard to cortical malformations
n1=en:stillbirth | n2=en:variable phenotype, particularly with regard to cortical malformations | rel=r_associated | relid=0 | w=24
- en:stillbirth --
r_associated #0: 24 / 0.258 ->
en:virtually all patients with this condition are female
n1=en:stillbirth | n2=en:virtually all patients with this condition are female | rel=r_associated | relid=0 | w=24
- en:stillbirth --
r_associated #0: 24 / 0.258 ->
fausse couche
n1=en:stillbirth | n2=fausse couche | rel=r_associated | relid=0 | w=24
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
en:congenital abnormality
n1=en:stillbirth | n2=en:congenital abnormality | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
en:female reproductive system
n1=en:stillbirth | n2=en:female reproductive system | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
en:necrotic process
n1=en:stillbirth | n2=en:necrotic process | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
en:phenotypic variation (may affect language expression, reception, and/or articulation)
n1=en:stillbirth | n2=en:phenotypic variation (may affect language expression, reception, and/or articulation) | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
en:possible x-linked dominant inheritance
n1=en:stillbirth | n2=en:possible x-linked dominant inheritance | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
en:precipitated by general anesthesia
n1=en:stillbirth | n2=en:precipitated by general anesthesia | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
en:prelingual onset
n1=en:stillbirth | n2=en:prelingual onset | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
en:slight male predominance (3:2)
n1=en:stillbirth | n2=en:slight male predominance (3:2) | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
en:subtype 3a comprises myoclonus and dementia
n1=en:stillbirth | n2=en:subtype 3a comprises myoclonus and dementia | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
en:two unrelated consanguineous families (saudi arabian and israeli palestinian) have been reported (last curated february 2014)
n1=en:stillbirth | n2=en:two unrelated consanguineous families (saudi arabian and israeli palestinian) have been reported (last curated february 2014) | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
mortalité périnatale (taux de)
n1=en:stillbirth | n2=mortalité périnatale (taux de) | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
rapport entre mort-nés et naissance
n1=en:stillbirth | n2=rapport entre mort-nés et naissance | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 23 / 0.247 ->
stérilité féminine
n1=en:stillbirth | n2=stérilité féminine | rel=r_associated | relid=0 | w=23
- en:stillbirth --
r_associated #0: 22 / 0.237 ->
avortement thérapeutique
n1=en:stillbirth | n2=avortement thérapeutique | rel=r_associated | relid=0 | w=22
- en:stillbirth --
r_associated #0: 22 / 0.237 ->
en:anatomic structures
n1=en:stillbirth | n2=en:anatomic structures | rel=r_associated | relid=0 | w=22
- en:stillbirth --
r_associated #0: 22 / 0.237 ->
en:decapitation
n1=en:stillbirth | n2=en:decapitation | rel=r_associated | relid=0 | w=22
- en:stillbirth --
r_associated #0: 22 / 0.237 ->
en:pelvic pain
n1=en:stillbirth | n2=en:pelvic pain | rel=r_associated | relid=0 | w=22
- en:stillbirth --
r_associated #0: 22 / 0.237 ->
en:some patients show improvement during summer or with fever
n1=en:stillbirth | n2=en:some patients show improvement during summer or with fever | rel=r_associated | relid=0 | w=22
- en:stillbirth --
r_associated #0: 21 / 0.226 ->
en:cephalohematoma
n1=en:stillbirth | n2=en:cephalohematoma | rel=r_associated | relid=0 | w=21
- en:stillbirth --
r_associated #0: 21 / 0.226 ->
en:hearing loss affects all frequencies
n1=en:stillbirth | n2=en:hearing loss affects all frequencies | rel=r_associated | relid=0 | w=21
- en:stillbirth --
r_associated #0: 21 / 0.226 ->
en:lethal tight skin contracture syndrome (disorder)
n1=en:stillbirth | n2=en:lethal tight skin contracture syndrome (disorder) | rel=r_associated | relid=0 | w=21
- en:stillbirth --
r_associated #0: 21 / 0.226 ->
en:multiple prenatal fractures
n1=en:stillbirth | n2=en:multiple prenatal fractures | rel=r_associated | relid=0 | w=21
- en:stillbirth --
r_associated #0: 21 / 0.226 ->
en:sign or symptom
n1=en:stillbirth | n2=en:sign or symptom | rel=r_associated | relid=0 | w=21
- en:stillbirth --
r_associated #0: 21 / 0.226 ->
en:symptoms precipitated by alcohol, caffeine, fatigue, stress, exertion, ovulation, menstruation
n1=en:stillbirth | n2=en:symptoms precipitated by alcohol, caffeine, fatigue, stress, exertion, ovulation, menstruation | rel=r_associated | relid=0 | w=21
- en:stillbirth --
r_associated #0: 21 / 0.226 ->
en:symptoms precipitated by stress, exertion, fatigue, alcohol
n1=en:stillbirth | n2=en:symptoms precipitated by stress, exertion, fatigue, alcohol | rel=r_associated | relid=0 | w=21
- en:stillbirth --
r_associated #0: 21 / 0.226 ->
infertilité de la femme
n1=en:stillbirth | n2=infertilité de la femme | rel=r_associated | relid=0 | w=21
- en:stillbirth --
r_associated #0: 21 / 0.226 ->
maladies des ovaires
n1=en:stillbirth | n2=maladies des ovaires | rel=r_associated | relid=0 | w=21
- en:stillbirth --
r_associated #0: 21 / 0.226 ->
monde
n1=en:stillbirth | n2=monde | rel=r_associated | relid=0 | w=21
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
à la mort
n1=en:stillbirth | n2=à la mort | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
à la vie
n1=en:stillbirth | n2=à la vie | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
à la vie à la mort
n1=en:stillbirth | n2=à la vie à la mort | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
à vie
n1=en:stillbirth | n2=à vie | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
accouchement normal
n1=en:stillbirth | n2=accouchement normal | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
accouchement par voie vaginale
n1=en:stillbirth | n2=accouchement par voie vaginale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
accouchement par voies naturelles
n1=en:stillbirth | n2=accouchement par voies naturelles | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
algie articulaire
n1=en:stillbirth | n2=algie articulaire | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
anomalie du développement
n1=en:stillbirth | n2=anomalie du développement | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
arthralgie
n1=en:stillbirth | n2=arthralgie | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
asphyxia
n1=en:stillbirth | n2=asphyxia | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
asphyxie
n1=en:stillbirth | n2=asphyxie | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
atonie de l'utérus
n1=en:stillbirth | n2=atonie de l'utérus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
autopsie
n1=en:stillbirth | n2=autopsie | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
avortement accidentel
n1=en:stillbirth | n2=avortement accidentel | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
avortement spontané
n1=en:stillbirth | n2=avortement spontané | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
blennorragie
n1=en:stillbirth | n2=blennorragie | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
cancer de l'utérus
n1=en:stillbirth | n2=cancer de l'utérus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
cancer de la vulve
n1=en:stillbirth | n2=cancer de la vulve | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
Cancer de la vulve
n1=en:stillbirth | n2=Cancer de la vulve | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
cancer du col de l'utérus
n1=en:stillbirth | n2=cancer du col de l'utérus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
cancer du col utérin
n1=en:stillbirth | n2=cancer du col utérin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
Cancer du col utérin
n1=en:stillbirth | n2=Cancer du col utérin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
Cancer utérin
n1=en:stillbirth | n2=Cancer utérin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
cancer utérin
n1=en:stillbirth | n2=cancer utérin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
cancer vulvaire
n1=en:stillbirth | n2=cancer vulvaire | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
carcinome utérin
n1=en:stillbirth | n2=carcinome utérin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
cas de décès
n1=en:stillbirth | n2=cas de décès | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
circulaire du cordon
n1=en:stillbirth | n2=circulaire du cordon | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
death
n1=en:stillbirth | n2=death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
décès accidentel
n1=en:stillbirth | n2=décès accidentel | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
décès soudain inexpliqué dans l'épilepsie
n1=en:stillbirth | n2=décès soudain inexpliqué dans l'épilepsie | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
déficience congénitale
n1=en:stillbirth | n2=déficience congénitale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
déformation congénitale
n1=en:stillbirth | n2=déformation congénitale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
dépistage des lésions du col de l'utérus
n1=en:stillbirth | n2=dépistage des lésions du col de l'utérus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
détresse foetale
n1=en:stillbirth | n2=détresse foetale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
difformité congénitale
n1=en:stillbirth | n2=difformité congénitale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
douleur articulaire
n1=en:stillbirth | n2=douleur articulaire | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
douleur dans une articulation
n1=en:stillbirth | n2=douleur dans une articulation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:(3) adult nonnephropathic (219750)
n1=en:stillbirth | n2=en:(3) adult nonnephropathic (219750) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:20% die before age one (usually secondary to renal or laryngeal defects)
n1=en:stillbirth | n2=en:20% die before age one (usually secondary to renal or laryngeal defects) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:50% of cases represent new mutations associated with advanced paternal age
n1=en:stillbirth | n2=en:50% of cases represent new mutations associated with advanced paternal age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:a milder form has also been reported
n1=en:stillbirth | n2=en:a milder form has also been reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:abnormal sensitivity to therapeutic radiation
n1=en:stillbirth | n2=en:abnormal sensitivity to therapeutic radiation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:about 20% of female mutation carriers may show mild muscle weakness
n1=en:stillbirth | n2=en:about 20% of female mutation carriers may show mild muscle weakness | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:absence seizures show onset between 3.5 and 4 years
n1=en:stillbirth | n2=en:absence seizures show onset between 3.5 and 4 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:acyesis
n1=en:stillbirth | n2=en:acyesis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:adrenal insufficiency usually develops later (first decade)
n1=en:stillbirth | n2=en:adrenal insufficiency usually develops later (first decade) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:adult onset
n1=en:stillbirth | n2=en:adult onset | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:adult onset (20 to 50 years)
n1=en:stillbirth | n2=en:adult onset (20 to 50 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:adult onset (wide range of age)
n1=en:stillbirth | n2=en:adult onset (wide range of age) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:adult onset from second to seventh decade
n1=en:stillbirth | n2=en:adult onset from second to seventh decade | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:adult onset has been reported
n1=en:stillbirth | n2=en:adult onset has been reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:adult onset of neurologic symptoms has been reported in 1 family
n1=en:stillbirth | n2=en:adult onset of neurologic symptoms has been reported in 1 family | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:affected individuals are born with normal-appearing skin and develop scaling a few days after birth
n1=en:stillbirth | n2=en:affected individuals are born with normal-appearing skin and develop scaling a few days after birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:affected individuals have a relatively mild ichthyosis phenotype
n1=en:stillbirth | n2=en:affected individuals have a relatively mild ichthyosis phenotype | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:affected individuals may have more than 1 cardiac structural defect, or none at all
n1=en:stillbirth | n2=en:affected individuals may have more than 1 cardiac structural defect, or none at all | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:age at diagnosis 24 +/- 18 years for dominant disease
n1=en:stillbirth | n2=en:age at diagnosis 24 +/- 18 years for dominant disease | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:age at onset 14 to 44 years
n1=en:stillbirth | n2=en:age at onset 14 to 44 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:age at onset 8 to 55 years (mean 40 years)
n1=en:stillbirth | n2=en:age at onset 8 to 55 years (mean 40 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:age at onset from 3 to 51 years (mean 19.2 years)
n1=en:stillbirth | n2=en:age at onset from 3 to 51 years (mean 19.2 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:age of onset between 5 and 10 years of age
n1=en:stillbirth | n2=en:age of onset between 5 and 10 years of age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:age of onset of distal lower limb weakness 8-16 years
n1=en:stillbirth | n2=en:age of onset of distal lower limb weakness 8-16 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:age of onset ranges from 1 to 47 years
n1=en:stillbirth | n2=en:age of onset ranges from 1 to 47 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:age of onset usually 1 week to 2 years
n1=en:stillbirth | n2=en:age of onset usually 1 week to 2 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:age of onset varies ranging from 3 weeks to 22 years
n1=en:stillbirth | n2=en:age of onset varies ranging from 3 weeks to 22 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:age of onset/diagnosis 12-35 years
n1=en:stillbirth | n2=en:age of onset/diagnosis 12-35 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:agonal death struggle
n1=en:stillbirth | n2=en:agonal death struggle | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:all cases sporadic (18 males, 7 females)
n1=en:stillbirth | n2=en:all cases sporadic (18 males, 7 females) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:all features are unilateral
n1=en:stillbirth | n2=en:all features are unilateral | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:all reported mutations have occurred de novo
n1=en:stillbirth | n2=en:all reported mutations have occurred de novo | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:allelic disorder to benign hereditary chorea (118700), which is less severe
n1=en:stillbirth | n2=en:allelic disorder to benign hereditary chorea (118700), which is less severe | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:allelic disorder to choreoathetosis, congenital hypothyroidism, and neonatal respiratory distress (610978), which is a more severe disorder
n1=en:stillbirth | n2=en:allelic disorder to choreoathetosis, congenital hypothyroidism, and neonatal respiratory distress (610978), which is a more severe disorder | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:allelic disorder to early-onset sarcoidosis (609464)
n1=en:stillbirth | n2=en:allelic disorder to early-onset sarcoidosis (609464) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:allelic disorder to potassium-aggravated myotonia (608390)
n1=en:stillbirth | n2=en:allelic disorder to potassium-aggravated myotonia (608390) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:allelic to diastrophic dysplasia (222600), achondrogenesis, type 1b (600972), and multiple epiphyseal dysplasia, type 4 (226900)
n1=en:stillbirth | n2=en:allelic to diastrophic dysplasia (222600), achondrogenesis, type 1b (600972), and multiple epiphyseal dysplasia, type 4 (226900) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:allelic to hydropic and prenatally lethal chondrodystrophy (215140)
n1=en:stillbirth | n2=en:allelic to hydropic and prenatally lethal chondrodystrophy (215140) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:allelic to hypoparathyroidism-retardation-dysmorphism syndrome (241410)
n1=en:stillbirth | n2=en:allelic to hypoparathyroidism-retardation-dysmorphism syndrome (241410) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:allelic to metaphyseal dysplasia without hypotrichosis (250460)
n1=en:stillbirth | n2=en:allelic to metaphyseal dysplasia without hypotrichosis (250460) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:anemia is responsive to corticosteroid treatment
n1=en:stillbirth | n2=en:anemia is responsive to corticosteroid treatment | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:aortic dissection may occur in second decade of life
n1=en:stillbirth | n2=en:aortic dissection may occur in second decade of life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:approximately 40% of cases are inherited or new germline mutations
n1=en:stillbirth | n2=en:approximately 40% of cases are inherited or new germline mutations | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:approximately 50% of patients have situs inversus
n1=en:stillbirth | n2=en:approximately 50% of patients have situs inversus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:approximately 70-80% of cases are de novo and sporadic
n1=en:stillbirth | n2=en:approximately 70-80% of cases are de novo and sporadic | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:approximately half of the mutations are de novo
n1=en:stillbirth | n2=en:approximately half of the mutations are de novo | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:approximately one-third of patients eventually lose outer hair cell function and have profound sensorineural deafness (after 10 to 20 years)
n1=en:stillbirth | n2=en:approximately one-third of patients eventually lose outer hair cell function and have profound sensorineural deafness (after 10 to 20 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:asphyxia
n1=en:stillbirth | n2=en:asphyxia | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:associated with advanced paternal age
n1=en:stillbirth | n2=en:associated with advanced paternal age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:associated with hemodialysis
n1=en:stillbirth | n2=en:associated with hemodialysis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:associated with increased frequency of autoimmune diseases
n1=en:stillbirth | n2=en:associated with increased frequency of autoimmune diseases | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:associated with iron deficiency anemia
n1=en:stillbirth | n2=en:associated with iron deficiency anemia | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:associated with smoking
n1=en:stillbirth | n2=en:associated with smoking | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:asymptomatic patients may show changes on sd-oct
n1=en:stillbirth | n2=en:asymptomatic patients may show changes on sd-oct | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:ataxia is nonprogressive
n1=en:stillbirth | n2=en:ataxia is nonprogressive | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:attacks more common in women
n1=en:stillbirth | n2=en:attacks more common in women | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise
n1=en:stillbirth | n2=en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:autoimmune features are variable
n1=en:stillbirth | n2=en:autoimmune features are variable | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:autopsy
n1=en:stillbirth | n2=en:autopsy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:autosomal recessive disorder tends to be more severe
n1=en:stillbirth | n2=en:autosomal recessive disorder tends to be more severe | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:autosomal recessive form (277720) has also been described
n1=en:stillbirth | n2=en:autosomal recessive form (277720) has also been described | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:autosomal recessive inheritance with earlier onset has been reported in 3 patients
n1=en:stillbirth | n2=en:autosomal recessive inheritance with earlier onset has been reported in 3 patients | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:average age at diagnosis 17.8 years (range 2-35 years)
n1=en:stillbirth | n2=en:average age at diagnosis 17.8 years (range 2-35 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:average age at onset between 40 and 50 years
n1=en:stillbirth | n2=en:average age at onset between 40 and 50 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:average disease duration of 7 years
n1=en:stillbirth | n2=en:average disease duration of 7 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:average onset 6-10 months (range 3-24)
n1=en:stillbirth | n2=en:average onset 6-10 months (range 3-24) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:average onset of seizures 6 months (range 3-12)
n1=en:stillbirth | n2=en:average onset of seizures 6 months (range 3-12) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:based on a report of 4 patients from 2 consanguineous families (last curated august 2015)
n1=en:stillbirth | n2=en:based on a report of 4 patients from 2 consanguineous families (last curated august 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:based on one jordanian family (last curated august 2015)
n1=en:stillbirth | n2=en:based on one jordanian family (last curated august 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:based on one large dutch family (last curated august 2015)
n1=en:stillbirth | n2=en:based on one large dutch family (last curated august 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:based on one sib pair each in their seventies
n1=en:stillbirth | n2=en:based on one sib pair each in their seventies | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:based on report of 2 individuals (last curated november 2013)
n1=en:stillbirth | n2=en:based on report of 2 individuals (last curated november 2013) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:based on report of 2 sibs in 2008
n1=en:stillbirth | n2=en:based on report of 2 sibs in 2008 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:based on report of 4 patients from 1 family (last curated july 2015)
n1=en:stillbirth | n2=en:based on report of 4 patients from 1 family (last curated july 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:birth canal
n1=en:stillbirth | n2=en:birth canal | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:birth defect
n1=en:stillbirth | n2=en:birth defect | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:bleeding is usually delayed-onset after challenge
n1=en:stillbirth | n2=en:bleeding is usually delayed-onset after challenge | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:blistering may worsen during the summer
n1=en:stillbirth | n2=en:blistering may worsen during the summer | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:blisters are precipitated by minor skin trauma
n1=en:stillbirth | n2=en:blisters are precipitated by minor skin trauma | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:born after precipitate delivery
n1=en:stillbirth | n2=en:born after precipitate delivery | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:both autosomal dominant and autosomal recessive inheritance has been described
n1=en:stillbirth | n2=en:both autosomal dominant and autosomal recessive inheritance has been described | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:both mutations occurred de novo
n1=en:stillbirth | n2=en:both mutations occurred de novo | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:boys are more often affected than girls (3:2)
n1=en:stillbirth | n2=en:boys are more often affected than girls (3:2) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:breast disorder
n1=en:stillbirth | n2=en:breast disorder | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:breech extraction - delivered
n1=en:stillbirth | n2=en:breech extraction - delivered | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:breech presentation
n1=en:stillbirth | n2=en:breech presentation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:brittle-bone disease
n1=en:stillbirth | n2=en:brittle-bone disease | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:brow delivery
n1=en:stillbirth | n2=en:brow delivery | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:can also be caused by contiguous gene deletion on chromosome 22q11.2
n1=en:stillbirth | n2=en:can also be caused by contiguous gene deletion on chromosome 22q11.2 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:cardiac death
n1=en:stillbirth | n2=en:cardiac death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:cardiac examination is usually unremarkable
n1=en:stillbirth | n2=en:cardiac examination is usually unremarkable | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:cardiomyopathy is not a feature
n1=en:stillbirth | n2=en:cardiomyopathy is not a feature | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:carneous mole
n1=en:stillbirth | n2=en:carneous mole | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:carrier females may have mild intellectual disability
n1=en:stillbirth | n2=en:carrier females may have mild intellectual disability | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:carrier females show no phenotypic abnormalities, but may have learning difficulties
n1=en:stillbirth | n2=en:carrier females show no phenotypic abnormalities, but may have learning difficulties | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:caused by inheritance of the mutation on the paternal allele (imprinting)
n1=en:stillbirth | n2=en:caused by inheritance of the mutation on the paternal allele (imprinting) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:caused by somatic mutations
n1=en:stillbirth | n2=en:caused by somatic mutations | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:cerebral death
n1=en:stillbirth | n2=en:cerebral death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:cervical cancer
n1=en:stillbirth | n2=en:cervical cancer | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:cervical cancer screening
n1=en:stillbirth | n2=en:cervical cancer screening | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:chelation therapy can result in clinical improvement
n1=en:stillbirth | n2=en:chelation therapy can result in clinical improvement | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:chemical intrauterine disorder
n1=en:stillbirth | n2=en:chemical intrauterine disorder | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:child death
n1=en:stillbirth | n2=en:child death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:child often can sit unsupported but never ambulates
n1=en:stillbirth | n2=en:child often can sit unsupported but never ambulates | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:child's sudden death
n1=en:stillbirth | n2=en:child's sudden death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:childhood onset
n1=en:stillbirth | n2=en:childhood onset | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:childhood or adolescent onset (usually less than 25 years)
n1=en:stillbirth | n2=en:childhood or adolescent onset (usually less than 25 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:chronic course with exacerbations and remissions
n1=en:stillbirth | n2=en:chronic course with exacerbations and remissions | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:classic severe form shows onset at 2 to 3 months of age
n1=en:stillbirth | n2=en:classic severe form shows onset at 2 to 3 months of age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:clinical and biochemical abnormalities disappear with age
n1=en:stillbirth | n2=en:clinical and biochemical abnormalities disappear with age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:clinical presentation varies from asymptomatic to fulminant course
n1=en:stillbirth | n2=en:clinical presentation varies from asymptomatic to fulminant course | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:clinical spectrum in males ranges from lethal neonatal onset to milder forms with first recognized episode in late childhood or even in adulthood
n1=en:stillbirth | n2=en:clinical spectrum in males ranges from lethal neonatal onset to milder forms with first recognized episode in late childhood or even in adulthood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:clinical variability, both pure and complicated forms
n1=en:stillbirth | n2=en:clinical variability, both pure and complicated forms | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:clinically 'silent' nystagmus evident on eye movement recording in carrier females
n1=en:stillbirth | n2=en:clinically 'silent' nystagmus evident on eye movement recording in carrier females | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:clinically resembles essential tremor, but not responsive to beta-adrenergic blockers
n1=en:stillbirth | n2=en:clinically resembles essential tremor, but not responsive to beta-adrenergic blockers | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:clonidine can alleviate hyperhidrosis
n1=en:stillbirth | n2=en:clonidine can alleviate hyperhidrosis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:cold-induced sweating develops late in the first decade
n1=en:stillbirth | n2=en:cold-induced sweating develops late in the first decade | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:coloboma is associated with larger microdeletion (490kb) of 11q13
n1=en:stillbirth | n2=en:coloboma is associated with larger microdeletion (490kb) of 11q13 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:color vision defects may not be part of the phenotype
n1=en:stillbirth | n2=en:color vision defects may not be part of the phenotype | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:compound heterozygosity common
n1=en:stillbirth | n2=en:compound heterozygosity common | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:condition is experienced by patients as harmless and is often discovered incidentally
n1=en:stillbirth | n2=en:condition is experienced by patients as harmless and is often discovered incidentally | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:condyloma acuminatum
n1=en:stillbirth | n2=en:condyloma acuminatum | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:cone-shaped epiphyses appear in early childhood and disappear with premature fusion of growth plate before puberty
n1=en:stillbirth | n2=en:cone-shaped epiphyses appear in early childhood and disappear with premature fusion of growth plate before puberty | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:congenital anomaly
n1=en:stillbirth | n2=en:congenital anomaly | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:congenital defect
n1=en:stillbirth | n2=en:congenital defect | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:congenital malformation
n1=en:stillbirth | n2=en:congenital malformation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:congenital onset
n1=en:stillbirth | n2=en:congenital onset | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:contractures other than plantar are less common and less severe
n1=en:stillbirth | n2=en:contractures other than plantar are less common and less severe | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:cot death
n1=en:stillbirth | n2=en:cot death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:crib death
n1=en:stillbirth | n2=en:crib death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:cutaneous symptoms induced by cold exposure or cooling
n1=en:stillbirth | n2=en:cutaneous symptoms induced by cold exposure or cooling | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:dead - sudden death
n1=en:stillbirth | n2=en:dead - sudden death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:dead fetus
n1=en:stillbirth | n2=en:dead fetus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:deafness tends to occur before other neurologic signs, except in patients with very early onset
n1=en:stillbirth | n2=en:deafness tends to occur before other neurologic signs, except in patients with very early onset | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death
n1=en:stillbirth | n2=en:death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death and sudden death
n1=en:stillbirth | n2=en:death and sudden death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death before age 40
n1=en:stillbirth | n2=en:death before age 40 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death by natural cause
n1=en:stillbirth | n2=en:death by natural cause | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death due to rapidly progressive pulmonary fibrosis in infancy
n1=en:stillbirth | n2=en:death due to rapidly progressive pulmonary fibrosis in infancy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death due to respiratory insufficiency within minutes to hours after birth
n1=en:stillbirth | n2=en:death due to respiratory insufficiency within minutes to hours after birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death from pneumonia
n1=en:stillbirth | n2=en:death from pneumonia | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death in adolescence
n1=en:stillbirth | n2=en:death in adolescence | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death in childhood may occur due to end-stage renal disease
n1=en:stillbirth | n2=en:death in childhood may occur due to end-stage renal disease | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death in early adulthood
n1=en:stillbirth | n2=en:death in early adulthood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death in early childhood may occur
n1=en:stillbirth | n2=en:death in early childhood may occur | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death in fourth to fifth decade
n1=en:stillbirth | n2=en:death in fourth to fifth decade | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death in infancy in 2 patients
n1=en:stillbirth | n2=en:death in infancy in 2 patients | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death in infancy secondary to respiratory insufficiency/pneumonia
n1=en:stillbirth | n2=en:death in infancy secondary to respiratory insufficiency/pneumonia | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death in majority of infants soon after birth
n1=en:stillbirth | n2=en:death in majority of infants soon after birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death in perinatal period
n1=en:stillbirth | n2=en:death in perinatal period | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death in the first years of life
n1=en:stillbirth | n2=en:death in the first years of life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death in third or fourth decades, usually due to respiratory infection
n1=en:stillbirth | n2=en:death in third or fourth decades, usually due to respiratory infection | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death in utero or in early infancy is common
n1=en:stillbirth | n2=en:death in utero or in early infancy is common | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death may occur in infancy
n1=en:stillbirth | n2=en:death may occur in infancy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death of unknown cause
n1=en:stillbirth | n2=en:death of unknown cause | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death often in the teenage years
n1=en:stillbirth | n2=en:death often in the teenage years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death often occurs in childhood
n1=en:stillbirth | n2=en:death often occurs in childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death secondary to renal failure, cardiac or cerebrovascular disease
n1=en:stillbirth | n2=en:death secondary to renal failure, cardiac or cerebrovascular disease | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death secondary to respiratory infection or failure before age 2 years
n1=en:stillbirth | n2=en:death secondary to respiratory infection or failure before age 2 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death usually in childhood
n1=en:stillbirth | n2=en:death usually in childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death usually in first year of life
n1=en:stillbirth | n2=en:death usually in first year of life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death usually in infancy due to respiratory failure
n1=en:stillbirth | n2=en:death usually in infancy due to respiratory failure | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:death usually in newborn period or infancy
n1=en:stillbirth | n2=en:death usually in newborn period or infancy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:delivery of shoulder presentation function
n1=en:stillbirth | n2=en:delivery of shoulder presentation function | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:dentists, women
n1=en:stillbirth | n2=en:dentists, women | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:deposits may recur in graft after corneal transplantation
n1=en:stillbirth | n2=en:deposits may recur in graft after corneal transplantation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:developmental fault
n1=en:stillbirth | n2=en:developmental fault | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:diagnosis made when at least 2/3 features present (optic nerve hypoplasia, hypopituitarism with pituitary hypoplasia, midline forebrain defects)
n1=en:stillbirth | n2=en:diagnosis made when at least 2/3 features present (optic nerve hypoplasia, hypopituitarism with pituitary hypoplasia, midline forebrain defects) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:diagnosis requires 3 major features (a positive family history is also considered a major feature) and at least 3 minor features
n1=en:stillbirth | n2=en:diagnosis requires 3 major features (a positive family history is also considered a major feature) and at least 3 minor features | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:diagnosis within the first 3 months of life
n1=en:stillbirth | n2=en:diagnosis within the first 3 months of life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:diarrhea worsens in parallel with increases in severity of skin disease
n1=en:stillbirth | n2=en:diarrhea worsens in parallel with increases in severity of skin disease | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:discordant phenotype among monozygotic twins has been reported
n1=en:stillbirth | n2=en:discordant phenotype among monozygotic twins has been reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:disease shows slow progression
n1=en:stillbirth | n2=en:disease shows slow progression | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:disorder of muscle tone of newborn, unspecified
n1=en:stillbirth | n2=en:disorder of muscle tone of newborn, unspecified | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:distinct from pseudopili annulati (613241)
n1=en:stillbirth | n2=en:distinct from pseudopili annulati (613241) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:diurnal fluctuation
n1=en:stillbirth | n2=en:diurnal fluctuation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:diurnal fluctuation of neurologic symptoms
n1=en:stillbirth | n2=en:diurnal fluctuation of neurologic symptoms | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:divided into isolated cases (75-80%), familial (10-15%), and syndromal (1-5%)
n1=en:stillbirth | n2=en:divided into isolated cases (75-80%), familial (10-15%), and syndromal (1-5%) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:dramatic improvement with proper treatment
n1=en:stillbirth | n2=en:dramatic improvement with proper treatment | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:drowning
n1=en:stillbirth | n2=en:drowning | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:drug-induced dyskinesias occur in a subset of patients
n1=en:stillbirth | n2=en:drug-induced dyskinesias occur in a subset of patients | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:dwarfism not detectable at birth
n1=en:stillbirth | n2=en:dwarfism not detectable at birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:dysmorphic facial features reported in 1 family
n1=en:stillbirth | n2=en:dysmorphic facial features reported in 1 family | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:earlier onset is associated with a more severe disorder
n1=en:stillbirth | n2=en:earlier onset is associated with a more severe disorder | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:earlier onset is associated with more rapid progression
n1=en:stillbirth | n2=en:earlier onset is associated with more rapid progression | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:early adult onset has been reported
n1=en:stillbirth | n2=en:early adult onset has been reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:early death (in some patients)
n1=en:stillbirth | n2=en:early death (in some patients) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:early death (usually by 3 years of age)
n1=en:stillbirth | n2=en:early death (usually by 3 years of age) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:early death due to sepsis
n1=en:stillbirth | n2=en:early death due to sepsis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:early death in males
n1=en:stillbirth | n2=en:early death in males | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:early death may occur
n1=en:stillbirth | n2=en:early death may occur | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:early death occurs in affected infants (days to months after disease onset)
n1=en:stillbirth | n2=en:early death occurs in affected infants (days to months after disease onset) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:early death often occurs from cardiac failure or infection
n1=en:stillbirth | n2=en:early death often occurs from cardiac failure or infection | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:early onset (9-48 years, but reported up to 68 years)
n1=en:stillbirth | n2=en:early onset (9-48 years, but reported up to 68 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:electromyography may be normal in infancy, but shows myopathic pattern in adolescence and adulthood
n1=en:stillbirth | n2=en:electromyography may be normal in infancy, but shows myopathic pattern in adolescence and adulthood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:elevated body temperatures to 42 degrees celsius
n1=en:stillbirth | n2=en:elevated body temperatures to 42 degrees celsius | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:embryo loss
n1=en:stillbirth | n2=en:embryo loss | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:end-stage renal failure may occur
n1=en:stillbirth | n2=en:end-stage renal failure may occur | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:episode frequency is monthly to yearly, and decreases with age
n1=en:stillbirth | n2=en:episode frequency is monthly to yearly, and decreases with age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:episodes are triggered by cold exposure
n1=en:stillbirth | n2=en:episodes are triggered by cold exposure | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:episodes brought on by fasting or infection
n1=en:stillbirth | n2=en:episodes brought on by fasting or infection | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:episodes last from several hours to days
n1=en:stillbirth | n2=en:episodes last from several hours to days | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:episodes may be triggered by exercise, emotional stress, head trauma, angiography, lack of sleep, heat
n1=en:stillbirth | n2=en:episodes may be triggered by exercise, emotional stress, head trauma, angiography, lack of sleep, heat | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:episodes occur 30 minutes to 3 hours after exposure to cold
n1=en:stillbirth | n2=en:episodes occur 30 minutes to 3 hours after exposure to cold | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:episodes tend to decrease with age
n1=en:stillbirth | n2=en:episodes tend to decrease with age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:estimated frequence 1/3000 to 1/5000
n1=en:stillbirth | n2=en:estimated frequence 1/3000 to 1/5000 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:estimated frequency 1/2000-1/4000 individuals
n1=en:stillbirth | n2=en:estimated frequency 1/2000-1/4000 individuals | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:estimated incidence of 1-2 in 10,000
n1=en:stillbirth | n2=en:estimated incidence of 1-2 in 10,000 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:evidence of systemic iron overload seen in 1 family
n1=en:stillbirth | n2=en:evidence of systemic iron overload seen in 1 family | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:exacerbated by stress
n1=en:stillbirth | n2=en:exacerbated by stress | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:excessive postsurgical blood loss
n1=en:stillbirth | n2=en:excessive postsurgical blood loss | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:excessive skin picking of sores
n1=en:stillbirth | n2=en:excessive skin picking of sores | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:extrapyramidal signs show a favorable response to levodopa
n1=en:stillbirth | n2=en:extrapyramidal signs show a favorable response to levodopa | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:eye involvement begins at birth, neurologic involvement begins later
n1=en:stillbirth | n2=en:eye involvement begins at birth, neurologic involvement begins later | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:face to pubes birth
n1=en:stillbirth | n2=en:face to pubes birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:facial dysmorphic features are mild
n1=en:stillbirth | n2=en:facial dysmorphic features are mild | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:facial palsy often transient in infancy
n1=en:stillbirth | n2=en:facial palsy often transient in infancy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:Fallopian tube
n1=en:stillbirth | n2=en:Fallopian tube | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fallopian tube
n1=en:stillbirth | n2=en:fallopian tube | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:familial occurrence is rare
n1=en:stillbirth | n2=en:familial occurrence is rare | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:family a had a severe multisystem disorder resulting in death before age 2 years
n1=en:stillbirth | n2=en:family a had a severe multisystem disorder resulting in death before age 2 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fatal before age 2 years
n1=en:stillbirth | n2=en:fatal before age 2 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fatal in first few months of life in most cases
n1=en:stillbirth | n2=en:fatal in first few months of life in most cases | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fatal without lung transplant
n1=en:stillbirth | n2=en:fatal without lung transplant | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:favorable response to 3,4-diaminopyridine
n1=en:stillbirth | n2=en:favorable response to 3,4-diaminopyridine | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:favorable response to ephedrine treatment
n1=en:stillbirth | n2=en:favorable response to ephedrine treatment | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:favorable response to ursodeoxycholic acid treatment
n1=en:stillbirth | n2=en:favorable response to ursodeoxycholic acid treatment | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:features are variable
n1=en:stillbirth | n2=en:features are variable | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:feeding problems in newborn
n1=en:stillbirth | n2=en:feeding problems in newborn | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:feet are unaffected in some patients
n1=en:stillbirth | n2=en:feet are unaffected in some patients | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:female carriers may be affected
n1=en:stillbirth | n2=en:female carriers may be affected | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:female carriers may be mildly affected
n1=en:stillbirth | n2=en:female carriers may be mildly affected | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:female carriers may have asymptomatic hypercalciuria or hypophosphatemia only
n1=en:stillbirth | n2=en:female carriers may have asymptomatic hypercalciuria or hypophosphatemia only | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:female carriers may show intermittent hematuria
n1=en:stillbirth | n2=en:female carriers may show intermittent hematuria | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:female internal genitalia structure
n1=en:stillbirth | n2=en:female internal genitalia structure | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:female reproductive system disorder
n1=en:stillbirth | n2=en:female reproductive system disorder | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:female sheath
n1=en:stillbirth | n2=en:female sheath | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:females often show milder phenotype with later onset of cardiac symptoms
n1=en:stillbirth | n2=en:females often show milder phenotype with later onset of cardiac symptoms | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fetal distress
n1=en:stillbirth | n2=en:fetal distress | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fetal health and development
n1=en:stillbirth | n2=en:fetal health and development | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fetal resorption
n1=en:stillbirth | n2=en:fetal resorption | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:few familial (parent offspring) cases reported
n1=en:stillbirth | n2=en:few familial (parent offspring) cases reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fibroma of the uterus
n1=en:stillbirth | n2=en:fibroma of the uterus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fibromyoma uteri
n1=en:stillbirth | n2=en:fibromyoma uteri | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:first fracture in early childhood
n1=en:stillbirth | n2=en:first fracture in early childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fishy body odor
n1=en:stillbirth | n2=en:fishy body odor | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:foetal distress
n1=en:stillbirth | n2=en:foetal distress | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:foot deformities are present in infancy or childhood
n1=en:stillbirth | n2=en:foot deformities are present in infancy or childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:for life
n1=en:stillbirth | n2=en:for life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:forceps delivery finding
n1=en:stillbirth | n2=en:forceps delivery finding | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:found dead
n1=en:stillbirth | n2=en:found dead | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:four clinically indistinguishable biochemically distinct forms (see 252900, 252920, 252930)
n1=en:stillbirth | n2=en:four clinically indistinguishable biochemically distinct forms (see 252900, 252920, 252930) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:four patients from 3 families have been reported (last curated march 2016)
n1=en:stillbirth | n2=en:four patients from 3 families have been reported (last curated march 2016) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:four separate types - (1) severe perinatal ('lethal') form, (2) severe infantile form, (3) childhood form, and (4) adult form
n1=en:stillbirth | n2=en:four separate types - (1) severe perinatal ('lethal') form, (2) severe infantile form, (3) childhood form, and (4) adult form | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:four unrelated families have been reported (last curated august 2015)
n1=en:stillbirth | n2=en:four unrelated families have been reported (last curated august 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:four unrelated families have been reported (last curated september 2015)
n1=en:stillbirth | n2=en:four unrelated families have been reported (last curated september 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:four unrelated patients have been reported (last curated june 2014)
n1=en:stillbirth | n2=en:four unrelated patients have been reported (last curated june 2014) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fracture frequency decreased post puberty
n1=en:stillbirth | n2=en:fracture frequency decreased post puberty | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fractures and dental caries and premature secondary tooth loss occur in adulthood
n1=en:stillbirth | n2=en:fractures and dental caries and premature secondary tooth loss occur in adulthood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fractures can occur in utero, during labor and delivery, or in newborn period
n1=en:stillbirth | n2=en:fractures can occur in utero, during labor and delivery, or in newborn period | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:fractures decrease after puberty but increase after menopause
n1=en:stillbirth | n2=en:fractures decrease after puberty but increase after menopause | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:frequency and severity of symptoms do not worsen with age
n1=en:stillbirth | n2=en:frequency and severity of symptoms do not worsen with age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:frequency of infections decreases after 3 years of age
n1=en:stillbirth | n2=en:frequency of infections decreases after 3 years of age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:full recovery after attacks
n1=en:stillbirth | n2=en:full recovery after attacks | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:gaia stillbirth level of diagnostic certainty terminology
n1=en:stillbirth | n2=en:gaia stillbirth level of diagnostic certainty terminology | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:gastric suction pump, home model, portable or stationary, electric
n1=en:stillbirth | n2=en:gastric suction pump, home model, portable or stationary, electric | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:genetic heterogeneity (may be caused by mutation in nuclear-encoded or mitochondrial-encoded genes)
n1=en:stillbirth | n2=en:genetic heterogeneity (may be caused by mutation in nuclear-encoded or mitochondrial-encoded genes) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:genetic heterogeneity (see 116800 for summary)
n1=en:stillbirth | n2=en:genetic heterogeneity (see 116800 for summary) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:genetic heterogeneity (see 161800)
n1=en:stillbirth | n2=en:genetic heterogeneity (see 161800) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:genetic heterogeneity (see 605407)
n1=en:stillbirth | n2=en:genetic heterogeneity (see 605407) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:genetic heterogeneity (see 609192)
n1=en:stillbirth | n2=en:genetic heterogeneity (see 609192) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:genetic heterogeneity (see mcc1 deficiency 210200)
n1=en:stillbirth | n2=en:genetic heterogeneity (see mcc1 deficiency 210200) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:genital herpes
n1=en:stillbirth | n2=en:genital herpes | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:glucocorticoid deficiency occurs in mid-childhood
n1=en:stillbirth | n2=en:glucocorticoid deficiency occurs in mid-childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:gonadal and somatic mosaicism reported in parent
n1=en:stillbirth | n2=en:gonadal and somatic mosaicism reported in parent | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:gonococcia
n1=en:stillbirth | n2=en:gonococcia | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:gonococcis
n1=en:stillbirth | n2=en:gonococcis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:gonorrhea
n1=en:stillbirth | n2=en:gonorrhea | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:good response to steroid treatment
n1=en:stillbirth | n2=en:good response to steroid treatment | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:gradual progression
n1=en:stillbirth | n2=en:gradual progression | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:great variation in extent of hypertrophy in mutation-positive individuals
n1=en:stillbirth | n2=en:great variation in extent of hypertrophy in mutation-positive individuals | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hair regrowth may occur later in life
n1=en:stillbirth | n2=en:hair regrowth may occur later in life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hairy elbows become apparent in infancy and regress during adolescence
n1=en:stillbirth | n2=en:hairy elbows become apparent in infancy and regress during adolescence | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hand and foot lesions can severely limit dexterity (due to flexion contractures) and mobility (due to painful fissures)
n1=en:stillbirth | n2=en:hand and foot lesions can severely limit dexterity (due to flexion contractures) and mobility (due to painful fissures) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hands clenched at birth but loosen in infancy
n1=en:stillbirth | n2=en:hands clenched at birth but loosen in infancy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hearing loss is usually severe by age 20 years
n1=en:stillbirth | n2=en:hearing loss is usually severe by age 20 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hearing loss ma be fluctuating or progressive
n1=en:stillbirth | n2=en:hearing loss ma be fluctuating or progressive | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hearing loss may be congenital or rapidly progressive leading to severe hearing loss by age 3 years
n1=en:stillbirth | n2=en:hearing loss may be congenital or rapidly progressive leading to severe hearing loss by age 3 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hearing loss occurs in late childhood
n1=en:stillbirth | n2=en:hearing loss occurs in late childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hearing loss occurs later if at all
n1=en:stillbirth | n2=en:hearing loss occurs later if at all | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hearing loss progresses to profound deafness
n1=en:stillbirth | n2=en:hearing loss progresses to profound deafness | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hematuria may become apparent after respiratory infections (synpharyngitic)
n1=en:stillbirth | n2=en:hematuria may become apparent after respiratory infections (synpharyngitic) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hemorrhagic complication of pregnancy
n1=en:stillbirth | n2=en:hemorrhagic complication of pregnancy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hepatic failure develops in first months of life
n1=en:stillbirth | n2=en:hepatic failure develops in first months of life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hepatomegaly improves with age and disappears around puberty
n1=en:stillbirth | n2=en:hepatomegaly improves with age and disappears around puberty | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:herpes genitalis
n1=en:stillbirth | n2=en:herpes genitalis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:herpes progenitalis
n1=en:stillbirth | n2=en:herpes progenitalis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:herpes simplex infections
n1=en:stillbirth | n2=en:herpes simplex infections | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygote may have elevated serum phosphate and elevated serum 1,25-dihydroxycholecalciferol
n1=en:stillbirth | n2=en:heterozygote may have elevated serum phosphate and elevated serum 1,25-dihydroxycholecalciferol | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygotes are not affected
n1=en:stillbirth | n2=en:heterozygotes are not affected | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygotes at risk of developing acute, symptomatic methemoglobinemia after exposure to exogenous, methemoglobin-inducing agents
n1=en:stillbirth | n2=en:heterozygotes at risk of developing acute, symptomatic methemoglobinemia after exposure to exogenous, methemoglobin-inducing agents | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygotes exhibit blue sclerae and soft velvety skin
n1=en:stillbirth | n2=en:heterozygotes exhibit blue sclerae and soft velvety skin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygotes may also show increased susceptibility to toxic effects of thiopurine treatment
n1=en:stillbirth | n2=en:heterozygotes may also show increased susceptibility to toxic effects of thiopurine treatment | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygotes may exhibit syndromic manifestations
n1=en:stillbirth | n2=en:heterozygotes may exhibit syndromic manifestations | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygous carriers exhibit palmoplantar hyperkeratosis (see 148700)
n1=en:stillbirth | n2=en:heterozygous carriers exhibit palmoplantar hyperkeratosis (see 148700) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygous carriers have blue sclerae, small joint hypermobility, and mild thinning of cornea
n1=en:stillbirth | n2=en:heterozygous carriers have blue sclerae, small joint hypermobility, and mild thinning of cornea | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygous female carriers may manifest symptoms
n1=en:stillbirth | n2=en:heterozygous female carriers may manifest symptoms | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygous females may exhibit variable degrees of enzyme deficiency
n1=en:stillbirth | n2=en:heterozygous females may exhibit variable degrees of enzyme deficiency | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygous females may have situs inversus or other midline defects
n1=en:stillbirth | n2=en:heterozygous females may have situs inversus or other midline defects | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygous females more mildly affected than hemizygous males
n1=en:stillbirth | n2=en:heterozygous females more mildly affected than hemizygous males | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:heterozygous mutation carriers may have late-onset of mild symptoms
n1=en:stillbirth | n2=en:heterozygous mutation carriers may have late-onset of mild symptoms | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:high frequencies affected before low frequencies
n1=en:stillbirth | n2=en:high frequencies affected before low frequencies | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:high frequency hearing loss progresses to include all frequencies
n1=en:stillbirth | n2=en:high frequency hearing loss progresses to include all frequencies | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:high frequency of absence seizures (several per day)
n1=en:stillbirth | n2=en:high frequency of absence seizures (several per day) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:high frequency of levodopa-induced dyskinesias
n1=en:stillbirth | n2=en:high frequency of levodopa-induced dyskinesias | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:high mortality in infancy and early childhood (in some patients)
n1=en:stillbirth | n2=en:high mortality in infancy and early childhood (in some patients) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:high pain threshold
n1=en:stillbirth | n2=en:high pain threshold | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:high recurrence rate
n1=en:stillbirth | n2=en:high recurrence rate | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:high risk of recurrence after surgery
n1=en:stillbirth | n2=en:high risk of recurrence after surgery | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly penetrant, but low morbidity
n1=en:stillbirth | n2=en:highly penetrant, but low morbidity | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable age at onset (range 9 to 69 years)
n1=en:stillbirth | n2=en:highly variable age at onset (range 9 to 69 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable clinical phenotype
n1=en:stillbirth | n2=en:highly variable clinical phenotype | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable expression
n1=en:stillbirth | n2=en:highly variable expression | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable frequency and duration of episodes
n1=en:stillbirth | n2=en:highly variable frequency and duration of episodes | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable frequency and severity of attacks
n1=en:stillbirth | n2=en:highly variable frequency and severity of attacks | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable organ involvement and severity
n1=en:stillbirth | n2=en:highly variable organ involvement and severity | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable phenotype and severity
n1=en:stillbirth | n2=en:highly variable phenotype and severity | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable phenotype including fluctuating phenotype ('fluctuans') or severe phenotype ('permanens')
n1=en:stillbirth | n2=en:highly variable phenotype including fluctuating phenotype ('fluctuans') or severe phenotype ('permanens') | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable phenotype that includes several subtypes (see, e.g., 607485, 601104)
n1=en:stillbirth | n2=en:highly variable phenotype that includes several subtypes (see, e.g., 607485, 601104) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable phenotype with respect to facial dysmorphism and neurologic features
n1=en:stillbirth | n2=en:highly variable phenotype with respect to facial dysmorphism and neurologic features | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable phenotype, even within families
n1=en:stillbirth | n2=en:highly variable phenotype, even within families | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable phenotype, ranging from asymptomatic to severe
n1=en:stillbirth | n2=en:highly variable phenotype, ranging from asymptomatic to severe | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable phenotype, some adults may be asymptomatic
n1=en:stillbirth | n2=en:highly variable phenotype, some adults may be asymptomatic | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable severity and features
n1=en:stillbirth | n2=en:highly variable severity and features | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:highly variable severity, ranging from death in utero to survival to adulthood with normal intelligence
n1=en:stillbirth | n2=en:highly variable severity, ranging from death in utero to survival to adulthood with normal intelligence | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hip joint replacement often necessary
n1=en:stillbirth | n2=en:hip joint replacement often necessary | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:home childbirth
n1=en:stillbirth | n2=en:home childbirth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:homozygotes have more severe disease with earlier onset of thrombosis
n1=en:stillbirth | n2=en:homozygotes have more severe disease with earlier onset of thrombosis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:horn of uterus
n1=en:stillbirth | n2=en:horn of uterus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:however, neonatal seizures, severe mental retardation, distinct dysmorphic features, and mitochondrial dysfunction are unique to 2p21 deletion syndrome (2p21del)
n1=en:stillbirth | n2=en:however, neonatal seizures, severe mental retardation, distinct dysmorphic features, and mitochondrial dysfunction are unique to 2p21 deletion syndrome (2p21del) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:Huguier's disease
n1=en:stillbirth | n2=en:Huguier's disease | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:human death
n1=en:stillbirth | n2=en:human death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:human papillomavirus
n1=en:stillbirth | n2=en:human papillomavirus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hydrops fetalis is associated with death in utero (90%) or within 2 days of birth
n1=en:stillbirth | n2=en:hydrops fetalis is associated with death in utero (90%) or within 2 days of birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hyperkeratosis often present at birth but may appear later
n1=en:stillbirth | n2=en:hyperkeratosis often present at birth but may appear later | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hyperlipidemia may be partially responsive to fat-restricted diet
n1=en:stillbirth | n2=en:hyperlipidemia may be partially responsive to fat-restricted diet | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hyperpigmented patches increased in size and number with age
n1=en:stillbirth | n2=en:hyperpigmented patches increased in size and number with age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hypersensitivity to ionizing radiation
n1=en:stillbirth | n2=en:hypersensitivity to ionizing radiation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hyperthermia in early childhood
n1=en:stillbirth | n2=en:hyperthermia in early childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:hypothyroidism is less severe in individuals with high dietary iodine intake
n1=en:stillbirth | n2=en:hypothyroidism is less severe in individuals with high dietary iodine intake | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:icelandic families
n1=en:stillbirth | n2=en:icelandic families | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:immunologic defects are variable
n1=en:stillbirth | n2=en:immunologic defects are variable | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:improvement with age
n1=en:stillbirth | n2=en:improvement with age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:in general, men have more severe disease than women
n1=en:stillbirth | n2=en:in general, men have more severe disease than women | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:in severe attacks, hemiplegia or coma may last days to weeks
n1=en:stillbirth | n2=en:in severe attacks, hemiplegia or coma may last days to weeks | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:in the absence of hydrops, death occurs within 3 months
n1=en:stillbirth | n2=en:in the absence of hydrops, death occurs within 3 months | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence - 1/16,000 live births
n1=en:stillbirth | n2=en:incidence - 1/16,000 live births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence 1 in 15,000-28,000 births
n1=en:stillbirth | n2=en:incidence 1 in 15,000-28,000 births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence 1 in 30,000 male births
n1=en:stillbirth | n2=en:incidence 1 in 30,000 male births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence 1 in 8,000 live births
n1=en:stillbirth | n2=en:incidence 1 in 8,000 live births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence 1-1.5/1,000 live births
n1=en:stillbirth | n2=en:incidence 1-1.5/1,000 live births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence 1/100,000 - 1/200,000 live births
n1=en:stillbirth | n2=en:incidence 1/100,000 - 1/200,000 live births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence 5-50 per million (children) and 10-40 per million (adults)
n1=en:stillbirth | n2=en:incidence 5-50 per million (children) and 10-40 per million (adults) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence 8/1,000 newborns
n1=en:stillbirth | n2=en:incidence 8/1,000 newborns | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence is estimated to be between 1 in 2,000 and 1 in 7,000 live births
n1=en:stillbirth | n2=en:incidence is estimated to be between 1 in 2,000 and 1 in 7,000 live births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 1.5 million births
n1=en:stillbirth | n2=en:incidence of 1 in 1.5 million births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 10,000 live births
n1=en:stillbirth | n2=en:incidence of 1 in 10,000 live births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 10,000 to 1 in 20,000
n1=en:stillbirth | n2=en:incidence of 1 in 10,000 to 1 in 20,000 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 100,000 births
n1=en:stillbirth | n2=en:incidence of 1 in 100,000 births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 100,000 to 125,000 at birth
n1=en:stillbirth | n2=en:incidence of 1 in 100,000 to 125,000 at birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 120,000 live births
n1=en:stillbirth | n2=en:incidence of 1 in 120,000 live births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 25,000 livebirths
n1=en:stillbirth | n2=en:incidence of 1 in 25,000 livebirths | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 250,000 births
n1=en:stillbirth | n2=en:incidence of 1 in 250,000 births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 3,500 boys
n1=en:stillbirth | n2=en:incidence of 1 in 3,500 boys | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 300,000
n1=en:stillbirth | n2=en:incidence of 1 in 300,000 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 39,000
n1=en:stillbirth | n2=en:incidence of 1 in 39,000 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 5,000 to 1 in 10,000
n1=en:stillbirth | n2=en:incidence of 1 in 5,000 to 1 in 10,000 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 50,000 to 1 in 100,000
n1=en:stillbirth | n2=en:incidence of 1 in 50,000 to 1 in 100,000 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence of 1 in 57,000
n1=en:stillbirth | n2=en:incidence of 1 in 57,000 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence ranges from 1 in 40,000 to 1 in 350,000 births
n1=en:stillbirth | n2=en:incidence ranges from 1 in 40,000 to 1 in 350,000 births | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence worldwide of 1 in 30,000 to 50,000
n1=en:stillbirth | n2=en:incidence worldwide of 1 in 30,000 to 50,000 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incidence, 1 in 500 heterozygotes, 1 in 1,000,000 homozygotes
n1=en:stillbirth | n2=en:incidence, 1 in 500 heterozygotes, 1 in 1,000,000 homozygotes | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incomplete penetrance
n1=en:stillbirth | n2=en:incomplete penetrance | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incomplete penetrance (50%)
n1=en:stillbirth | n2=en:incomplete penetrance (50%) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incomplete penetrance (range 13% to 77% by 50 years of age)
n1=en:stillbirth | n2=en:incomplete penetrance (range 13% to 77% by 50 years of age) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incomplete penetrance in carrier females
n1=en:stillbirth | n2=en:incomplete penetrance in carrier females | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incomplete penetrance in some families
n1=en:stillbirth | n2=en:incomplete penetrance in some families | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incomplete penetrance of optic atrophy
n1=en:stillbirth | n2=en:incomplete penetrance of optic atrophy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incomplete penetrance with 45 to 51 repeats
n1=en:stillbirth | n2=en:incomplete penetrance with 45 to 51 repeats | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:incomplete, but high, penetrance
n1=en:stillbirth | n2=en:incomplete, but high, penetrance | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:increased aneuploidy in offspring
n1=en:stillbirth | n2=en:increased aneuploidy in offspring | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:increased incidence in asian countries (e.g., 1.46 per 10,000 live births in taiwan)
n1=en:stillbirth | n2=en:increased incidence in asian countries (e.g., 1.46 per 10,000 live births in taiwan) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:increased male to female ratio (7.5:1)
n1=en:stillbirth | n2=en:increased male to female ratio (7.5:1) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:increased paternal age
n1=en:stillbirth | n2=en:increased paternal age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:increased recurrence risk with parental translocation
n1=en:stillbirth | n2=en:increased recurrence risk with parental translocation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:increased risk of developing early-onset aggressive cancers
n1=en:stillbirth | n2=en:increased risk of developing early-onset aggressive cancers | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:increased risk of early death
n1=en:stillbirth | n2=en:increased risk of early death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:increased risk of myeloproliferative disorders in those with somatic mutations
n1=en:stillbirth | n2=en:increased risk of myeloproliferative disorders in those with somatic mutations | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:increased sensitivity to valproic acid toxicity
n1=en:stillbirth | n2=en:increased sensitivity to valproic acid toxicity | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:increased susceptibility to malignant hyperthermia
n1=en:stillbirth | n2=en:increased susceptibility to malignant hyperthermia | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:increased susceptibility to multiple carcinomas
n1=en:stillbirth | n2=en:increased susceptibility to multiple carcinomas | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:independent ambulation is maintained
n1=en:stillbirth | n2=en:independent ambulation is maintained | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:individuals do not develop erythrocytosis under hypoxic conditions
n1=en:stillbirth | n2=en:individuals do not develop erythrocytosis under hypoxic conditions | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:induced vaginal delivery
n1=en:stillbirth | n2=en:induced vaginal delivery | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:induction of labor
n1=en:stillbirth | n2=en:induction of labor | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infant death
n1=en:stillbirth | n2=en:infant death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infant loss
n1=en:stillbirth | n2=en:infant loss | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infant mortality
n1=en:stillbirth | n2=en:infant mortality | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infantile form accounts for 90% of cases
n1=en:stillbirth | n2=en:infantile form accounts for 90% of cases | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infantile form has onset within first 6 months of life
n1=en:stillbirth | n2=en:infantile form has onset within first 6 months of life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infantile onset
n1=en:stillbirth | n2=en:infantile onset | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infantile onset with hepatic involvement
n1=en:stillbirth | n2=en:infantile onset with hepatic involvement | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infantile, late-infantile, juvenile, and adult onset have been reported
n1=en:stillbirth | n2=en:infantile, late-infantile, juvenile, and adult onset have been reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infants are stillborn or die shortly after birth
n1=en:stillbirth | n2=en:infants are stillborn or die shortly after birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infants may have acute life-threatening crises
n1=en:stillbirth | n2=en:infants may have acute life-threatening crises | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infants show normal size and appearance
n1=en:stillbirth | n2=en:infants show normal size and appearance | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infections may precipitate ketotic episodes
n1=en:stillbirth | n2=en:infections may precipitate ketotic episodes | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infectious intrauterine disorder
n1=en:stillbirth | n2=en:infectious intrauterine disorder | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:infertilitas feminis
n1=en:stillbirth | n2=en:infertilitas feminis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:inflammatory arthritis may develop in 30% of patients
n1=en:stillbirth | n2=en:inflammatory arthritis may develop in 30% of patients | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:inflammatory bowel disease may develop in childhood or adolescence
n1=en:stillbirth | n2=en:inflammatory bowel disease may develop in childhood or adolescence | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:inheritance pattern is unclear
n1=en:stillbirth | n2=en:inheritance pattern is unclear | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:initial development may appear normal
n1=en:stillbirth | n2=en:initial development may appear normal | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:initial hearing loss is mild progressing to severe or profound by the seventh decade
n1=en:stillbirth | n2=en:initial hearing loss is mild progressing to severe or profound by the seventh decade | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:initially normal rod responses may become significantly reduced at older age
n1=en:stillbirth | n2=en:initially normal rod responses may become significantly reduced at older age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:insidious onset
n1=en:stillbirth | n2=en:insidious onset | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:intellectual regression and loss of speech precede the onset of motor retardation by more than 10 years
n1=en:stillbirth | n2=en:intellectual regression and loss of speech precede the onset of motor retardation by more than 10 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:interfamilial and intrafamilial clinical heterogeneity
n1=en:stillbirth | n2=en:interfamilial and intrafamilial clinical heterogeneity | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:intermediate expression in females
n1=en:stillbirth | n2=en:intermediate expression in females | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:intermittent exacerbations
n1=en:stillbirth | n2=en:intermittent exacerbations | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:internal organ rupture may occur
n1=en:stillbirth | n2=en:internal organ rupture may occur | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:intracellular accumulation of material can occur in neuronal and nonneuronal cells
n1=en:stillbirth | n2=en:intracellular accumulation of material can occur in neuronal and nonneuronal cells | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:intrafamilial phenotypic variability ranging from transient or permanent neonatal diabetes (610582) to mody (616329) to impaired fasting glucose or impaired glucose tolerance
n1=en:stillbirth | n2=en:intrafamilial phenotypic variability ranging from transient or permanent neonatal diabetes (610582) to mody (616329) to impaired fasting glucose or impaired glucose tolerance | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:intrafamilial phenotypic variation may occur
n1=en:stillbirth | n2=en:intrafamilial phenotypic variation may occur | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:intrafamilial variability in degree of hypotrichosis
n1=en:stillbirth | n2=en:intrafamilial variability in degree of hypotrichosis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:intrafamilial variability in nail changes
n1=en:stillbirth | n2=en:intrafamilial variability in nail changes | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:intrafamilial variability in number of missing teeth
n1=en:stillbirth | n2=en:intrafamilial variability in number of missing teeth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:intrafamilial variability in severity of hypothyroidism
n1=en:stillbirth | n2=en:intrafamilial variability in severity of hypothyroidism | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:intrauterine death, affecting management of mother, antepartum condition or complication
n1=en:stillbirth | n2=en:intrauterine death, affecting management of mother, antepartum condition or complication | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:isolated finding
n1=en:stillbirth | n2=en:isolated finding | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:itch, pain, and body malodor often
n1=en:stillbirth | n2=en:itch, pain, and body malodor often | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:joint laxity decreases with age
n1=en:stillbirth | n2=en:joint laxity decreases with age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:joint pain
n1=en:stillbirth | n2=en:joint pain | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:joint symptoms begin in third or fourth decade
n1=en:stillbirth | n2=en:joint symptoms begin in third or fourth decade | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:juvenile form has onset between 4 and 19 years
n1=en:stillbirth | n2=en:juvenile form has onset between 4 and 19 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:juvenile onset 4 years to puberty
n1=en:stillbirth | n2=en:juvenile onset 4 years to puberty | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:juvenile rigid early-onset form more often paternally inherited
n1=en:stillbirth | n2=en:juvenile rigid early-onset form more often paternally inherited | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:ketogenic diet may be effective
n1=en:stillbirth | n2=en:ketogenic diet may be effective | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:l-dopa-induced dyskinesias
n1=en:stillbirth | n2=en:l-dopa-induced dyskinesias | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lack of treatment results in early death
n1=en:stillbirth | n2=en:lack of treatment results in early death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:late adult onset (after age 55 years)
n1=en:stillbirth | n2=en:late adult onset (after age 55 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:late fetal mortality
n1=en:stillbirth | n2=en:late fetal mortality | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:late infantile onset 6-24 months
n1=en:stillbirth | n2=en:late infantile onset 6-24 months | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:late-adult onset
n1=en:stillbirth | n2=en:late-adult onset | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:late-adult onset (fifth to sixth decade)
n1=en:stillbirth | n2=en:late-adult onset (fifth to sixth decade) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:late-adult onset (usually after age 50 years)
n1=en:stillbirth | n2=en:late-adult onset (usually after age 50 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:late-adult onset has been reported
n1=en:stillbirth | n2=en:late-adult onset has been reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:late-onset, slowly progressing form of retinitis pigmentosa
n1=en:stillbirth | n2=en:late-onset, slowly progressing form of retinitis pigmentosa | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:later onset (late childhood to young adult) has been reported
n1=en:stillbirth | n2=en:later onset (late childhood to young adult) has been reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:later onset can also occur (up to age 17 years)
n1=en:stillbirth | n2=en:later onset can also occur (up to age 17 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:later onset has been reported
n1=en:stillbirth | n2=en:later onset has been reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:later onset in females
n1=en:stillbirth | n2=en:later onset in females | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:later onset may occur
n1=en:stillbirth | n2=en:later onset may occur | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:later onset of hearing loss in some patients
n1=en:stillbirth | n2=en:later onset of hearing loss in some patients | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:later onset of neurologic features
n1=en:stillbirth | n2=en:later onset of neurologic features | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:later onset of optic atrophy (mean 19 years, range 5 to 50 years)
n1=en:stillbirth | n2=en:later onset of optic atrophy (mean 19 years, range 5 to 50 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:leakage of fluid ('gusher') if the stapes is disturbed
n1=en:stillbirth | n2=en:leakage of fluid ('gusher') if the stapes is disturbed | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:left side involvement more frequent than right side involvement
n1=en:stillbirth | n2=en:left side involvement more frequent than right side involvement | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:left sided involvement occurs more frequently
n1=en:stillbirth | n2=en:left sided involvement occurs more frequently | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:leg pain during childhood
n1=en:stillbirth | n2=en:leg pain during childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:leiomyoma
n1=en:stillbirth | n2=en:leiomyoma | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:leiomyoma of the uterus
n1=en:stillbirth | n2=en:leiomyoma of the uterus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:length of attack, 3 to 7 days
n1=en:stillbirth | n2=en:length of attack, 3 to 7 days | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lesions apparent at birth
n1=en:stillbirth | n2=en:lesions apparent at birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lesions are present at birth or become apparent in infancy
n1=en:stillbirth | n2=en:lesions are present at birth or become apparent in infancy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lesions continue to grow until epiphyseal plate closure
n1=en:stillbirth | n2=en:lesions continue to grow until epiphyseal plate closure | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lesions increase in size and number with age
n1=en:stillbirth | n2=en:lesions increase in size and number with age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lesions provoked by friction, sun exposure, heat, and injury
n1=en:stillbirth | n2=en:lesions provoked by friction, sun exposure, heat, and injury | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:less than 20% have onset at 18 years of age or less (dominant and recessive)
n1=en:stillbirth | n2=en:less than 20% have onset at 18 years of age or less (dominant and recessive) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lethal
n1=en:stillbirth | n2=en:lethal | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lethal in males
n1=en:stillbirth | n2=en:lethal in males | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lethal in utero or perinatal lethal
n1=en:stillbirth | n2=en:lethal in utero or perinatal lethal | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:levodopa-induced dyskinesias
n1=en:stillbirth | n2=en:levodopa-induced dyskinesias | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:life-threatening infections
n1=en:stillbirth | n2=en:life-threatening infections | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lifelong occurrence
n1=en:stillbirth | n2=en:lifelong occurrence | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lifetime
n1=en:stillbirth | n2=en:lifetime | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lifetime risk of breast cancer in mutation carriers is 60 to 85%
n1=en:stillbirth | n2=en:lifetime risk of breast cancer in mutation carriers is 60 to 85% | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lifetime risk of ovarian cancer in mutation carriers is 10 to 20%
n1=en:stillbirth | n2=en:lifetime risk of ovarian cancer in mutation carriers is 10 to 20% | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:likely allelic to sc phocomelia syndrome (269000)
n1=en:stillbirth | n2=en:likely allelic to sc phocomelia syndrome (269000) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:limb malformations are variable
n1=en:stillbirth | n2=en:limb malformations are variable | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lipodystrophic appearance may be mild or not present
n1=en:stillbirth | n2=en:lipodystrophic appearance may be mild or not present | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:live birth
n1=en:stillbirth | n2=en:live birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:live born infants die within few hours of birth
n1=en:stillbirth | n2=en:live born infants die within few hours of birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:liveborn often die within first week of life
n1=en:stillbirth | n2=en:liveborn often die within first week of life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:liver disease may be the most predominant finding
n1=en:stillbirth | n2=en:liver disease may be the most predominant finding | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:liver size returns to normal after 3 months to 3 years
n1=en:stillbirth | n2=en:liver size returns to normal after 3 months to 3 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:liver symptoms improve with age and disappear after puberty
n1=en:stillbirth | n2=en:liver symptoms improve with age and disappear after puberty | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:long headache duration (greater than 12 hours)
n1=en:stillbirth | n2=en:long headache duration (greater than 12 hours) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:loss of human life
n1=en:stillbirth | n2=en:loss of human life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:loss of independent ambulation (in 2 of 3 patients)
n1=en:stillbirth | n2=en:loss of independent ambulation (in 2 of 3 patients) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:loss of independent ambulation in the second decade
n1=en:stillbirth | n2=en:loss of independent ambulation in the second decade | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:loss of life
n1=en:stillbirth | n2=en:loss of life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:loss of tumor suppressor gene
n1=en:stillbirth | n2=en:loss of tumor suppressor gene | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:low birth weight
n1=en:stillbirth | n2=en:low birth weight | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lower limb involvement occurs before upper limb involvement
n1=en:stillbirth | n2=en:lower limb involvement occurs before upper limb involvement | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:lower limb weakness is presenting feature
n1=en:stillbirth | n2=en:lower limb weakness is presenting feature | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:macerated stillbirth
n1=en:stillbirth | n2=en:macerated stillbirth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:madelung deformity more frequent and more severe in females
n1=en:stillbirth | n2=en:madelung deformity more frequent and more severe in females | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:major cause of death is heart failure
n1=en:stillbirth | n2=en:major cause of death is heart failure | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:major fluid shifts may occur in severe cases
n1=en:stillbirth | n2=en:major fluid shifts may occur in severe cases | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:major physical defect
n1=en:stillbirth | n2=en:major physical defect | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority are isolated cases
n1=en:stillbirth | n2=en:majority are isolated cases | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority are stillborn or die in early neonatal period
n1=en:stillbirth | n2=en:majority are stillborn or die in early neonatal period | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority die in neonatal period secondary to respiratory insufficiency
n1=en:stillbirth | n2=en:majority die in neonatal period secondary to respiratory insufficiency | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority of cases (95%) are sporadic
n1=en:stillbirth | n2=en:majority of cases (95%) are sporadic | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority of cases are male
n1=en:stillbirth | n2=en:majority of cases are male | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority of cases are sporadic, often in tall, thin men
n1=en:stillbirth | n2=en:majority of cases are sporadic, often in tall, thin men | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority of cases diagnosed at age 10-15 years
n1=en:stillbirth | n2=en:majority of cases diagnosed at age 10-15 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority of cases have been sporadic
n1=en:stillbirth | n2=en:majority of cases have been sporadic | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority of cases sporadic
n1=en:stillbirth | n2=en:majority of cases sporadic | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority of children die before age 2
n1=en:stillbirth | n2=en:majority of children die before age 2 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority of children die between 6 months and 5 yrs
n1=en:stillbirth | n2=en:majority of children die between 6 months and 5 yrs | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority of patients are ambulatory
n1=en:stillbirth | n2=en:majority of patients are ambulatory | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority of patients are stillborn or die before 5 months of age
n1=en:stillbirth | n2=en:majority of patients are stillborn or die before 5 months of age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority of patients die in neonatal period secondary to respiratory insufficiency
n1=en:stillbirth | n2=en:majority of patients die in neonatal period secondary to respiratory insufficiency | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:majority of patients have normal intelligence
n1=en:stillbirth | n2=en:majority of patients have normal intelligence | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:male patients have more severe disease than female patients
n1=en:stillbirth | n2=en:male patients have more severe disease than female patients | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:male predominance of 3:1 to 5:1
n1=en:stillbirth | n2=en:male predominance of 3:1 to 5:1 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:male to female ratio 4:1
n1=en:stillbirth | n2=en:male to female ratio 4:1 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:male to female ratio is greater than 3:1
n1=en:stillbirth | n2=en:male to female ratio is greater than 3:1 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:male-to-female ratio of 3:2 in childhood cases
n1=en:stillbirth | n2=en:male-to-female ratio of 3:2 in childhood cases | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:male-to-female ratio, 1.8 to 1
n1=en:stillbirth | n2=en:male-to-female ratio, 1.8 to 1 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:males are more severely affected
n1=en:stillbirth | n2=en:males are more severely affected | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:males are most severely affected, but females can also be affected
n1=en:stillbirth | n2=en:males are most severely affected, but females can also be affected | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:males carry mutations in the somatic mosaic state
n1=en:stillbirth | n2=en:males carry mutations in the somatic mosaic state | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:males may be more affected than females
n1=en:stillbirth | n2=en:males may be more affected than females | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:males more affected than females (2 to 2.5:1)
n1=en:stillbirth | n2=en:males more affected than females (2 to 2.5:1) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:males tend to have earlier onset than females
n1=en:stillbirth | n2=en:males tend to have earlier onset than females | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:malignant breast neoplasm
n1=en:stillbirth | n2=en:malignant breast neoplasm | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:malignant neoplasm of vulva
n1=en:stillbirth | n2=en:malignant neoplasm of vulva | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:malignant uterine neoplasm
n1=en:stillbirth | n2=en:malignant uterine neoplasm | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:malignant vulvar neoplasm
n1=en:stillbirth | n2=en:malignant vulvar neoplasm | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mammiplasty
n1=en:stillbirth | n2=en:mammiplasty | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mammography
n1=en:stillbirth | n2=en:mammography | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mammoplasty
n1=en:stillbirth | n2=en:mammoplasty | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:management of homocystinuria includes low methionine, cystine supplemented diet for pyridoxine nonresponders and pyridoxine supplementation for pyridoxine responders
n1=en:stillbirth | n2=en:management of homocystinuria includes low methionine, cystine supplemented diet for pyridoxine nonresponders and pyridoxine supplementation for pyridoxine responders | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:manifestations continue to appear until 5th decade
n1=en:stillbirth | n2=en:manifestations continue to appear until 5th decade | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:manifests in infancy (including neonatal lethal) or childhood
n1=en:stillbirth | n2=en:manifests in infancy (including neonatal lethal) or childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:many adults with typical form remain ambulatory
n1=en:stillbirth | n2=en:many adults with typical form remain ambulatory | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:many cases are asymptomatic
n1=en:stillbirth | n2=en:many cases are asymptomatic | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:many cases due to de novo mutation
n1=en:stillbirth | n2=en:many cases due to de novo mutation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:many features are present only in an untreated patient
n1=en:stillbirth | n2=en:many features are present only in an untreated patient | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:many patients become wheelchair-bound
n1=en:stillbirth | n2=en:many patients become wheelchair-bound | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:many patients lose independent mobility after 25 years
n1=en:stillbirth | n2=en:many patients lose independent mobility after 25 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:many patients require cardiac pacemakers
n1=en:stillbirth | n2=en:many patients require cardiac pacemakers | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:marked clinical variability within families
n1=en:stillbirth | n2=en:marked clinical variability within families | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:marked heterogeneity
n1=en:stillbirth | n2=en:marked heterogeneity | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:marked intrafamilial and interfamilial variability
n1=en:stillbirth | n2=en:marked intrafamilial and interfamilial variability | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:marked intrafamilial variability of clinical features
n1=en:stillbirth | n2=en:marked intrafamilial variability of clinical features | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:marked phenotypic variability, even within an individual
n1=en:stillbirth | n2=en:marked phenotypic variability, even within an individual | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:marked variation in severity - severe early onset disease (neonatal period) and milder juvenile disease (onset 8-13 years)
n1=en:stillbirth | n2=en:marked variation in severity - severe early onset disease (neonatal period) and milder juvenile disease (onset 8-13 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:maternal anticipation bias
n1=en:stillbirth | n2=en:maternal anticipation bias | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:maternal imprinting
n1=en:stillbirth | n2=en:maternal imprinting | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:maternal oligohydramnios
n1=en:stillbirth | n2=en:maternal oligohydramnios | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may be asymptomatic
n1=en:stillbirth | n2=en:may be asymptomatic | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may be due to imprinting defect
n1=en:stillbirth | n2=en:may be due to imprinting defect | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may be fatal in infancy
n1=en:stillbirth | n2=en:may be fatal in infancy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may be lethal if untreated
n1=en:stillbirth | n2=en:may be lethal if untreated | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may be lethal in the neonatal period
n1=en:stillbirth | n2=en:may be lethal in the neonatal period | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may be precipitated by minor illness (e.g., viral infection, fever)
n1=en:stillbirth | n2=en:may be precipitated by minor illness (e.g., viral infection, fever) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may be progressive
n1=en:stillbirth | n2=en:may be progressive | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may be triggered by medications, including antineoplastic agents, immunotherapeutic agents, and antiplatelet agents
n1=en:stillbirth | n2=en:may be triggered by medications, including antineoplastic agents, immunotherapeutic agents, and antiplatelet agents | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may be triggered by minor head trauma
n1=en:stillbirth | n2=en:may be triggered by minor head trauma | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may fade with age
n1=en:stillbirth | n2=en:may fade with age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may have seasonal variance in severity
n1=en:stillbirth | n2=en:may have seasonal variance in severity | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may manifest as late-onset 'parkinsonian' phenotype without severe ataxic features
n1=en:stillbirth | n2=en:may manifest as late-onset 'parkinsonian' phenotype without severe ataxic features | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may not be clinically manifest until middle life
n1=en:stillbirth | n2=en:may not be clinically manifest until middle life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may occur in adults (also in pregnancy)
n1=en:stillbirth | n2=en:may occur in adults (also in pregnancy) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may progress to other body regions after many years
n1=en:stillbirth | n2=en:may progress to other body regions after many years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may regress
n1=en:stillbirth | n2=en:may regress | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may result in death in neonatal period or early childhood
n1=en:stillbirth | n2=en:may result in death in neonatal period or early childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may result in early death from severe diarrhea
n1=en:stillbirth | n2=en:may result in early death from severe diarrhea | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may result in sudden death
n1=en:stillbirth | n2=en:may result in sudden death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:may show good response to levodopa
n1=en:stillbirth | n2=en:may show good response to levodopa | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at diagnosis 8.8 years (range 0.2-23 years)
n1=en:stillbirth | n2=en:mean age at diagnosis 8.8 years (range 0.2-23 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset 10.6 years
n1=en:stillbirth | n2=en:mean age at onset 10.6 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset 15.2 years
n1=en:stillbirth | n2=en:mean age at onset 15.2 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset 22 years (range 7 to 50 years)
n1=en:stillbirth | n2=en:mean age at onset 22 years (range 7 to 50 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset 24 years (range 14 to 33 years)
n1=en:stillbirth | n2=en:mean age at onset 24 years (range 14 to 33 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset 28 years
n1=en:stillbirth | n2=en:mean age at onset 28 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset 32 years
n1=en:stillbirth | n2=en:mean age at onset 32 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset 33 years (range 20-60)
n1=en:stillbirth | n2=en:mean age at onset 33 years (range 20-60) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset 35 years (range 20-60)
n1=en:stillbirth | n2=en:mean age at onset 35 years (range 20-60) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset 46.5 years (range 19-64)
n1=en:stillbirth | n2=en:mean age at onset 46.5 years (range 19-64) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset 57-60 years
n1=en:stillbirth | n2=en:mean age at onset 57-60 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset 66.8 years (range 47-77)
n1=en:stillbirth | n2=en:mean age at onset 66.8 years (range 47-77) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset is 13 years (range 6 to 43)
n1=en:stillbirth | n2=en:mean age at onset is 13 years (range 6 to 43) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset of bone fractures, 24 years
n1=en:stillbirth | n2=en:mean age at onset of bone fractures, 24 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset of cerebellar ataxia is 52.8 years
n1=en:stillbirth | n2=en:mean age at onset of cerebellar ataxia is 52.8 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset of dementia is 57 years
n1=en:stillbirth | n2=en:mean age at onset of dementia is 57 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset of hypoglycemia may be delayed (median, 9 months, diagnosis sometimes made in adulthood)
n1=en:stillbirth | n2=en:mean age at onset of hypoglycemia may be delayed (median, 9 months, diagnosis sometimes made in adulthood) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset of migraines is 42 years
n1=en:stillbirth | n2=en:mean age at onset of migraines is 42 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at onset of proximal muscle weakness, 31 years
n1=en:stillbirth | n2=en:mean age at onset of proximal muscle weakness, 31 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age at termination 3 to 4 years
n1=en:stillbirth | n2=en:mean age at termination 3 to 4 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of diagnosis 40 years
n1=en:stillbirth | n2=en:mean age of diagnosis 40 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of diagnosis of renal cell carcinoma is 46 years
n1=en:stillbirth | n2=en:mean age of diagnosis of renal cell carcinoma is 46 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of onset 16 to 19 years
n1=en:stillbirth | n2=en:mean age of onset 16 to 19 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of onset 20.6 years
n1=en:stillbirth | n2=en:mean age of onset 20.6 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of onset 22 years (range 5-54)
n1=en:stillbirth | n2=en:mean age of onset 22 years (range 5-54) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of onset 30 years (range 25-42)
n1=en:stillbirth | n2=en:mean age of onset 30 years (range 25-42) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of onset 31 years (range 5-60)
n1=en:stillbirth | n2=en:mean age of onset 31 years (range 5-60) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of onset 35-40 years
n1=en:stillbirth | n2=en:mean age of onset 35-40 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of onset 50 to 52 years
n1=en:stillbirth | n2=en:mean age of onset 50 to 52 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of onset about 62 years (45-79 years)
n1=en:stillbirth | n2=en:mean age of onset about 62 years (45-79 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of onset in third decade
n1=en:stillbirth | n2=en:mean age of onset in third decade | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of onset, 5 years
n1=en:stillbirth | n2=en:mean age of onset, 5 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean age of presentation of renal cancer is 50 years, but earlier onset has been reported
n1=en:stillbirth | n2=en:mean age of presentation of renal cancer is 50 years, but earlier onset has been reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mean survival 5 months
n1=en:stillbirth | n2=en:mean survival 5 months | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:medial onset of end stage renal disease 13 years
n1=en:stillbirth | n2=en:medial onset of end stage renal disease 13 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:median age at diagnosis, 59 years
n1=en:stillbirth | n2=en:median age at diagnosis, 59 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:median age at onset 23 years
n1=en:stillbirth | n2=en:median age at onset 23 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:median age at onset of puberty is 5.75 years in affected girls and 8.1 years in affected boys
n1=en:stillbirth | n2=en:median age at onset of puberty is 5.75 years in affected girls and 8.1 years in affected boys | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:median age of diagnosis is 28 years
n1=en:stillbirth | n2=en:median age of diagnosis is 28 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:median age of onset of nail dystrophy - 7 years (range 1-6 years)
n1=en:stillbirth | n2=en:median age of onset of nail dystrophy - 7 years (range 1-6 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:median age of onset of pigmentation - 8 years (range 1-15 years)
n1=en:stillbirth | n2=en:median age of onset of pigmentation - 8 years (range 1-15 years) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:median onset of neurologic symptoms is 13 years (range 5 to 28)
n1=en:stillbirth | n2=en:median onset of neurologic symptoms is 13 years (range 5 to 28) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:median survival 5.7 years
n1=en:stillbirth | n2=en:median survival 5.7 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:median survival is > 50 years
n1=en:stillbirth | n2=en:median survival is > 50 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:medullary thyroid cancer is aggressive and can occur in childhood
n1=en:stillbirth | n2=en:medullary thyroid cancer is aggressive and can occur in childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:menopause
n1=en:stillbirth | n2=en:menopause | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:menses
n1=en:stillbirth | n2=en:menses | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:menstrual period
n1=en:stillbirth | n2=en:menstrual period | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:menstrual periods
n1=en:stillbirth | n2=en:menstrual periods | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:menstruating
n1=en:stillbirth | n2=en:menstruating | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:menstruation
n1=en:stillbirth | n2=en:menstruation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mesomelia becomes more evident with age
n1=en:stillbirth | n2=en:mesomelia becomes more evident with age | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:metabolic encephalomyopathic crises often triggered by infection
n1=en:stillbirth | n2=en:metabolic encephalomyopathic crises often triggered by infection | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:midline defects
n1=en:stillbirth | n2=en:midline defects | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:mild asymmetric regional disease (e.g. 180380.0029)
n1=en:stillbirth | n2=en:mild asymmetric regional disease (e.g. 180380.0029) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy
n1=en:stillbirth | n2=en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:milder form with onset in childhood, absence seizures, and learning difficulties
n1=en:stillbirth | n2=en:milder form with onset in childhood, absence seizures, and learning difficulties | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:miscellaneous
n1=en:stillbirth | n2=en:miscellaneous | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:most patients become wheelchair-bound in the second or third decades
n1=en:stillbirth | n2=en:most patients become wheelchair-bound in the second or third decades | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:multiple birth
n1=en:stillbirth | n2=en:multiple birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:natural childbirth assistance
n1=en:stillbirth | n2=en:natural childbirth assistance | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:neonatal death
n1=en:stillbirth | n2=en:neonatal death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:neonatal sepsis
n1=en:stillbirth | n2=en:neonatal sepsis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:nine patients have been reported (last curated july 2015)
n1=en:stillbirth | n2=en:nine patients have been reported (last curated july 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:no consistent dysmorphic facial phenotype
n1=en:stillbirth | n2=en:no consistent dysmorphic facial phenotype | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:no extraocular findings
n1=en:stillbirth | n2=en:no extraocular findings | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:no situs inversus
n1=en:stillbirth | n2=en:no situs inversus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:non-cancer related death
n1=en:stillbirth | n2=en:non-cancer related death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:normal delivery
n1=en:stillbirth | n2=en:normal delivery | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:nuchal cord
n1=en:stillbirth | n2=en:nuchal cord | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:occurs in a southern maryland tri-racial inbred population known as the brandywine isolate
n1=en:stillbirth | n2=en:occurs in a southern maryland tri-racial inbred population known as the brandywine isolate | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:one family and 2 unrelated patients have been reported (last curated december 2015)
n1=en:stillbirth | n2=en:one family and 2 unrelated patients have been reported (last curated december 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:one lebanese family has been reported
n1=en:stillbirth | n2=en:one lebanese family has been reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:one patient has been reported (last curated august 2015)
n1=en:stillbirth | n2=en:one patient has been reported (last curated august 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:one patient reported (last curated november 2012)
n1=en:stillbirth | n2=en:one patient reported (last curated november 2012) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:onset in early infancy
n1=en:stillbirth | n2=en:onset in early infancy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:onset in first decade (as early as infancy in some)
n1=en:stillbirth | n2=en:onset in first decade (as early as infancy in some) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:onset in first decade after normal early development
n1=en:stillbirth | n2=en:onset in first decade after normal early development | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:onset of lymphedema around puberty
n1=en:stillbirth | n2=en:onset of lymphedema around puberty | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:onset of night blindness varies among patients from early childhood to mid thirties
n1=en:stillbirth | n2=en:onset of night blindness varies among patients from early childhood to mid thirties | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:onset of overgrowth in the first year of life (in most cases)
n1=en:stillbirth | n2=en:onset of overgrowth in the first year of life (in most cases) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:onset of symptoms in early childhood in most patients
n1=en:stillbirth | n2=en:onset of symptoms in early childhood in most patients | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:onset of visual dysfunction in early childhood
n1=en:stillbirth | n2=en:onset of visual dysfunction in early childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:onset usually in childhood or adolescence
n1=en:stillbirth | n2=en:onset usually in childhood or adolescence | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:opportunistic infection
n1=en:stillbirth | n2=en:opportunistic infection | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:osteoglophonic, derived from greek meaning hollowed out
n1=en:stillbirth | n2=en:osteoglophonic, derived from greek meaning hollowed out | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:other abnormal products of conception
n1=en:stillbirth | n2=en:other abnormal products of conception | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:other conditions originating in the perinatal period
n1=en:stillbirth | n2=en:other conditions originating in the perinatal period | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:ovarian cyst
n1=en:stillbirth | n2=en:ovarian cyst | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:ovarian duct
n1=en:stillbirth | n2=en:ovarian duct | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:paralysis
n1=en:stillbirth | n2=en:paralysis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:patient b is 1 child born of unrelated scandinavian parents with a more severe phenotype with onset in the neonatal period
n1=en:stillbirth | n2=en:patient b is 1 child born of unrelated scandinavian parents with a more severe phenotype with onset in the neonatal period | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:patient b presented with asymptomatic increased serum creatine kinase and no clinical muscle symptoms
n1=en:stillbirth | n2=en:patient b presented with asymptomatic increased serum creatine kinase and no clinical muscle symptoms | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:patient died during operation
n1=en:stillbirth | n2=en:patient died during operation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:patients may die in infancy or childhood due to respiratory failure
n1=en:stillbirth | n2=en:patients may die in infancy or childhood due to respiratory failure | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:patients with homozygous, compound heterozygous, and heterozygous mutation have been reported
n1=en:stillbirth | n2=en:patients with homozygous, compound heterozygous, and heterozygous mutation have been reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:pelvic inflammatory disease
n1=en:stillbirth | n2=en:pelvic inflammatory disease | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:penetrance estimated to be 80%
n1=en:stillbirth | n2=en:penetrance estimated to be 80% | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:perinatal mortality demographics
n1=en:stillbirth | n2=en:perinatal mortality demographics | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:perinatal period
n1=en:stillbirth | n2=en:perinatal period | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:perinatal terminology
n1=en:stillbirth | n2=en:perinatal terminology | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:periods
n1=en:stillbirth | n2=en:periods | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:phenotype is due to hypomorphic nonmosaic mutation in the ebp gene
n1=en:stillbirth | n2=en:phenotype is due to hypomorphic nonmosaic mutation in the ebp gene | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:physical defect
n1=en:stillbirth | n2=en:physical defect | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:pigmentation not always butterfly-shaped
n1=en:stillbirth | n2=en:pigmentation not always butterfly-shaped | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:placenta
n1=en:stillbirth | n2=en:placenta | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:polyhydramnios
n1=en:stillbirth | n2=en:polyhydramnios | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:poor fetal development
n1=en:stillbirth | n2=en:poor fetal development | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:post mortem examination
n1=en:stillbirth | n2=en:post mortem examination | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:postmature pregnancy delivered
n1=en:stillbirth | n2=en:postmature pregnancy delivered | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:postmortem examination
n1=en:stillbirth | n2=en:postmortem examination | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:postpartum hemorrhage
n1=en:stillbirth | n2=en:postpartum hemorrhage | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:precipitation by pregnancy
n1=en:stillbirth | n2=en:precipitation by pregnancy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:pregnancy outcome
n1=en:stillbirth | n2=en:pregnancy outcome | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:premature baby death
n1=en:stillbirth | n2=en:premature baby death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:premature birth of newborn
n1=en:stillbirth | n2=en:premature birth of newborn | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:premature labor
n1=en:stillbirth | n2=en:premature labor | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:premature rupture of membrane
n1=en:stillbirth | n2=en:premature rupture of membrane | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:prenatal disorder
n1=en:stillbirth | n2=en:prenatal disorder | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:prenatal nutritional deficiency
n1=en:stillbirth | n2=en:prenatal nutritional deficiency | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:presence of severe midfacial and limb defects and birth length less than 37cm associated with stillborn or early infant death
n1=en:stillbirth | n2=en:presence of severe midfacial and limb defects and birth length less than 37cm associated with stillborn or early infant death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:preterm birth
n1=en:stillbirth | n2=en:preterm birth | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:preterm infant
n1=en:stillbirth | n2=en:preterm infant | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:pyogenic arthritis, pyoderma gangrenosum and acne
n1=en:stillbirth | n2=en:pyogenic arthritis, pyoderma gangrenosum and acne | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:quadruplet pregnancy with fetal loss and retention of one or more fetus(es), antepartum condition or complication
n1=en:stillbirth | n2=en:quadruplet pregnancy with fetal loss and retention of one or more fetus(es), antepartum condition or complication | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:quinidine therapy may be effective
n1=en:stillbirth | n2=en:quinidine therapy may be effective | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:reactions and intoxications due to drugs administered to fetus and newborn
n1=en:stillbirth | n2=en:reactions and intoxications due to drugs administered to fetus and newborn | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:reactions and intoxications due to drugs administered to newborn
n1=en:stillbirth | n2=en:reactions and intoxications due to drugs administered to newborn | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:recurrent episodes of liver failure during intercurrent infections
n1=en:stillbirth | n2=en:recurrent episodes of liver failure during intercurrent infections | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:recurrent fetal loss
n1=en:stillbirth | n2=en:recurrent fetal loss | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:relatively mild phenotype
n1=en:stillbirth | n2=en:relatively mild phenotype | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:retinal holes were present in an asymptomatic female carrier
n1=en:stillbirth | n2=en:retinal holes were present in an asymptomatic female carrier | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:retinitis pigmentosa
n1=en:stillbirth | n2=en:retinitis pigmentosa | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:seizures remit spontaneously by age 5 years
n1=en:stillbirth | n2=en:seizures remit spontaneously by age 5 years | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:sexual infantilism
n1=en:stillbirth | n2=en:sexual infantilism | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:sexually transmitted disease
n1=en:stillbirth | n2=en:sexually transmitted disease | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:sexually transmitted disorder
n1=en:stillbirth | n2=en:sexually transmitted disorder | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:sexually transmitted infection
n1=en:stillbirth | n2=en:sexually transmitted infection | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:short umbilical cord
n1=en:stillbirth | n2=en:short umbilical cord | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:SIDS
n1=en:stillbirth | n2=en:SIDS | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:sids
n1=en:stillbirth | n2=en:sids | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:signs and symptoms
n1=en:stillbirth | n2=en:signs and symptoms | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:single umbilical artery
n1=en:stillbirth | n2=en:single umbilical artery | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:skewed x-inactivation, with complete skewing in some individuals
n1=en:stillbirth | n2=en:skewed x-inactivation, with complete skewing in some individuals | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:some patients have onset in second decade of life
n1=en:stillbirth | n2=en:some patients have onset in second decade of life | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:some patients may show normal early development before seizure onset
n1=en:stillbirth | n2=en:some patients may show normal early development before seizure onset | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:STD
n1=en:stillbirth | n2=en:STD | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:Stein-Leventhal syndrome
n1=en:stillbirth | n2=en:Stein-Leventhal syndrome | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:STI
n1=en:stillbirth | n2=en:STI | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:stillbirth and foetal death
n1=en:stillbirth | n2=en:stillbirth and foetal death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:Stokes-Adams syndrome
n1=en:stillbirth | n2=en:Stokes-Adams syndrome | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:stokes-adams syndrome
n1=en:stillbirth | n2=en:stokes-adams syndrome | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:sudden cardiac death
n1=en:stillbirth | n2=en:sudden cardiac death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:suffocation
n1=en:stillbirth | n2=en:suffocation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:surviving males are postzygotic mosaic for ebp mutations
n1=en:stillbirth | n2=en:surviving males are postzygotic mosaic for ebp mutations | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:symptoms present from infancy or early childhood
n1=en:stillbirth | n2=en:symptoms present from infancy or early childhood | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:teratosis
n1=en:stillbirth | n2=en:teratosis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:thanatopsy
n1=en:stillbirth | n2=en:thanatopsy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:the death
n1=en:stillbirth | n2=en:the death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:therapeutic abortion
n1=en:stillbirth | n2=en:therapeutic abortion | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:therapy is placement of implantable cardioverter defibrillator (icd)
n1=en:stillbirth | n2=en:therapy is placement of implantable cardioverter defibrillator (icd) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:three fetuses from 1 family have been reported (last curated august 2015)
n1=en:stillbirth | n2=en:three fetuses from 1 family have been reported (last curated august 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:three unrelated consanguineous families (libyan, egyptian, and pakistani origin) have been reported (last curated july 2015)
n1=en:stillbirth | n2=en:three unrelated consanguineous families (libyan, egyptian, and pakistani origin) have been reported (last curated july 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:three unrelated families have been reported (last curated october 2015)
n1=en:stillbirth | n2=en:three unrelated families have been reported (last curated october 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:three unrelated patients have been reported (last curated december 2015)
n1=en:stillbirth | n2=en:three unrelated patients have been reported (last curated december 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:three unrelated patients have been reported (last curated july 2015)
n1=en:stillbirth | n2=en:three unrelated patients have been reported (last curated july 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:to death
n1=en:stillbirth | n2=en:to death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:to the death
n1=en:stillbirth | n2=en:to the death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:treatment with sulfonylurea can be effective
n1=en:stillbirth | n2=en:treatment with sulfonylurea can be effective | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:trichomonas infection
n1=en:stillbirth | n2=en:trichomonas infection | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:triplet pregnancy with fetal loss and retention of one or more fetus(es), antepartum condition or complication
n1=en:stillbirth | n2=en:triplet pregnancy with fetal loss and retention of one or more fetus(es), antepartum condition or complication | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:tuba uterina
n1=en:stillbirth | n2=en:tuba uterina | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:tumor suppressor gene
n1=en:stillbirth | n2=en:tumor suppressor gene | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:tumors and pregnancy
n1=en:stillbirth | n2=en:tumors and pregnancy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:twenty-five percent of affected babies are stillborn
n1=en:stillbirth | n2=en:twenty-five percent of affected babies are stillborn | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:two families with confirmed adra2b mutations have been reported (last curated june 2015)
n1=en:stillbirth | n2=en:two families with confirmed adra2b mutations have been reported (last curated june 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:two sibs each from unrelated saudi arabian families reported (last curated may 2014)
n1=en:stillbirth | n2=en:two sibs each from unrelated saudi arabian families reported (last curated may 2014) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:two sibs from a consanguineous syrian family have been reported (last curated july 2015)
n1=en:stillbirth | n2=en:two sibs from a consanguineous syrian family have been reported (last curated july 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:two sibs have been reported (last curated november 2015)
n1=en:stillbirth | n2=en:two sibs have been reported (last curated november 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:two sisters born of consanguineous palestinian parents have been reported (last curated september 2015)
n1=en:stillbirth | n2=en:two sisters born of consanguineous palestinian parents have been reported (last curated september 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:two unrelated consanguineous families have been reported (last curated july 2015)
n1=en:stillbirth | n2=en:two unrelated consanguineous families have been reported (last curated july 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:two unrelated families have been reported (last curated february 2016)
n1=en:stillbirth | n2=en:two unrelated families have been reported (last curated february 2016) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:two unrelated families have been reported (last curated june 2015)
n1=en:stillbirth | n2=en:two unrelated families have been reported (last curated june 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:two unrelated families have been reported (last curated october 2015)
n1=en:stillbirth | n2=en:two unrelated families have been reported (last curated october 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:two unrelated patients have been reported (last curated august 2015)
n1=en:stillbirth | n2=en:two unrelated patients have been reported (last curated august 2015) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:unintended pregnancy
n1=en:stillbirth | n2=en:unintended pregnancy | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:until dead
n1=en:stillbirth | n2=en:until dead | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:until death
n1=en:stillbirth | n2=en:until death | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:until death do you part
n1=en:stillbirth | n2=en:until death do you part | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:until death you do part
n1=en:stillbirth | n2=en:until death you do part | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:until I die
n1=en:stillbirth | n2=en:until I die | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:until you die
n1=en:stillbirth | n2=en:until you die | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:uterine cancer
n1=en:stillbirth | n2=en:uterine cancer | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:uterine corpus leiomyoma
n1=en:stillbirth | n2=en:uterine corpus leiomyoma | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:uterine disorder
n1=en:stillbirth | n2=en:uterine disorder | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:uterine fibroids
n1=en:stillbirth | n2=en:uterine fibroids | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:uterine inertia
n1=en:stillbirth | n2=en:uterine inertia | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:uterine leiomyoma
n1=en:stillbirth | n2=en:uterine leiomyoma | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:uterine myoma
n1=en:stillbirth | n2=en:uterine myoma | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:uterine rupture
n1=en:stillbirth | n2=en:uterine rupture | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:uterine tube
n1=en:stillbirth | n2=en:uterine tube | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:uterus
n1=en:stillbirth | n2=en:uterus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:vagina
n1=en:stillbirth | n2=en:vagina | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:vaginal delivery
n1=en:stillbirth | n2=en:vaginal delivery | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:vaginal disorder
n1=en:stillbirth | n2=en:vaginal disorder | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:vaginal hemorrhage
n1=en:stillbirth | n2=en:vaginal hemorrhage | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:variable severity of clinical and radiologic manifestations
n1=en:stillbirth | n2=en:variable severity of clinical and radiologic manifestations | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:vulvar disorder
n1=en:stillbirth | n2=en:vulvar disorder | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:vulvar tumor
n1=en:stillbirth | n2=en:vulvar tumor | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:weakness during pregnancy in some affected females has been reported
n1=en:stillbirth | n2=en:weakness during pregnancy in some affected females has been reported | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:woman
n1=en:stillbirth | n2=en:woman | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:womb
n1=en:stillbirth | n2=en:womb | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
en:women's health
n1=en:stillbirth | n2=en:women's health | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
endométriose
n1=en:stillbirth | n2=endométriose | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
épidémiologique
n1=en:stillbirth | n2=épidémiologique | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
ethnologique
n1=en:stillbirth | n2=ethnologique | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
Fallope (trompe de)
n1=en:stillbirth | n2=Fallope (trompe de) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
fibrome de l'utérus
n1=en:stillbirth | n2=fibrome de l'utérus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
fibrome utérin
n1=en:stillbirth | n2=fibrome utérin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
fibromes utérins
n1=en:stillbirth | n2=fibromes utérins | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
fibromyome de l'utérus
n1=en:stillbirth | n2=fibromyome de l'utérus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
fibromyome utérin
n1=en:stillbirth | n2=fibromyome utérin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
gonococcie
n1=en:stillbirth | n2=gonococcie | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
gonorrhée
n1=en:stillbirth | n2=gonorrhée | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
herpès génital
n1=en:stillbirth | n2=herpès génital | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
human papillomavirus
n1=en:stillbirth | n2=human papillomavirus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
hydramnios
n1=en:stillbirth | n2=hydramnios | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
inertie utérine
n1=en:stillbirth | n2=inertie utérine | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
infection sexuellement transmissible
n1=en:stillbirth | n2=infection sexuellement transmissible | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
IST
(infection sexuellement transmissible)
n1=en:stillbirth | n2=IST (infection sexuellement transmissible) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
jusqu'à ce que mort s'en suive
n1=en:stillbirth | n2=jusqu'à ce que mort s'en suive | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
jusqu'à ce que mort s'ensuive
n1=en:stillbirth | n2=jusqu'à ce que mort s'ensuive | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
jusqu'à la mort
n1=en:stillbirth | n2=jusqu'à la mort | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
kyste à l'ovaire
n1=en:stillbirth | n2=kyste à l'ovaire | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
kyste de l'ovaire
n1=en:stillbirth | n2=kyste de l'ovaire | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
kyste ovarien
n1=en:stillbirth | n2=kyste ovarien | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
kyste ovarien bénin
n1=en:stillbirth | n2=kyste ovarien bénin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
kyste rétentionnel de l'ovaire
n1=en:stillbirth | n2=kyste rétentionnel de l'ovaire | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
la ménopause
n1=en:stillbirth | n2=la ménopause | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
léiomyome
n1=en:stillbirth | n2=léiomyome | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
leiomyome
n1=en:stillbirth | n2=leiomyome | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
léiomyome de l'utérus
n1=en:stillbirth | n2=léiomyome de l'utérus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
léiomyome de l'utérus non précisé
n1=en:stillbirth | n2=léiomyome de l'utérus non précisé | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
léiomyome utérin
n1=en:stillbirth | n2=léiomyome utérin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
léiomyomes
n1=en:stillbirth | n2=léiomyomes | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
létal
n1=en:stillbirth | n2=létal | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
lifetime
n1=en:stillbirth | n2=lifetime | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
maladie congénitale
n1=en:stillbirth | n2=maladie congénitale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
maladie infectieuse sexuellement transmissible
n1=en:stillbirth | n2=maladie infectieuse sexuellement transmissible | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
maladie infectieuse transmise sexuellement
n1=en:stillbirth | n2=maladie infectieuse transmise sexuellement | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
maladie opportuniste
n1=en:stillbirth | n2=maladie opportuniste | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
maladie sexuellement transmissible
n1=en:stillbirth | n2=maladie sexuellement transmissible | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
Maladie sexuellement transmissible
n1=en:stillbirth | n2=Maladie sexuellement transmissible | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
maladie transmissible sexuellement
n1=en:stillbirth | n2=maladie transmissible sexuellement | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
maladie vénérienne
n1=en:stillbirth | n2=maladie vénérienne | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
maladies sexuellement transmises
n1=en:stillbirth | n2=maladies sexuellement transmises | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
maladies vénériennes
n1=en:stillbirth | n2=maladies vénériennes | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
malformation congénitale
n1=en:stillbirth | n2=malformation congénitale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mammographie
n1=en:stillbirth | n2=mammographie | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mammoplastie
n1=en:stillbirth | n2=mammoplastie | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mastographie
n1=en:stillbirth | n2=mastographie | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
ménopause
n1=en:stillbirth | n2=ménopause | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
ménopausée
n1=en:stillbirth | n2=ménopausée | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
menstruation
n1=en:stillbirth | n2=menstruation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
menstrues
n1=en:stillbirth | n2=menstrues | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort cardiaque subite
n1=en:stillbirth | n2=mort cardiaque subite | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort cérébrale
n1=en:stillbirth | n2=mort cérébrale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort clinique
n1=en:stillbirth | n2=mort clinique | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort d'homme
n1=en:stillbirth | n2=mort d'homme | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort d'hommes
n1=en:stillbirth | n2=mort d'hommes | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort du nouveau-né
n1=en:stillbirth | n2=mort du nouveau-né | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort néonatale
n1=en:stillbirth | n2=mort néonatale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort relative
n1=en:stillbirth | n2=mort relative | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort soudaine d'origine cardiaque
n1=en:stillbirth | n2=mort soudaine d'origine cardiaque | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort subite cardiaque
n1=en:stillbirth | n2=mort subite cardiaque | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort subite du nourrisson
n1=en:stillbirth | n2=mort subite du nourrisson | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort subite inexpliquée d'épilepsie
n1=en:stillbirth | n2=mort subite inexpliquée d'épilepsie | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mort subite origine cardiaque
n1=en:stillbirth | n2=mort subite origine cardiaque | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mortalité foetale tardive
n1=en:stillbirth | n2=mortalité foetale tardive | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
Mortalité infantile
n1=en:stillbirth | n2=Mortalité infantile | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mortalité infantile
n1=en:stillbirth | n2=mortalité infantile | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
MST
n1=en:stillbirth | n2=MST | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
MST
(maladie sexuellement transmissible)
n1=en:stillbirth | n2=MST (maladie sexuellement transmissible) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
mts
n1=en:stillbirth | n2=mts | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
myome utérin
n1=en:stillbirth | n2=myome utérin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
naissance d'un enfant vivant
n1=en:stillbirth | n2=naissance d'un enfant vivant | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
naissance multiple
n1=en:stillbirth | n2=naissance multiple | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
naissance vivante
n1=en:stillbirth | n2=naissance vivante | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
non précisé, léiomyome de l'utérus
n1=en:stillbirth | n2=non précisé, léiomyome de l'utérus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
ostéoporose
n1=en:stillbirth | n2=ostéoporose | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
paralysis
n1=en:stillbirth | n2=paralysis | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
pathologie congénitale
n1=en:stillbirth | n2=pathologie congénitale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
période périnatale
n1=en:stillbirth | n2=période périnatale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
périodes
n1=en:stillbirth | n2=périodes | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
polyhydramnios
n1=en:stillbirth | n2=polyhydramnios | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
présentation du siège
n1=en:stillbirth | n2=présentation du siège | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
REGLES
n1=en:stillbirth | n2=REGLES | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
rétinite pigmentaire
n1=en:stillbirth | n2=rétinite pigmentaire | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
rétinite pigmentaire d'apparition tardive
n1=en:stillbirth | n2=rétinite pigmentaire d'apparition tardive | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
rétinite pigmentaire liée à la PDEB (1-bp del, his557-to-tyr)
n1=en:stillbirth | n2=rétinite pigmentaire liée à la PDEB (1-bp del, his557-to-tyr) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
rétinite pigmentaire liée à la périphérine (pro219leu)
n1=en:stillbirth | n2=rétinite pigmentaire liée à la périphérine (pro219leu) | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
rétinite pigmentaire liée à la rhodopsine
n1=en:stillbirth | n2=rétinite pigmentaire liée à la rhodopsine | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
rétinite pigmentaire liée au sexe récessive 3
n1=en:stillbirth | n2=rétinite pigmentaire liée au sexe récessive 3 | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
rétinite pigmentaire sénile
n1=en:stillbirth | n2=rétinite pigmentaire sénile | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
rétinite pigmentaire, surdité, retard mental, et hypogonadisme
n1=en:stillbirth | n2=rétinite pigmentaire, surdité, retard mental, et hypogonadisme | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
rétinopathie pigmentaire
n1=en:stillbirth | n2=rétinopathie pigmentaire | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
sein maternel
n1=en:stillbirth | n2=sein maternel | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
septicémie du nouveau-né
n1=en:stillbirth | n2=septicémie du nouveau-né | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
septicémie néonatale
n1=en:stillbirth | n2=septicémie néonatale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
signes et symptômes
n1=en:stillbirth | n2=signes et symptômes | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
souffrance foetale
n1=en:stillbirth | n2=souffrance foetale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
suffocation
n1=en:stillbirth | n2=suffocation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
syndrome de la mort subite du nourrisson
n1=en:stillbirth | n2=syndrome de la mort subite du nourrisson | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
tare congénitale
n1=en:stillbirth | n2=tare congénitale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
trompe de Fallope
n1=en:stillbirth | n2=trompe de Fallope | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
trompe fallope
n1=en:stillbirth | n2=trompe fallope | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
trompe utérine
n1=en:stillbirth | n2=trompe utérine | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
Trompe utérine
n1=en:stillbirth | n2=Trompe utérine | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
tube utérin
n1=en:stillbirth | n2=tube utérin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
tumeur de la vulve
n1=en:stillbirth | n2=tumeur de la vulve | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
tumeur maligne de l'utérus
n1=en:stillbirth | n2=tumeur maligne de l'utérus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
tumeur maligne de la vulve
n1=en:stillbirth | n2=tumeur maligne de la vulve | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
tumeur maligne utérine
n1=en:stillbirth | n2=tumeur maligne utérine | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
tumeur maligne vulvaire
n1=en:stillbirth | n2=tumeur maligne vulvaire | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
un décès accidentel
n1=en:stillbirth | n2=un décès accidentel | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
une anomalie congénitale
n1=en:stillbirth | n2=une anomalie congénitale | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
uterus
n1=en:stillbirth | n2=uterus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
utérus
n1=en:stillbirth | n2=utérus | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
utérus fibromateux
n1=en:stillbirth | n2=utérus fibromateux | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
vagin
n1=en:stillbirth | n2=vagin | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
vagina
n1=en:stillbirth | n2=vagina | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
vice de conformation
n1=en:stillbirth | n2=vice de conformation | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 20 / 0.215 ->
vies perdues
n1=en:stillbirth | n2=vies perdues | rel=r_associated | relid=0 | w=20
- en:stillbirth --
r_associated #0: 15 / 0.161 ->
en:pediatrics
n1=en:stillbirth | n2=en:pediatrics | rel=r_associated | relid=0 | w=15
- en:stillbirth --
r_associated #0: 15 / 0.161 ->
en:specialized branches of medicine
n1=en:stillbirth | n2=en:specialized branches of medicine | rel=r_associated | relid=0 | w=15
- en:stillbirth --
r_associated #0: 15 / 0.161 ->
Spécialités médicales
n1=en:stillbirth | n2=Spécialités médicales | rel=r_associated | relid=0 | w=15
- en:stillbirth --
r_associated #0: 10 / 0.108 ->
en:fetal death
n1=en:stillbirth | n2=en:fetal death | rel=r_associated | relid=0 | w=10
- en:stillbirth --
r_associated #0: 10 / 0.108 ->
en:fetal intrapartum death
n1=en:stillbirth | n2=en:fetal intrapartum death | rel=r_associated | relid=0 | w=10
- en:stillbirth --
r_associated #0: 10 / 0.108 ->
en:intrauterine fetal death
n1=en:stillbirth | n2=en:intrauterine fetal death | rel=r_associated | relid=0 | w=10
- en:stillbirth --
r_associated #0: 10 / 0.108 ->
mort du foetus in utero
n1=en:stillbirth | n2=mort du foetus in utero | rel=r_associated | relid=0 | w=10
- en:stillbirth --
r_associated #0: 10 / 0.108 ->
mort foetale
n1=en:stillbirth | n2=mort foetale | rel=r_associated | relid=0 | w=10
- en:stillbirth --
r_associated #0: 10 / 0.108 ->
mort foetale in utero
n1=en:stillbirth | n2=mort foetale in utero | rel=r_associated | relid=0 | w=10
- en:stillbirth --
r_associated #0: 10 / 0.108 ->
mort foetale intrapartum
n1=en:stillbirth | n2=mort foetale intrapartum | rel=r_associated | relid=0 | w=10
- en:stillbirth --
r_associated #0: 10 / 0.108 ->
mortinatalités
n1=en:stillbirth | n2=mortinatalités | rel=r_associated | relid=0 | w=10
- en:stillbirth --
r_associated #0: 10 / 0.108 ->
morts foetales
n1=en:stillbirth | n2=morts foetales | rel=r_associated | relid=0 | w=10
- en:stillbirth --
r_associated #0: 10 / 0.108 ->
natalité
n1=en:stillbirth | n2=natalité | rel=r_associated | relid=0 | w=10
- en:stillbirth --
r_associated #0: 5 / 0.054 ->
en:stillborn baby
n1=en:stillbirth | n2=en:stillborn baby | rel=r_associated | relid=0 | w=5
| ≈ 1377 relations entrantes
- anomalie congénitale ---
r_associated #0: 419 -->
en:stillbirth
n1=anomalie congénitale | n2=en:stillbirth | rel=r_associated | relid=0 | w=419
- en:congenital abnormality ---
r_associated #0: 418 -->
en:stillbirth
n1=en:congenital abnormality | n2=en:stillbirth | rel=r_associated | relid=0 | w=418
- en:therapeutic abortion procedure ---
r_associated #0: 379 -->
en:stillbirth
n1=en:therapeutic abortion procedure | n2=en:stillbirth | rel=r_associated | relid=0 | w=379
- avortement thérapeutique ---
r_associated #0: 375 -->
en:stillbirth
n1=avortement thérapeutique | n2=en:stillbirth | rel=r_associated | relid=0 | w=375
- leiomyome ---
r_associated #0: 364 -->
en:stillbirth
n1=leiomyome | n2=en:stillbirth | rel=r_associated | relid=0 | w=364
- fibrome utérin ---
r_associated #0: 361 -->
en:stillbirth
n1=fibrome utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=361
- fibromyome utérin ---
r_associated #0: 361 -->
en:stillbirth
n1=fibromyome utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=361
- myome utérin ---
r_associated #0: 361 -->
en:stillbirth
n1=myome utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=361
- en:uterine corpus leiomyoma ---
r_associated #0: 360 -->
en:stillbirth
n1=en:uterine corpus leiomyoma | n2=en:stillbirth | rel=r_associated | relid=0 | w=360
- en:uterine fibroids ---
r_associated #0: 360 -->
en:stillbirth
n1=en:uterine fibroids | n2=en:stillbirth | rel=r_associated | relid=0 | w=360
- fibromes utérins ---
r_associated #0: 359 -->
en:stillbirth
n1=fibromes utérins | n2=en:stillbirth | rel=r_associated | relid=0 | w=359
- malformation congénitale ---
r_associated #0: 356 -->
en:stillbirth
n1=malformation congénitale | n2=en:stillbirth | rel=r_associated | relid=0 | w=356
- utérus fibromateux ---
r_associated #0: 356 -->
en:stillbirth
n1=utérus fibromateux | n2=en:stillbirth | rel=r_associated | relid=0 | w=356
- en:SIDS ---
r_associated #0: 355 -->
en:stillbirth
n1=en:SIDS | n2=en:stillbirth | rel=r_associated | relid=0 | w=355
- en:cot death ---
r_associated #0: 355 -->
en:stillbirth
n1=en:cot death | n2=en:stillbirth | rel=r_associated | relid=0 | w=355
- mort subite du nourrisson ---
r_associated #0: 355 -->
en:stillbirth
n1=mort subite du nourrisson | n2=en:stillbirth | rel=r_associated | relid=0 | w=355
- en:congenital anomaly ---
r_associated #0: 353 -->
en:stillbirth
n1=en:congenital anomaly | n2=en:stillbirth | rel=r_associated | relid=0 | w=353
- en:sudden infant death syndrome ---
r_associated #0: 352 -->
en:stillbirth
n1=en:sudden infant death syndrome | n2=en:stillbirth | rel=r_associated | relid=0 | w=352
- léiomyome de l'utérus ---
r_associated #0: 351 -->
en:stillbirth
n1=léiomyome de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=351
- fibrome de l'utérus ---
r_associated #0: 349 -->
en:stillbirth
n1=fibrome de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=349
- syndrome de la mort subite du nourrisson ---
r_associated #0: 345 -->
en:stillbirth
n1=syndrome de la mort subite du nourrisson | n2=en:stillbirth | rel=r_associated | relid=0 | w=345
- non précisé, léiomyome de l'utérus ---
r_associated #0: 341 -->
en:stillbirth
n1=non précisé, léiomyome de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=341
- fibromyome de l'utérus ---
r_associated #0: 336 -->
en:stillbirth
n1=fibromyome de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=336
- léiomyome utérin ---
r_associated #0: 331 -->
en:stillbirth
n1=léiomyome utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=331
- en:congenital defect ---
r_associated #0: 310 -->
en:stillbirth
n1=en:congenital defect | n2=en:stillbirth | rel=r_associated | relid=0 | w=310
- en:womb ---
r_associated #0: 310 -->
en:stillbirth
n1=en:womb | n2=en:stillbirth | rel=r_associated | relid=0 | w=310
- utérus ---
r_associated #0: 309 -->
en:stillbirth
n1=utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=309
- en:ovarian disorder ---
r_associated #0: 304 -->
en:stillbirth
n1=en:ovarian disorder | n2=en:stillbirth | rel=r_associated | relid=0 | w=304
- maladies des ovaires ---
r_associated #0: 302 -->
en:stillbirth
n1=maladies des ovaires | n2=en:stillbirth | rel=r_associated | relid=0 | w=302
- maladie des ovaires ---
r_associated #0: 301 -->
en:stillbirth
n1=maladie des ovaires | n2=en:stillbirth | rel=r_associated | relid=0 | w=301
- déformation congénitale ---
r_associated #0: 296 -->
en:stillbirth
n1=déformation congénitale | n2=en:stillbirth | rel=r_associated | relid=0 | w=296
- déficience congénitale ---
r_associated #0: 295 -->
en:stillbirth
n1=déficience congénitale | n2=en:stillbirth | rel=r_associated | relid=0 | w=295
- léiomyome ---
r_associated #0: 285 -->
en:stillbirth
n1=léiomyome | n2=en:stillbirth | rel=r_associated | relid=0 | w=285
- maladie infectieuse transmise sexuellement ---
r_associated #0: 275 -->
en:stillbirth
n1=maladie infectieuse transmise sexuellement | n2=en:stillbirth | rel=r_associated | relid=0 | w=275
- en:sexually transmitted disorder ---
r_associated #0: 268 -->
en:stillbirth
n1=en:sexually transmitted disorder | n2=en:stillbirth | rel=r_associated | relid=0 | w=268
- infection sexuellement transmissible ---
r_associated #0: 266 -->
en:stillbirth
n1=infection sexuellement transmissible | n2=en:stillbirth | rel=r_associated | relid=0 | w=266
- en:crib death ---
r_associated #0: 265 -->
en:stillbirth
n1=en:crib death | n2=en:stillbirth | rel=r_associated | relid=0 | w=265
- maladie infectieuse sexuellement transmissible ---
r_associated #0: 265 -->
en:stillbirth
n1=maladie infectieuse sexuellement transmissible | n2=en:stillbirth | rel=r_associated | relid=0 | w=265
- maladie sexuellement transmissible ---
r_associated #0: 265 -->
en:stillbirth
n1=maladie sexuellement transmissible | n2=en:stillbirth | rel=r_associated | relid=0 | w=265
- infertilité de la femme ---
r_associated #0: 264 -->
en:stillbirth
n1=infertilité de la femme | n2=en:stillbirth | rel=r_associated | relid=0 | w=264
- en:female infertility ---
r_associated #0: 263 -->
en:stillbirth
n1=en:female infertility | n2=en:stillbirth | rel=r_associated | relid=0 | w=263
- léiomyome de l'utérus non précisé ---
r_associated #0: 240 -->
en:stillbirth
n1=léiomyome de l'utérus non précisé | n2=en:stillbirth | rel=r_associated | relid=0 | w=240
- mts ---
r_associated #0: 230 -->
en:stillbirth
n1=mts | n2=en:stillbirth | rel=r_associated | relid=0 | w=230
- maladie transmissible sexuellement ---
r_associated #0: 225 -->
en:stillbirth
n1=maladie transmissible sexuellement | n2=en:stillbirth | rel=r_associated | relid=0 | w=225
- léiomyomes ---
r_associated #0: 214 -->
en:stillbirth
n1=léiomyomes | n2=en:stillbirth | rel=r_associated | relid=0 | w=214
- difformité congénitale ---
r_associated #0: 205 -->
en:stillbirth
n1=difformité congénitale | n2=en:stillbirth | rel=r_associated | relid=0 | w=205
- maladie congénitale ---
r_associated #0: 203 -->
en:stillbirth
n1=maladie congénitale | n2=en:stillbirth | rel=r_associated | relid=0 | w=203
- maladie vénérienne ---
r_associated #0: 200 -->
en:stillbirth
n1=maladie vénérienne | n2=en:stillbirth | rel=r_associated | relid=0 | w=200
- MST
(maladie sexuellement transmissible) ---
r_associated #0: 195 -->
en:stillbirth
n1=MST (maladie sexuellement transmissible) | n2=en:stillbirth | rel=r_associated | relid=0 | w=195
- en:STD ---
r_associated #0: 195 -->
en:stillbirth
n1=en:STD | n2=en:stillbirth | rel=r_associated | relid=0 | w=195
- en:sexually transmitted disease ---
r_associated #0: 195 -->
en:stillbirth
n1=en:sexually transmitted disease | n2=en:stillbirth | rel=r_associated | relid=0 | w=195
- en:sexually transmitted infection ---
r_associated #0: 195 -->
en:stillbirth
n1=en:sexually transmitted infection | n2=en:stillbirth | rel=r_associated | relid=0 | w=195
- pathologie congénitale ---
r_associated #0: 195 -->
en:stillbirth
n1=pathologie congénitale | n2=en:stillbirth | rel=r_associated | relid=0 | w=195
- en:uterus ---
r_associated #0: 181 -->
en:stillbirth
n1=en:uterus | n2=en:stillbirth | rel=r_associated | relid=0 | w=181
- mort du nouveau-né ---
r_associated #0: 173 -->
en:stillbirth
n1=mort du nouveau-né | n2=en:stillbirth | rel=r_associated | relid=0 | w=173
- mort néonatale ---
r_associated #0: 173 -->
en:stillbirth
n1=mort néonatale | n2=en:stillbirth | rel=r_associated | relid=0 | w=173
- kyste ovarien ---
r_associated #0: 171 -->
en:stillbirth
n1=kyste ovarien | n2=en:stillbirth | rel=r_associated | relid=0 | w=171
- kyste à l'ovaire ---
r_associated #0: 171 -->
en:stillbirth
n1=kyste à l'ovaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=171
- en:neonatal death ---
r_associated #0: 170 -->
en:stillbirth
n1=en:neonatal death | n2=en:stillbirth | rel=r_associated | relid=0 | w=170
- en:ovarian cyst ---
r_associated #0: 170 -->
en:stillbirth
n1=en:ovarian cyst | n2=en:stillbirth | rel=r_associated | relid=0 | w=170
- kyste de l'ovaire ---
r_associated #0: 170 -->
en:stillbirth
n1=kyste de l'ovaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=170
- kyste ovarien bénin ---
r_associated #0: 170 -->
en:stillbirth
n1=kyste ovarien bénin | n2=en:stillbirth | rel=r_associated | relid=0 | w=170
- kyste rétentionnel de l'ovaire ---
r_associated #0: 170 -->
en:stillbirth
n1=kyste rétentionnel de l'ovaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=170
- septicémie du nouveau-né ---
r_associated #0: 168 -->
en:stillbirth
n1=septicémie du nouveau-né | n2=en:stillbirth | rel=r_associated | relid=0 | w=168
- infertilité féminine ---
r_associated #0: 166 -->
en:stillbirth
n1=infertilité féminine | n2=en:stillbirth | rel=r_associated | relid=0 | w=166
- cancer de la vulve ---
r_associated #0: 165 -->
en:stillbirth
n1=cancer de la vulve | n2=en:stillbirth | rel=r_associated | relid=0 | w=165
- septicémie néonatale ---
r_associated #0: 165 -->
en:stillbirth
n1=septicémie néonatale | n2=en:stillbirth | rel=r_associated | relid=0 | w=165
- en:malignant vulvar neoplasm ---
r_associated #0: 164 -->
en:stillbirth
n1=en:malignant vulvar neoplasm | n2=en:stillbirth | rel=r_associated | relid=0 | w=164
- cancer vulvaire ---
r_associated #0: 162 -->
en:stillbirth
n1=cancer vulvaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=162
- stérilité féminine ---
r_associated #0: 161 -->
en:stillbirth
n1=stérilité féminine | n2=en:stillbirth | rel=r_associated | relid=0 | w=161
- douleur dans une articulation ---
r_associated #0: 160 -->
en:stillbirth
n1=douleur dans une articulation | n2=en:stillbirth | rel=r_associated | relid=0 | w=160
- tumeur de la vulve ---
r_associated #0: 160 -->
en:stillbirth
n1=tumeur de la vulve | n2=en:stillbirth | rel=r_associated | relid=0 | w=160
- tumeur maligne vulvaire ---
r_associated #0: 160 -->
en:stillbirth
n1=tumeur maligne vulvaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=160
- détresse foetale ---
r_associated #0: 158 -->
en:stillbirth
n1=détresse foetale | n2=en:stillbirth | rel=r_associated | relid=0 | w=158
- en:neonatal sepsis ---
r_associated #0: 158 -->
en:stillbirth
n1=en:neonatal sepsis | n2=en:stillbirth | rel=r_associated | relid=0 | w=158
- en:fetal distress ---
r_associated #0: 157 -->
en:stillbirth
n1=en:fetal distress | n2=en:stillbirth | rel=r_associated | relid=0 | w=157
- en:arthralgia ---
r_associated #0: 152 -->
en:stillbirth
n1=en:arthralgia | n2=en:stillbirth | rel=r_associated | relid=0 | w=152
- algie articulaire ---
r_associated #0: 150 -->
en:stillbirth
n1=algie articulaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=150
- en:malignant neoplasm of vulva ---
r_associated #0: 150 -->
en:stillbirth
n1=en:malignant neoplasm of vulva | n2=en:stillbirth | rel=r_associated | relid=0 | w=150
- tumeur maligne de la vulve ---
r_associated #0: 150 -->
en:stillbirth
n1=tumeur maligne de la vulve | n2=en:stillbirth | rel=r_associated | relid=0 | w=150
- arthralgie ---
r_associated #0: 145 -->
en:stillbirth
n1=arthralgie | n2=en:stillbirth | rel=r_associated | relid=0 | w=145
- douleur articulaire ---
r_associated #0: 145 -->
en:stillbirth
n1=douleur articulaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=145
- en:congenital malformation ---
r_associated #0: 130 -->
en:stillbirth
n1=en:congenital malformation | n2=en:stillbirth | rel=r_associated | relid=0 | w=130
- cancer du col de l'utérus ---
r_associated #0: 125 -->
en:stillbirth
n1=cancer du col de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=125
- cancer du col utérin ---
r_associated #0: 125 -->
en:stillbirth
n1=cancer du col utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=125
- souffrance foetale ---
r_associated #0: 125 -->
en:stillbirth
n1=souffrance foetale | n2=en:stillbirth | rel=r_associated | relid=0 | w=125
- en:cervical cancer ---
r_associated #0: 121 -->
en:stillbirth
n1=en:cervical cancer | n2=en:stillbirth | rel=r_associated | relid=0 | w=121
- en:birth defect ---
r_associated #0: 120 -->
en:stillbirth
n1=en:birth defect | n2=en:stillbirth | rel=r_associated | relid=0 | w=120
- Cancer du col utérin ---
r_associated #0: 115 -->
en:stillbirth
n1=Cancer du col utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=115
- cancer utérin ---
r_associated #0: 111 -->
en:stillbirth
n1=cancer utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=111
- Cancer utérin ---
r_associated #0: 110 -->
en:stillbirth
n1=Cancer utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=110
- en:STI ---
r_associated #0: 110 -->
en:stillbirth
n1=en:STI | n2=en:stillbirth | rel=r_associated | relid=0 | w=110
- uterus ---
r_associated #0: 100 -->
en:stillbirth
n1=uterus | n2=en:stillbirth | rel=r_associated | relid=0 | w=100
- mammoplastie ---
r_associated #0: 99 -->
en:stillbirth
n1=mammoplastie | n2=en:stillbirth | rel=r_associated | relid=0 | w=99
- polyhydramnios ---
r_associated #0: 96 -->
en:stillbirth
n1=polyhydramnios | n2=en:stillbirth | rel=r_associated | relid=0 | w=96
- en:mammoplasty ---
r_associated #0: 95 -->
en:stillbirth
n1=en:mammoplasty | n2=en:stillbirth | rel=r_associated | relid=0 | w=95
- en:polyhydramnios ---
r_associated #0: 95 -->
en:stillbirth
n1=en:polyhydramnios | n2=en:stillbirth | rel=r_associated | relid=0 | w=95
- en:joint pain ---
r_associated #0: 90 -->
en:stillbirth
n1=en:joint pain | n2=en:stillbirth | rel=r_associated | relid=0 | w=90
- ostéoporose ---
r_associated #0: 88 -->
en:stillbirth
n1=ostéoporose | n2=en:stillbirth | rel=r_associated | relid=0 | w=88
- en:osteoporosis ---
r_associated #0: 87 -->
en:stillbirth
n1=en:osteoporosis | n2=en:stillbirth | rel=r_associated | relid=0 | w=87
- en:death ---
r_associated #0: 84 -->
en:stillbirth
n1=en:death | n2=en:stillbirth | rel=r_associated | relid=0 | w=84
- mort subite inexpliquée d'épilepsie ---
r_associated #0: 82 -->
en:stillbirth
n1=mort subite inexpliquée d'épilepsie | n2=en:stillbirth | rel=r_associated | relid=0 | w=82
- mort soudaine d'origine cardiaque ---
r_associated #0: 81 -->
en:stillbirth
n1=mort soudaine d'origine cardiaque | n2=en:stillbirth | rel=r_associated | relid=0 | w=81
- en:for life ---
r_associated #0: 80 -->
en:stillbirth
n1=en:for life | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:human death ---
r_associated #0: 80 -->
en:stillbirth
n1=en:human death | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:lifetime ---
r_associated #0: 80 -->
en:stillbirth
n1=en:lifetime | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:loss of human life ---
r_associated #0: 80 -->
en:stillbirth
n1=en:loss of human life | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:loss of life ---
r_associated #0: 80 -->
en:stillbirth
n1=en:loss of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:sudden cardiac death ---
r_associated #0: 80 -->
en:stillbirth
n1=en:sudden cardiac death | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:sudden unexplained death in epilepsy ---
r_associated #0: 80 -->
en:stillbirth
n1=en:sudden unexplained death in epilepsy | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:to death ---
r_associated #0: 80 -->
en:stillbirth
n1=en:to death | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:until dead ---
r_associated #0: 80 -->
en:stillbirth
n1=en:until dead | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:until death ---
r_associated #0: 80 -->
en:stillbirth
n1=en:until death | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:until death do you part ---
r_associated #0: 80 -->
en:stillbirth
n1=en:until death do you part | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:until death you do part ---
r_associated #0: 80 -->
en:stillbirth
n1=en:until death you do part | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:until you die ---
r_associated #0: 80 -->
en:stillbirth
n1=en:until you die | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- jusqu'à ce que mort s'en suive ---
r_associated #0: 80 -->
en:stillbirth
n1=jusqu'à ce que mort s'en suive | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- jusqu'à ce que mort s'ensuive ---
r_associated #0: 80 -->
en:stillbirth
n1=jusqu'à ce que mort s'ensuive | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- mort cardiaque subite ---
r_associated #0: 80 -->
en:stillbirth
n1=mort cardiaque subite | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- mort d'homme ---
r_associated #0: 80 -->
en:stillbirth
n1=mort d'homme | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- mort subite cardiaque ---
r_associated #0: 80 -->
en:stillbirth
n1=mort subite cardiaque | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- mort subite origine cardiaque ---
r_associated #0: 80 -->
en:stillbirth
n1=mort subite origine cardiaque | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- tare congénitale ---
r_associated #0: 80 -->
en:stillbirth
n1=tare congénitale | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- à la mort ---
r_associated #0: 80 -->
en:stillbirth
n1=à la mort | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- à la vie ---
r_associated #0: 80 -->
en:stillbirth
n1=à la vie | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- à vie ---
r_associated #0: 80 -->
en:stillbirth
n1=à vie | n2=en:stillbirth | rel=r_associated | relid=0 | w=80
- en:fallopian tube ---
r_associated #0: 78 -->
en:stillbirth
n1=en:fallopian tube | n2=en:stillbirth | rel=r_associated | relid=0 | w=78
- Cancer de la vulve ---
r_associated #0: 75 -->
en:stillbirth
n1=Cancer de la vulve | n2=en:stillbirth | rel=r_associated | relid=0 | w=75
- en:malignant uterine neoplasm ---
r_associated #0: 75 -->
en:stillbirth
n1=en:malignant uterine neoplasm | n2=en:stillbirth | rel=r_associated | relid=0 | w=75
- en:uterine cancer ---
r_associated #0: 75 -->
en:stillbirth
n1=en:uterine cancer | n2=en:stillbirth | rel=r_associated | relid=0 | w=75
- trompe de Fallope ---
r_associated #0: 75 -->
en:stillbirth
n1=trompe de Fallope | n2=en:stillbirth | rel=r_associated | relid=0 | w=75
- trompe utérine ---
r_associated #0: 75 -->
en:stillbirth
n1=trompe utérine | n2=en:stillbirth | rel=r_associated | relid=0 | w=75
- tumeur maligne utérine ---
r_associated #0: 75 -->
en:stillbirth
n1=tumeur maligne utérine | n2=en:stillbirth | rel=r_associated | relid=0 | w=75
- MV ---
r_associated #0: 72 -->
en:stillbirth
n1=MV | n2=en:stillbirth | rel=r_associated | relid=0 | w=72
- décès soudain inexpliqué dans l'épilepsie ---
r_associated #0: 71 -->
en:stillbirth
n1=décès soudain inexpliqué dans l'épilepsie | n2=en:stillbirth | rel=r_associated | relid=0 | w=71
- en:menstruation ---
r_associated #0: 70 -->
en:stillbirth
n1=en:menstruation | n2=en:stillbirth | rel=r_associated | relid=0 | w=70
- tube utérin ---
r_associated #0: 70 -->
en:stillbirth
n1=tube utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=70
- menstruation ---
r_associated #0: 67 -->
en:stillbirth
n1=menstruation | n2=en:stillbirth | rel=r_associated | relid=0 | w=67
- en:Fallopian tube ---
r_associated #0: 66 -->
en:stillbirth
n1=en:Fallopian tube | n2=en:stillbirth | rel=r_associated | relid=0 | w=66
- en:mammography ---
r_associated #0: 65 -->
en:stillbirth
n1=en:mammography | n2=en:stillbirth | rel=r_associated | relid=0 | w=65
- mammographie ---
r_associated #0: 64 -->
en:stillbirth
n1=mammographie | n2=en:stillbirth | rel=r_associated | relid=0 | w=64
- en:autopsy ---
r_associated #0: 63 -->
en:stillbirth
n1=en:autopsy | n2=en:stillbirth | rel=r_associated | relid=0 | w=63
- autopsie ---
r_associated #0: 60 -->
en:stillbirth
n1=autopsie | n2=en:stillbirth | rel=r_associated | relid=0 | w=60
- en:periods ---
r_associated #0: 60 -->
en:stillbirth
n1=en:periods | n2=en:stillbirth | rel=r_associated | relid=0 | w=60
- en:the death ---
r_associated #0: 60 -->
en:stillbirth
n1=en:the death | n2=en:stillbirth | rel=r_associated | relid=0 | w=60
- en:to the death ---
r_associated #0: 60 -->
en:stillbirth
n1=en:to the death | n2=en:stillbirth | rel=r_associated | relid=0 | w=60
- en:until I die ---
r_associated #0: 60 -->
en:stillbirth
n1=en:until I die | n2=en:stillbirth | rel=r_associated | relid=0 | w=60
- en:vagina ---
r_associated #0: 60 -->
en:stillbirth
n1=en:vagina | n2=en:stillbirth | rel=r_associated | relid=0 | w=60
- jusqu'à la mort ---
r_associated #0: 60 -->
en:stillbirth
n1=jusqu'à la mort | n2=en:stillbirth | rel=r_associated | relid=0 | w=60
- mort d'hommes ---
r_associated #0: 60 -->
en:stillbirth
n1=mort d'hommes | n2=en:stillbirth | rel=r_associated | relid=0 | w=60
- vagina ---
r_associated #0: 59 -->
en:stillbirth
n1=vagina | n2=en:stillbirth | rel=r_associated | relid=0 | w=59
- trompe fallope ---
r_associated #0: 56 -->
en:stillbirth
n1=trompe fallope | n2=en:stillbirth | rel=r_associated | relid=0 | w=56
- vagin ---
r_associated #0: 56 -->
en:stillbirth
n1=vagin | n2=en:stillbirth | rel=r_associated | relid=0 | w=56
- MST ---
r_associated #0: 55 -->
en:stillbirth
n1=MST | n2=en:stillbirth | rel=r_associated | relid=0 | w=55
- cancer de l'utérus ---
r_associated #0: 55 -->
en:stillbirth
n1=cancer de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=55
- carcinome utérin ---
r_associated #0: 55 -->
en:stillbirth
n1=carcinome utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=55
- en:horn of uterus ---
r_associated #0: 55 -->
en:stillbirth
n1=en:horn of uterus | n2=en:stillbirth | rel=r_associated | relid=0 | w=55
- en:human papillomavirus ---
r_associated #0: 52 -->
en:stillbirth
n1=en:human papillomavirus | n2=en:stillbirth | rel=r_associated | relid=0 | w=52
- vice de conformation ---
r_associated #0: 52 -->
en:stillbirth
n1=vice de conformation | n2=en:stillbirth | rel=r_associated | relid=0 | w=52
- avortement spontané ---
r_associated #0: 51 -->
en:stillbirth
n1=avortement spontané | n2=en:stillbirth | rel=r_associated | relid=0 | w=51
- en:sign or symptom ---
r_associated #0: 51 -->
en:stillbirth
n1=en:sign or symptom | n2=en:stillbirth | rel=r_associated | relid=0 | w=51
- human papillomavirus ---
r_associated #0: 51 -->
en:stillbirth
n1=human papillomavirus | n2=en:stillbirth | rel=r_associated | relid=0 | w=51
- menstrues ---
r_associated #0: 51 -->
en:stillbirth
n1=menstrues | n2=en:stillbirth | rel=r_associated | relid=0 | w=51
- mortalité infantile ---
r_associated #0: 51 -->
en:stillbirth
n1=mortalité infantile | n2=en:stillbirth | rel=r_associated | relid=0 | w=51
- en:menses ---
r_associated #0: 50 -->
en:stillbirth
n1=en:menses | n2=en:stillbirth | rel=r_associated | relid=0 | w=50
- en:miscarriage ---
r_associated #0: 50 -->
en:stillbirth
n1=en:miscarriage | n2=en:stillbirth | rel=r_associated | relid=0 | w=50
- en:spontaneous abortion ---
r_associated #0: 50 -->
en:stillbirth
n1=en:spontaneous abortion | n2=en:stillbirth | rel=r_associated | relid=0 | w=50
- fausse couche ---
r_associated #0: 50 -->
en:stillbirth
n1=fausse couche | n2=en:stillbirth | rel=r_associated | relid=0 | w=50
- tumeur maligne de l'utérus ---
r_associated #0: 50 -->
en:stillbirth
n1=tumeur maligne de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=50
- en:signs and symptoms ---
r_associated #0: 49 -->
en:stillbirth
n1=en:signs and symptoms | n2=en:stillbirth | rel=r_associated | relid=0 | w=49
- en:teratosis ---
r_associated #0: 49 -->
en:stillbirth
n1=en:teratosis | n2=en:stillbirth | rel=r_associated | relid=0 | w=49
- lifetime ---
r_associated #0: 49 -->
en:stillbirth
n1=lifetime | n2=en:stillbirth | rel=r_associated | relid=0 | w=49
- signes et symptômes ---
r_associated #0: 49 -->
en:stillbirth
n1=signes et symptômes | n2=en:stillbirth | rel=r_associated | relid=0 | w=49
- en:asphyxia ---
r_associated #0: 48 -->
en:stillbirth
n1=en:asphyxia | n2=en:stillbirth | rel=r_associated | relid=0 | w=48
- en:infant mortality ---
r_associated #0: 48 -->
en:stillbirth
n1=en:infant mortality | n2=en:stillbirth | rel=r_associated | relid=0 | w=48
- en:vulvar tumor ---
r_associated #0: 48 -->
en:stillbirth
n1=en:vulvar tumor | n2=en:stillbirth | rel=r_associated | relid=0 | w=48
- Trompe utérine ---
r_associated #0: 46 -->
en:stillbirth
n1=Trompe utérine | n2=en:stillbirth | rel=r_associated | relid=0 | w=46
- en:foetal distress ---
r_associated #0: 46 -->
en:stillbirth
n1=en:foetal distress | n2=en:stillbirth | rel=r_associated | relid=0 | w=46
- en:major physical defect ---
r_associated #0: 46 -->
en:stillbirth
n1=en:major physical defect | n2=en:stillbirth | rel=r_associated | relid=0 | w=46
- gonococcie ---
r_associated #0: 46 -->
en:stillbirth
n1=gonococcie | n2=en:stillbirth | rel=r_associated | relid=0 | w=46
- asphyxie ---
r_associated #0: 45 -->
en:stillbirth
n1=asphyxie | n2=en:stillbirth | rel=r_associated | relid=0 | w=45
- létal ---
r_associated #0: 45 -->
en:stillbirth
n1=létal | n2=en:stillbirth | rel=r_associated | relid=0 | w=45
- asphyxia ---
r_associated #0: 44 -->
en:stillbirth
n1=asphyxia | n2=en:stillbirth | rel=r_associated | relid=0 | w=44
- en:female sheath ---
r_associated #0: 44 -->
en:stillbirth
n1=en:female sheath | n2=en:stillbirth | rel=r_associated | relid=0 | w=44
- rétinite pigmentaire d'apparition tardive ---
r_associated #0: 44 -->
en:stillbirth
n1=rétinite pigmentaire d'apparition tardive | n2=en:stillbirth | rel=r_associated | relid=0 | w=44
- Mortalité infantile ---
r_associated #0: 43 -->
en:stillbirth
n1=Mortalité infantile | n2=en:stillbirth | rel=r_associated | relid=0 | w=43
- anomalie du développement ---
r_associated #0: 43 -->
en:stillbirth
n1=anomalie du développement | n2=en:stillbirth | rel=r_associated | relid=0 | w=43
- en:based on one jordanian family (last curated august 2015) ---
r_associated #0: 43 -->
en:stillbirth
n1=en:based on one jordanian family (last curated august 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=43
- en:episodes occur 30 minutes to 3 hours after exposure to cold ---
r_associated #0: 43 -->
en:stillbirth
n1=en:episodes occur 30 minutes to 3 hours after exposure to cold | n2=en:stillbirth | rel=r_associated | relid=0 | w=43
- en:heterozygous females may exhibit variable degrees of enzyme deficiency ---
r_associated #0: 43 -->
en:stillbirth
n1=en:heterozygous females may exhibit variable degrees of enzyme deficiency | n2=en:stillbirth | rel=r_associated | relid=0 | w=43
- en:incidence 1/100,000 - 1/200,000 live births ---
r_associated #0: 43 -->
en:stillbirth
n1=en:incidence 1/100,000 - 1/200,000 live births | n2=en:stillbirth | rel=r_associated | relid=0 | w=43
- en:low birth weight ---
r_associated #0: 43 -->
en:stillbirth
n1=en:low birth weight | n2=en:stillbirth | rel=r_associated | relid=0 | w=43
- en:may be progressive ---
r_associated #0: 43 -->
en:stillbirth
n1=en:may be progressive | n2=en:stillbirth | rel=r_associated | relid=0 | w=43
- en:three unrelated patients have been reported (last curated july 2015) ---
r_associated #0: 43 -->
en:stillbirth
n1=en:three unrelated patients have been reported (last curated july 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=43
- en:based on one large dutch family (last curated august 2015) ---
r_associated #0: 42 -->
en:stillbirth
n1=en:based on one large dutch family (last curated august 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:born after precipitate delivery ---
r_associated #0: 42 -->
en:stillbirth
n1=en:born after precipitate delivery | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:early death (usually by 3 years of age) ---
r_associated #0: 42 -->
en:stillbirth
n1=en:early death (usually by 3 years of age) | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:gonorrhea ---
r_associated #0: 42 -->
en:stillbirth
n1=en:gonorrhea | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:induction of labor ---
r_associated #0: 42 -->
en:stillbirth
n1=en:induction of labor | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:juvenile onset 4 years to puberty ---
r_associated #0: 42 -->
en:stillbirth
n1=en:juvenile onset 4 years to puberty | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:leiomyoma of the uterus ---
r_associated #0: 42 -->
en:stillbirth
n1=en:leiomyoma of the uterus | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:lethal ---
r_associated #0: 42 -->
en:stillbirth
n1=en:lethal | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:lethal tight skin contracture syndrome (disorder) ---
r_associated #0: 42 -->
en:stillbirth
n1=en:lethal tight skin contracture syndrome (disorder) | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:may manifest as late-onset 'parkinsonian' phenotype without severe ataxic features ---
r_associated #0: 42 -->
en:stillbirth
n1=en:may manifest as late-onset 'parkinsonian' phenotype without severe ataxic features | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:onset in early infancy ---
r_associated #0: 42 -->
en:stillbirth
n1=en:onset in early infancy | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:patients with homozygous, compound heterozygous, and heterozygous mutation have been reported ---
r_associated #0: 42 -->
en:stillbirth
n1=en:patients with homozygous, compound heterozygous, and heterozygous mutation have been reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:physical defect ---
r_associated #0: 42 -->
en:stillbirth
n1=en:physical defect | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:sensorineural hearing loss may be presenting feature ---
r_associated #0: 42 -->
en:stillbirth
n1=en:sensorineural hearing loss may be presenting feature | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:twin pregnancy with fetal loss and retention of one fetus, unspecified as to episode of care or not applicable ---
r_associated #0: 42 -->
en:stillbirth
n1=en:twin pregnancy with fetal loss and retention of one fetus, unspecified as to episode of care or not applicable | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- en:variable age of onset (range 4 months to 45 years) ---
r_associated #0: 42 -->
en:stillbirth
n1=en:variable age of onset (range 4 months to 45 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=42
- accouchement normal ---
r_associated #0: 41 -->
en:stillbirth
n1=accouchement normal | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- en:Huguier's disease ---
r_associated #0: 41 -->
en:stillbirth
n1=en:Huguier's disease | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- en:adult onset of neurologic symptoms has been reported in 1 family ---
r_associated #0: 41 -->
en:stillbirth
n1=en:adult onset of neurologic symptoms has been reported in 1 family | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- en:cardiac death ---
r_associated #0: 41 -->
en:stillbirth
n1=en:cardiac death | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- en:delivery of shoulder presentation function ---
r_associated #0: 41 -->
en:stillbirth
n1=en:delivery of shoulder presentation function | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- en:early death may occur ---
r_associated #0: 41 -->
en:stillbirth
n1=en:early death may occur | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- en:electromyography may be normal in infancy, but shows myopathic pattern in adolescence and adulthood ---
r_associated #0: 41 -->
en:stillbirth
n1=en:electromyography may be normal in infancy, but shows myopathic pattern in adolescence and adulthood | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- en:infants show normal size and appearance ---
r_associated #0: 41 -->
en:stillbirth
n1=en:infants show normal size and appearance | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- en:late-adult onset ---
r_associated #0: 41 -->
en:stillbirth
n1=en:late-adult onset | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- en:live born infants die within few hours of birth ---
r_associated #0: 41 -->
en:stillbirth
n1=en:live born infants die within few hours of birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- en:short survival (less than 10 years after onset) ---
r_associated #0: 41 -->
en:stillbirth
n1=en:short survival (less than 10 years after onset) | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- en:stokes-adams syndrome ---
r_associated #0: 41 -->
en:stillbirth
n1=en:stokes-adams syndrome | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- herpès génital ---
r_associated #0: 41 -->
en:stillbirth
n1=herpès génital | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- mortinatalité ---
r_associated #0: 41 -->
en:stillbirth
n1=mortinatalité | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- présentation du siège ---
r_associated #0: 41 -->
en:stillbirth
n1=présentation du siège | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- période périnatale ---
r_associated #0: 41 -->
en:stillbirth
n1=période périnatale | n2=en:stillbirth | rel=r_associated | relid=0 | w=41
- REGLES ---
r_associated #0: 40 -->
en:stillbirth
n1=REGLES | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:allelic to hydropic and prenatally lethal chondrodystrophy (215140) ---
r_associated #0: 40 -->
en:stillbirth
n1=en:allelic to hydropic and prenatally lethal chondrodystrophy (215140) | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:breech presentation ---
r_associated #0: 40 -->
en:stillbirth
n1=en:breech presentation | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:child often can sit unsupported but never ambulates ---
r_associated #0: 40 -->
en:stillbirth
n1=en:child often can sit unsupported but never ambulates | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:facial palsy often transient in infancy ---
r_associated #0: 40 -->
en:stillbirth
n1=en:facial palsy often transient in infancy | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:fracture frequency decreased post puberty ---
r_associated #0: 40 -->
en:stillbirth
n1=en:fracture frequency decreased post puberty | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:genetic heterogeneity (see mcc1 deficiency 210200) ---
r_associated #0: 40 -->
en:stillbirth
n1=en:genetic heterogeneity (see mcc1 deficiency 210200) | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:genital herpes ---
r_associated #0: 40 -->
en:stillbirth
n1=en:genital herpes | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:gradual progression ---
r_associated #0: 40 -->
en:stillbirth
n1=en:gradual progression | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:infant death ---
r_associated #0: 40 -->
en:stillbirth
n1=en:infant death | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:juvenile form has onset between 4 and 19 years ---
r_associated #0: 40 -->
en:stillbirth
n1=en:juvenile form has onset between 4 and 19 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:mean age at onset 35 years (range 20-60) ---
r_associated #0: 40 -->
en:stillbirth
n1=en:mean age at onset 35 years (range 20-60) | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:medullary thyroid cancer is aggressive and can occur in childhood ---
r_associated #0: 40 -->
en:stillbirth
n1=en:medullary thyroid cancer is aggressive and can occur in childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:normal delivery ---
r_associated #0: 40 -->
en:stillbirth
n1=en:normal delivery | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:premature baby death ---
r_associated #0: 40 -->
en:stillbirth
n1=en:premature baby death | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- mastographie ---
r_associated #0: 40 -->
en:stillbirth
n1=mastographie | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- mort cérébrale ---
r_associated #0: 40 -->
en:stillbirth
n1=mort cérébrale | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- mortinaissance ---
r_associated #0: 40 -->
en:stillbirth
n1=mortinaissance | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- ménopause ---
r_associated #0: 40 -->
en:stillbirth
n1=ménopause | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- ménopausée ---
r_associated #0: 40 -->
en:stillbirth
n1=ménopausée | n2=en:stillbirth | rel=r_associated | relid=0 | w=40
- en:birth canal ---
r_associated #0: 39 -->
en:stillbirth
n1=en:birth canal | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:death usually in childhood ---
r_associated #0: 39 -->
en:stillbirth
n1=en:death usually in childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:fibroma of the uterus ---
r_associated #0: 39 -->
en:stillbirth
n1=en:fibroma of the uterus | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:fractures can occur in utero, during labor and delivery, or in newborn period ---
r_associated #0: 39 -->
en:stillbirth
n1=en:fractures can occur in utero, during labor and delivery, or in newborn period | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:heterozygotes may also show increased susceptibility to toxic effects of thiopurine treatment ---
r_associated #0: 39 -->
en:stillbirth
n1=en:heterozygotes may also show increased susceptibility to toxic effects of thiopurine treatment | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:hypersensitivity to ionizing radiation ---
r_associated #0: 39 -->
en:stillbirth
n1=en:hypersensitivity to ionizing radiation | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:incidence of 1 in 5,000 to 1 in 10,000 ---
r_associated #0: 39 -->
en:stillbirth
n1=en:incidence of 1 in 5,000 to 1 in 10,000 | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:incomplete, but high, penetrance ---
r_associated #0: 39 -->
en:stillbirth
n1=en:incomplete, but high, penetrance | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:later onset (late childhood to young adult) has been reported ---
r_associated #0: 39 -->
en:stillbirth
n1=en:later onset (late childhood to young adult) has been reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:left sided involvement occurs more frequently ---
r_associated #0: 39 -->
en:stillbirth
n1=en:left sided involvement occurs more frequently | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:lesions apparent at birth ---
r_associated #0: 39 -->
en:stillbirth
n1=en:lesions apparent at birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:malignant vaginal neoplasm ---
r_associated #0: 39 -->
en:stillbirth
n1=en:malignant vaginal neoplasm | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:median survival is > 50 years ---
r_associated #0: 39 -->
en:stillbirth
n1=en:median survival is > 50 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:menopause ---
r_associated #0: 39 -->
en:stillbirth
n1=en:menopause | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:miscellaneous ---
r_associated #0: 39 -->
en:stillbirth
n1=en:miscellaneous | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- en:perinatal period ---
r_associated #0: 39 -->
en:stillbirth
n1=en:perinatal period | n2=en:stillbirth | rel=r_associated | relid=0 | w=39
- Maladie sexuellement transmissible ---
r_associated #0: 38 -->
en:stillbirth
n1=Maladie sexuellement transmissible | n2=en:stillbirth | rel=r_associated | relid=0 | w=38
- en:cardiomyopathy is not a feature ---
r_associated #0: 38 -->
en:stillbirth
n1=en:cardiomyopathy is not a feature | n2=en:stillbirth | rel=r_associated | relid=0 | w=38
- en:death in perinatal period ---
r_associated #0: 38 -->
en:stillbirth
n1=en:death in perinatal period | n2=en:stillbirth | rel=r_associated | relid=0 | w=38
- en:evidence of systemic iron overload seen in 1 family ---
r_associated #0: 38 -->
en:stillbirth
n1=en:evidence of systemic iron overload seen in 1 family | n2=en:stillbirth | rel=r_associated | relid=0 | w=38
- en:fibromyoma uteri ---
r_associated #0: 38 -->
en:stillbirth
n1=en:fibromyoma uteri | n2=en:stillbirth | rel=r_associated | relid=0 | w=38
- en:good response to steroid treatment ---
r_associated #0: 38 -->
en:stillbirth
n1=en:good response to steroid treatment | n2=en:stillbirth | rel=r_associated | relid=0 | w=38
- en:high frequencies affected before low frequencies ---
r_associated #0: 38 -->
en:stillbirth
n1=en:high frequencies affected before low frequencies | n2=en:stillbirth | rel=r_associated | relid=0 | w=38
- en:high frequency of absence seizures (several per day) ---
r_associated #0: 38 -->
en:stillbirth
n1=en:high frequency of absence seizures (several per day) | n2=en:stillbirth | rel=r_associated | relid=0 | w=38
- en:home childbirth ---
r_associated #0: 38 -->
en:stillbirth
n1=en:home childbirth | n2=en:stillbirth | rel=r_associated | relid=0 | w=38
- en:milder form with onset in childhood, absence seizures, and learning difficulties ---
r_associated #0: 38 -->
en:stillbirth
n1=en:milder form with onset in childhood, absence seizures, and learning difficulties | n2=en:stillbirth | rel=r_associated | relid=0 | w=38
- atonie de l'utérus ---
r_associated #0: 37 -->
en:stillbirth
n1=atonie de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:Stokes-Adams syndrome ---
r_associated #0: 37 -->
en:stillbirth
n1=en:Stokes-Adams syndrome | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:allelic disorder to choreoathetosis, congenital hypothyroidism, and neonatal respiratory distress (610978), which is a more severe disorder ---
r_associated #0: 37 -->
en:stillbirth
n1=en:allelic disorder to choreoathetosis, congenital hypothyroidism, and neonatal respiratory distress (610978), which is a more severe disorder | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:child's sudden death ---
r_associated #0: 37 -->
en:stillbirth
n1=en:child's sudden death | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:herpes genitalis ---
r_associated #0: 37 -->
en:stillbirth
n1=en:herpes genitalis | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:herpes progenitalis ---
r_associated #0: 37 -->
en:stillbirth
n1=en:herpes progenitalis | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:heterozygotes at risk of developing acute, symptomatic methemoglobinemia after exposure to exogenous, methemoglobin-inducing agents ---
r_associated #0: 37 -->
en:stillbirth
n1=en:heterozygotes at risk of developing acute, symptomatic methemoglobinemia after exposure to exogenous, methemoglobin-inducing agents | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:high risk of recurrence after surgery ---
r_associated #0: 37 -->
en:stillbirth
n1=en:high risk of recurrence after surgery | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:highly variable phenotype, some adults may be asymptomatic ---
r_associated #0: 37 -->
en:stillbirth
n1=en:highly variable phenotype, some adults may be asymptomatic | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:opportunistic infection ---
r_associated #0: 37 -->
en:stillbirth
n1=en:opportunistic infection | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:pregnancy outcome ---
r_associated #0: 37 -->
en:stillbirth
n1=en:pregnancy outcome | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:quadruplet pregnancy with fetal loss and retention of one or more fetus(es), antepartum condition or complication ---
r_associated #0: 37 -->
en:stillbirth
n1=en:quadruplet pregnancy with fetal loss and retention of one or more fetus(es), antepartum condition or complication | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:twin pregnancy with fetal loss and retention of one fetus, antepartum condition or complication ---
r_associated #0: 37 -->
en:stillbirth
n1=en:twin pregnancy with fetal loss and retention of one fetus, antepartum condition or complication | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- en:uterine leiomyoma ---
r_associated #0: 37 -->
en:stillbirth
n1=en:uterine leiomyoma | n2=en:stillbirth | rel=r_associated | relid=0 | w=37
- Fallope (trompe de) ---
r_associated #0: 36 -->
en:stillbirth
n1=Fallope (trompe de) | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:adrenal insufficiency usually develops later (first decade) ---
r_associated #0: 36 -->
en:stillbirth
n1=en:adrenal insufficiency usually develops later (first decade) | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:cerebral death ---
r_associated #0: 36 -->
en:stillbirth
n1=en:cerebral death | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:child death ---
r_associated #0: 36 -->
en:stillbirth
n1=en:child death | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:distinct from pseudopili annulati (613241) ---
r_associated #0: 36 -->
en:stillbirth
n1=en:distinct from pseudopili annulati (613241) | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:favorable response to ursodeoxycholic acid treatment ---
r_associated #0: 36 -->
en:stillbirth
n1=en:favorable response to ursodeoxycholic acid treatment | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:hair regrowth may occur later in life ---
r_associated #0: 36 -->
en:stillbirth
n1=en:hair regrowth may occur later in life | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:incidence of 1 in 10,000 live births ---
r_associated #0: 36 -->
en:stillbirth
n1=en:incidence of 1 in 10,000 live births | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:incidence, 1 in 500 heterozygotes, 1 in 1,000,000 homozygotes ---
r_associated #0: 36 -->
en:stillbirth
n1=en:incidence, 1 in 500 heterozygotes, 1 in 1,000,000 homozygotes | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:joint symptoms begin in third or fourth decade ---
r_associated #0: 36 -->
en:stillbirth
n1=en:joint symptoms begin in third or fourth decade | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:marked clinical variability within families ---
r_associated #0: 36 -->
en:stillbirth
n1=en:marked clinical variability within families | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:may show good response to levodopa ---
r_associated #0: 36 -->
en:stillbirth
n1=en:may show good response to levodopa | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:mean age at onset of dementia is 57 years ---
r_associated #0: 36 -->
en:stillbirth
n1=en:mean age at onset of dementia is 57 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:retinitis pigmentosa ---
r_associated #0: 36 -->
en:stillbirth
n1=en:retinitis pigmentosa | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:six patients have been reported (as of october 2011) ---
r_associated #0: 36 -->
en:stillbirth
n1=en:six patients have been reported (as of october 2011) | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:two unrelated consanguineous families (saudi arabian and israeli palestinian) have been reported (last curated february 2014) ---
r_associated #0: 36 -->
en:stillbirth
n1=en:two unrelated consanguineous families (saudi arabian and israeli palestinian) have been reported (last curated february 2014) | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:variable expression ---
r_associated #0: 36 -->
en:stillbirth
n1=en:variable expression | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- inertie utérine ---
r_associated #0: 36 -->
en:stillbirth
n1=inertie utérine | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- naissance multiple ---
r_associated #0: 36 -->
en:stillbirth
n1=naissance multiple | n2=en:stillbirth | rel=r_associated | relid=0 | w=36
- en:age at onset from 3 to 51 years (mean 19.2 years) ---
r_associated #0: 35 -->
en:stillbirth
n1=en:age at onset from 3 to 51 years (mean 19.2 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:approximately 50% of patients have situs inversus ---
r_associated #0: 35 -->
en:stillbirth
n1=en:approximately 50% of patients have situs inversus | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:based on report of 4 patients from 1 family (last curated july 2015) ---
r_associated #0: 35 -->
en:stillbirth
n1=en:based on report of 4 patients from 1 family (last curated july 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:brain death ---
r_associated #0: 35 -->
en:stillbirth
n1=en:brain death | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:breast disorder ---
r_associated #0: 35 -->
en:stillbirth
n1=en:breast disorder | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:clinical presentation varies from asymptomatic to fulminant course ---
r_associated #0: 35 -->
en:stillbirth
n1=en:clinical presentation varies from asymptomatic to fulminant course | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:cold-induced sweating develops late in the first decade ---
r_associated #0: 35 -->
en:stillbirth
n1=en:cold-induced sweating develops late in the first decade | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:color vision defects may not be part of the phenotype ---
r_associated #0: 35 -->
en:stillbirth
n1=en:color vision defects may not be part of the phenotype | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:compound heterozygosity common ---
r_associated #0: 35 -->
en:stillbirth
n1=en:compound heterozygosity common | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:condition is experienced by patients as harmless and is often discovered incidentally ---
r_associated #0: 35 -->
en:stillbirth
n1=en:condition is experienced by patients as harmless and is often discovered incidentally | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:deafness tends to occur before other neurologic signs, except in patients with very early onset ---
r_associated #0: 35 -->
en:stillbirth
n1=en:deafness tends to occur before other neurologic signs, except in patients with very early onset | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:death due to rapidly progressive pulmonary fibrosis in infancy ---
r_associated #0: 35 -->
en:stillbirth
n1=en:death due to rapidly progressive pulmonary fibrosis in infancy | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:death secondary to renal failure, cardiac or cerebrovascular disease ---
r_associated #0: 35 -->
en:stillbirth
n1=en:death secondary to renal failure, cardiac or cerebrovascular disease | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:dysmorphic facial features reported in 1 family ---
r_associated #0: 35 -->
en:stillbirth
n1=en:dysmorphic facial features reported in 1 family | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:episodes brought on by fasting or infection ---
r_associated #0: 35 -->
en:stillbirth
n1=en:episodes brought on by fasting or infection | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:feet are unaffected in some patients ---
r_associated #0: 35 -->
en:stillbirth
n1=en:feet are unaffected in some patients | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:female reproductive system ---
r_associated #0: 35 -->
en:stillbirth
n1=en:female reproductive system | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:full recovery after attacks ---
r_associated #0: 35 -->
en:stillbirth
n1=en:full recovery after attacks | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:heterozygous carriers have blue sclerae, small joint hypermobility, and mild thinning of cornea ---
r_associated #0: 35 -->
en:stillbirth
n1=en:heterozygous carriers have blue sclerae, small joint hypermobility, and mild thinning of cornea | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:highly penetrant, but low morbidity ---
r_associated #0: 35 -->
en:stillbirth
n1=en:highly penetrant, but low morbidity | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:highly variable frequency and duration of episodes ---
r_associated #0: 35 -->
en:stillbirth
n1=en:highly variable frequency and duration of episodes | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:highly variable phenotype, even within families ---
r_associated #0: 35 -->
en:stillbirth
n1=en:highly variable phenotype, even within families | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:in the absence of hydrops, death occurs within 3 months ---
r_associated #0: 35 -->
en:stillbirth
n1=en:in the absence of hydrops, death occurs within 3 months | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:incidence of 1 in 100,000 births ---
r_associated #0: 35 -->
en:stillbirth
n1=en:incidence of 1 in 100,000 births | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:incomplete penetrance (50%) ---
r_associated #0: 35 -->
en:stillbirth
n1=en:incomplete penetrance (50%) | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:increased recurrence risk with parental translocation ---
r_associated #0: 35 -->
en:stillbirth
n1=en:increased recurrence risk with parental translocation | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:increased risk of developing early-onset aggressive cancers ---
r_associated #0: 35 -->
en:stillbirth
n1=en:increased risk of developing early-onset aggressive cancers | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:inflammatory arthritis may develop in 30% of patients ---
r_associated #0: 35 -->
en:stillbirth
n1=en:inflammatory arthritis may develop in 30% of patients | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:internal organ rupture may occur ---
r_associated #0: 35 -->
en:stillbirth
n1=en:internal organ rupture may occur | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:later onset has been reported ---
r_associated #0: 35 -->
en:stillbirth
n1=en:later onset has been reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:later onset may occur ---
r_associated #0: 35 -->
en:stillbirth
n1=en:later onset may occur | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:left side involvement more frequent than right side involvement ---
r_associated #0: 35 -->
en:stillbirth
n1=en:left side involvement more frequent than right side involvement | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:lesions are present at birth or become apparent in infancy ---
r_associated #0: 35 -->
en:stillbirth
n1=en:lesions are present at birth or become apparent in infancy | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:male-to-female ratio of 3:2 in childhood cases ---
r_associated #0: 35 -->
en:stillbirth
n1=en:male-to-female ratio of 3:2 in childhood cases | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:males carry mutations in the somatic mosaic state ---
r_associated #0: 35 -->
en:stillbirth
n1=en:males carry mutations in the somatic mosaic state | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:manifests in infancy (including neonatal lethal) or childhood ---
r_associated #0: 35 -->
en:stillbirth
n1=en:manifests in infancy (including neonatal lethal) or childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:may progress to other body regions after many years ---
r_associated #0: 35 -->
en:stillbirth
n1=en:may progress to other body regions after many years | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:may result in early death from severe diarrhea ---
r_associated #0: 35 -->
en:stillbirth
n1=en:may result in early death from severe diarrhea | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:mean age at diagnosis 8.8 years (range 0.2-23 years) ---
r_associated #0: 35 -->
en:stillbirth
n1=en:mean age at diagnosis 8.8 years (range 0.2-23 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:mean age at onset 15.2 years ---
r_associated #0: 35 -->
en:stillbirth
n1=en:mean age at onset 15.2 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:mean age at onset 24 years (range 14 to 33 years) ---
r_associated #0: 35 -->
en:stillbirth
n1=en:mean age at onset 24 years (range 14 to 33 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:mean age at onset of migraines is 42 years ---
r_associated #0: 35 -->
en:stillbirth
n1=en:mean age at onset of migraines is 42 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:mean age of onset 16 to 19 years ---
r_associated #0: 35 -->
en:stillbirth
n1=en:mean age of onset 16 to 19 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:median age at diagnosis, 59 years ---
r_associated #0: 35 -->
en:stillbirth
n1=en:median age at diagnosis, 59 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:median onset of neurologic symptoms is 13 years (range 5 to 28) ---
r_associated #0: 35 -->
en:stillbirth
n1=en:median onset of neurologic symptoms is 13 years (range 5 to 28) | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:median survival 5.7 years ---
r_associated #0: 35 -->
en:stillbirth
n1=en:median survival 5.7 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:metabolic encephalomyopathic crises often triggered by infection ---
r_associated #0: 35 -->
en:stillbirth
n1=en:metabolic encephalomyopathic crises often triggered by infection | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:multiple birth ---
r_associated #0: 35 -->
en:stillbirth
n1=en:multiple birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:nine patients have been reported (last curated july 2015) ---
r_associated #0: 35 -->
en:stillbirth
n1=en:nine patients have been reported (last curated july 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:one lebanese family has been reported ---
r_associated #0: 35 -->
en:stillbirth
n1=en:one lebanese family has been reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:onset of overgrowth in the first year of life (in most cases) ---
r_associated #0: 35 -->
en:stillbirth
n1=en:onset of overgrowth in the first year of life (in most cases) | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:onset of symptoms in early childhood in most patients ---
r_associated #0: 35 -->
en:stillbirth
n1=en:onset of symptoms in early childhood in most patients | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:onset usually in childhood or adolescence ---
r_associated #0: 35 -->
en:stillbirth
n1=en:onset usually in childhood or adolescence | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:pelvic inflammatory disease ---
r_associated #0: 35 -->
en:stillbirth
n1=en:pelvic inflammatory disease | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:phenotypic variation (may affect language expression, reception, and/or articulation) ---
r_associated #0: 35 -->
en:stillbirth
n1=en:phenotypic variation (may affect language expression, reception, and/or articulation) | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:poor fetal development ---
r_associated #0: 35 -->
en:stillbirth
n1=en:poor fetal development | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:precipitated by fever ---
r_associated #0: 35 -->
en:stillbirth
n1=en:precipitated by fever | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:premature rupture of membrane ---
r_associated #0: 35 -->
en:stillbirth
n1=en:premature rupture of membrane | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:retinal holes were present in an asymptomatic female carrier ---
r_associated #0: 35 -->
en:stillbirth
n1=en:retinal holes were present in an asymptomatic female carrier | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:seizures remit spontaneously by age 5 years ---
r_associated #0: 35 -->
en:stillbirth
n1=en:seizures remit spontaneously by age 5 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:sexual infantilism ---
r_associated #0: 35 -->
en:stillbirth
n1=en:sexual infantilism | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:skeletal and facial features are variable ---
r_associated #0: 35 -->
en:stillbirth
n1=en:skeletal and facial features are variable | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:some patients may show a favorable response to oral coenzyme q10 supplementation ---
r_associated #0: 35 -->
en:stillbirth
n1=en:some patients may show a favorable response to oral coenzyme q10 supplementation | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:stein-leventhal syndrome ---
r_associated #0: 35 -->
en:stillbirth
n1=en:stein-leventhal syndrome | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:two sibs each from unrelated saudi arabian families reported (last curated may 2014) ---
r_associated #0: 35 -->
en:stillbirth
n1=en:two sibs each from unrelated saudi arabian families reported (last curated may 2014) | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:two unrelated families have been reported (last curated february 2016) ---
r_associated #0: 35 -->
en:stillbirth
n1=en:two unrelated families have been reported (last curated february 2016) | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:two unrelated patients have been reported (last curated august 2015) ---
r_associated #0: 35 -->
en:stillbirth
n1=en:two unrelated patients have been reported (last curated august 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:uterine inertia ---
r_associated #0: 35 -->
en:stillbirth
n1=en:uterine inertia | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:vulvar disorder ---
r_associated #0: 35 -->
en:stillbirth
n1=en:vulvar disorder | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- en:women's health ---
r_associated #0: 35 -->
en:stillbirth
n1=en:women's health | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- mam ---
r_associated #0: 35 -->
en:stillbirth
n1=mam | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- mort clinique ---
r_associated #0: 35 -->
en:stillbirth
n1=mort clinique | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- mort relative ---
r_associated #0: 35 -->
en:stillbirth
n1=mort relative | n2=en:stillbirth | rel=r_associated | relid=0 | w=35
- accouchement par voie vaginale ---
r_associated #0: 34 -->
en:stillbirth
n1=accouchement par voie vaginale | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- death ---
r_associated #0: 34 -->
en:stillbirth
n1=death | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:absence seizures show onset between 3.5 and 4 years ---
r_associated #0: 34 -->
en:stillbirth
n1=en:absence seizures show onset between 3.5 and 4 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:adult onset from second to seventh decade ---
r_associated #0: 34 -->
en:stillbirth
n1=en:adult onset from second to seventh decade | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:age of onset ranges from 1 to 47 years ---
r_associated #0: 34 -->
en:stillbirth
n1=en:age of onset ranges from 1 to 47 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:age of onset usually 1 week to 2 years ---
r_associated #0: 34 -->
en:stillbirth
n1=en:age of onset usually 1 week to 2 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:allelic disorder to benign hereditary chorea (118700), which is less severe ---
r_associated #0: 34 -->
en:stillbirth
n1=en:allelic disorder to benign hereditary chorea (118700), which is less severe | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:anemia is responsive to corticosteroid treatment ---
r_associated #0: 34 -->
en:stillbirth
n1=en:anemia is responsive to corticosteroid treatment | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:associated with increased frequency of autoimmune diseases ---
r_associated #0: 34 -->
en:stillbirth
n1=en:associated with increased frequency of autoimmune diseases | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:average age at onset between 40 and 50 years ---
r_associated #0: 34 -->
en:stillbirth
n1=en:average age at onset between 40 and 50 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:average disease duration of 7 years ---
r_associated #0: 34 -->
en:stillbirth
n1=en:average disease duration of 7 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:average onset 6-10 months (range 3-24) ---
r_associated #0: 34 -->
en:stillbirth
n1=en:average onset 6-10 months (range 3-24) | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:based on one sib pair each in their seventies ---
r_associated #0: 34 -->
en:stillbirth
n1=en:based on one sib pair each in their seventies | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:carrier females show no phenotypic abnormalities, but may have learning difficulties ---
r_associated #0: 34 -->
en:stillbirth
n1=en:carrier females show no phenotypic abnormalities, but may have learning difficulties | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:chelation therapy can result in clinical improvement ---
r_associated #0: 34 -->
en:stillbirth
n1=en:chelation therapy can result in clinical improvement | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:cutaneous symptoms induced by cold exposure or cooling ---
r_associated #0: 34 -->
en:stillbirth
n1=en:cutaneous symptoms induced by cold exposure or cooling | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:death by electrocution ---
r_associated #0: 34 -->
en:stillbirth
n1=en:death by electrocution | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:death in early adulthood ---
r_associated #0: 34 -->
en:stillbirth
n1=en:death in early adulthood | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:death of unknown cause ---
r_associated #0: 34 -->
en:stillbirth
n1=en:death of unknown cause | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:death secondary to respiratory infection or failure before age 2 years ---
r_associated #0: 34 -->
en:stillbirth
n1=en:death secondary to respiratory infection or failure before age 2 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:diagnosis requires 3 major features (a positive family history is also considered a major feature) and at least 3 minor features ---
r_associated #0: 34 -->
en:stillbirth
n1=en:diagnosis requires 3 major features (a positive family history is also considered a major feature) and at least 3 minor features | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:earlier onset is associated with a more severe disorder ---
r_associated #0: 34 -->
en:stillbirth
n1=en:earlier onset is associated with a more severe disorder | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:early death (in some patients) ---
r_associated #0: 34 -->
en:stillbirth
n1=en:early death (in some patients) | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:elevated body temperatures to 42 degrees celsius ---
r_associated #0: 34 -->
en:stillbirth
n1=en:elevated body temperatures to 42 degrees celsius | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:embryo loss ---
r_associated #0: 34 -->
en:stillbirth
n1=en:embryo loss | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:epidemiologic ---
r_associated #0: 34 -->
en:stillbirth
n1=en:epidemiologic | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:extrapyramidal signs show a favorable response to levodopa ---
r_associated #0: 34 -->
en:stillbirth
n1=en:extrapyramidal signs show a favorable response to levodopa | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:face to pubes birth ---
r_associated #0: 34 -->
en:stillbirth
n1=en:face to pubes birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:fatal in first few months of life in most cases ---
r_associated #0: 34 -->
en:stillbirth
n1=en:fatal in first few months of life in most cases | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:fatal without lung transplant ---
r_associated #0: 34 -->
en:stillbirth
n1=en:fatal without lung transplant | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:feeding problems in newborn ---
r_associated #0: 34 -->
en:stillbirth
n1=en:feeding problems in newborn | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:females often show milder phenotype with later onset of cardiac symptoms ---
r_associated #0: 34 -->
en:stillbirth
n1=en:females often show milder phenotype with later onset of cardiac symptoms | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:forceps delivery finding ---
r_associated #0: 34 -->
en:stillbirth
n1=en:forceps delivery finding | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:four unrelated families have been reported (last curated august 2015) ---
r_associated #0: 34 -->
en:stillbirth
n1=en:four unrelated families have been reported (last curated august 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:gastric suction pump, home model, portable or stationary, electric ---
r_associated #0: 34 -->
en:stillbirth
n1=en:gastric suction pump, home model, portable or stationary, electric | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:hands clenched at birth but loosen in infancy ---
r_associated #0: 34 -->
en:stillbirth
n1=en:hands clenched at birth but loosen in infancy | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:hearing loss affects all frequencies ---
r_associated #0: 34 -->
en:stillbirth
n1=en:hearing loss affects all frequencies | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:hepatomegaly improves with age and disappears around puberty ---
r_associated #0: 34 -->
en:stillbirth
n1=en:hepatomegaly improves with age and disappears around puberty | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:heterozygotes are not affected ---
r_associated #0: 34 -->
en:stillbirth
n1=en:heterozygotes are not affected | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:highly variable phenotype including fluctuating phenotype ('fluctuans') or severe phenotype ('permanens') ---
r_associated #0: 34 -->
en:stillbirth
n1=en:highly variable phenotype including fluctuating phenotype ('fluctuans') or severe phenotype ('permanens') | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:highly variable phenotype, ranging from asymptomatic to severe ---
r_associated #0: 34 -->
en:stillbirth
n1=en:highly variable phenotype, ranging from asymptomatic to severe | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:hyperkeratosis often present at birth but may appear later ---
r_associated #0: 34 -->
en:stillbirth
n1=en:hyperkeratosis often present at birth but may appear later | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:hyperthermia in early childhood ---
r_associated #0: 34 -->
en:stillbirth
n1=en:hyperthermia in early childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:incidence 5-50 per million (children) and 10-40 per million (adults) ---
r_associated #0: 34 -->
en:stillbirth
n1=en:incidence 5-50 per million (children) and 10-40 per million (adults) | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:incidence of 1 in 120,000 live births ---
r_associated #0: 34 -->
en:stillbirth
n1=en:incidence of 1 in 120,000 live births | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:incomplete penetrance ---
r_associated #0: 34 -->
en:stillbirth
n1=en:incomplete penetrance | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:incomplete penetrance of optic atrophy ---
r_associated #0: 34 -->
en:stillbirth
n1=en:incomplete penetrance of optic atrophy | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:increased paternal age ---
r_associated #0: 34 -->
en:stillbirth
n1=en:increased paternal age | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:infantile form accounts for 90% of cases ---
r_associated #0: 34 -->
en:stillbirth
n1=en:infantile form accounts for 90% of cases | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:inflammatory bowel disease may develop in childhood or adolescence ---
r_associated #0: 34 -->
en:stillbirth
n1=en:inflammatory bowel disease may develop in childhood or adolescence | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:intrafamilial phenotypic variation may occur ---
r_associated #0: 34 -->
en:stillbirth
n1=en:intrafamilial phenotypic variation may occur | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:lack of treatment results in early death ---
r_associated #0: 34 -->
en:stillbirth
n1=en:lack of treatment results in early death | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:late infantile onset 6-24 months ---
r_associated #0: 34 -->
en:stillbirth
n1=en:late infantile onset 6-24 months | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:late-onset, slowly progressing form of retinitis pigmentosa ---
r_associated #0: 34 -->
en:stillbirth
n1=en:late-onset, slowly progressing form of retinitis pigmentosa | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:leakage of fluid ('gusher') if the stapes is disturbed ---
r_associated #0: 34 -->
en:stillbirth
n1=en:leakage of fluid ('gusher') if the stapes is disturbed | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:lesions continue to grow until epiphyseal plate closure ---
r_associated #0: 34 -->
en:stillbirth
n1=en:lesions continue to grow until epiphyseal plate closure | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:loss of independent ambulation in the second decade ---
r_associated #0: 34 -->
en:stillbirth
n1=en:loss of independent ambulation in the second decade | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:lower limb involvement occurs before upper limb involvement ---
r_associated #0: 34 -->
en:stillbirth
n1=en:lower limb involvement occurs before upper limb involvement | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:majority of patients have normal intelligence ---
r_associated #0: 34 -->
en:stillbirth
n1=en:majority of patients have normal intelligence | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:many patients lose independent mobility after 25 years ---
r_associated #0: 34 -->
en:stillbirth
n1=en:many patients lose independent mobility after 25 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:may be asymptomatic ---
r_associated #0: 34 -->
en:stillbirth
n1=en:may be asymptomatic | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:may be fatal in infancy ---
r_associated #0: 34 -->
en:stillbirth
n1=en:may be fatal in infancy | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:may be lethal if untreated ---
r_associated #0: 34 -->
en:stillbirth
n1=en:may be lethal if untreated | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:mean age at onset 46.5 years (range 19-64) ---
r_associated #0: 34 -->
en:stillbirth
n1=en:mean age at onset 46.5 years (range 19-64) | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:mean age at onset of bone fractures, 24 years ---
r_associated #0: 34 -->
en:stillbirth
n1=en:mean age at onset of bone fractures, 24 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:mean age of diagnosis of renal cell carcinoma is 46 years ---
r_associated #0: 34 -->
en:stillbirth
n1=en:mean age of diagnosis of renal cell carcinoma is 46 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:natural childbirth assistance ---
r_associated #0: 34 -->
en:stillbirth
n1=en:natural childbirth assistance | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:no extraocular findings ---
r_associated #0: 34 -->
en:stillbirth
n1=en:no extraocular findings | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:no situs inversus ---
r_associated #0: 34 -->
en:stillbirth
n1=en:no situs inversus | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:nuchal cord ---
r_associated #0: 34 -->
en:stillbirth
n1=en:nuchal cord | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:one family and 2 unrelated patients have been reported (last curated december 2015) ---
r_associated #0: 34 -->
en:stillbirth
n1=en:one family and 2 unrelated patients have been reported (last curated december 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:one patient reported (last curated november 2012) ---
r_associated #0: 34 -->
en:stillbirth
n1=en:one patient reported (last curated november 2012) | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:onset in first decade after normal early development ---
r_associated #0: 34 -->
en:stillbirth
n1=en:onset in first decade after normal early development | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:ovarian duct ---
r_associated #0: 34 -->
en:stillbirth
n1=en:ovarian duct | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:pediatric adverse events terminology ---
r_associated #0: 34 -->
en:stillbirth
n1=en:pediatric adverse events terminology | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:perinatal mortality demographics ---
r_associated #0: 34 -->
en:stillbirth
n1=en:perinatal mortality demographics | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:postmature pregnancy delivered ---
r_associated #0: 34 -->
en:stillbirth
n1=en:postmature pregnancy delivered | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:postpartum hemorrhage ---
r_associated #0: 34 -->
en:stillbirth
n1=en:postpartum hemorrhage | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:precipitated by general anesthesia ---
r_associated #0: 34 -->
en:stillbirth
n1=en:precipitated by general anesthesia | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:prelingual onset ---
r_associated #0: 34 -->
en:stillbirth
n1=en:prelingual onset | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:psychology qualifier ---
r_associated #0: 34 -->
en:stillbirth
n1=en:psychology qualifier | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:reactions and intoxications due to drugs administered to fetus and newborn ---
r_associated #0: 34 -->
en:stillbirth
n1=en:reactions and intoxications due to drugs administered to fetus and newborn | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:recurrent episodes of liver failure during intercurrent infections ---
r_associated #0: 34 -->
en:stillbirth
n1=en:recurrent episodes of liver failure during intercurrent infections | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:small placenta ---
r_associated #0: 34 -->
en:stillbirth
n1=en:small placenta | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:subset of patients have leigh syndrome (256000) ---
r_associated #0: 34 -->
en:stillbirth
n1=en:subset of patients have leigh syndrome (256000) | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:three unrelated families have been reported (last curated october 2015) ---
r_associated #0: 34 -->
en:stillbirth
n1=en:three unrelated families have been reported (last curated october 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:two sisters born of consanguineous palestinian parents have been reported (last curated september 2015) ---
r_associated #0: 34 -->
en:stillbirth
n1=en:two sisters born of consanguineous palestinian parents have been reported (last curated september 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:unintended pregnancy ---
r_associated #0: 34 -->
en:stillbirth
n1=en:unintended pregnancy | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:uterine disorder ---
r_associated #0: 34 -->
en:stillbirth
n1=en:uterine disorder | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:uterine myoma ---
r_associated #0: 34 -->
en:stillbirth
n1=en:uterine myoma | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:vaginal delivery ---
r_associated #0: 34 -->
en:stillbirth
n1=en:vaginal delivery | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:variable age at onset, first to second decades ---
r_associated #0: 34 -->
en:stillbirth
n1=en:variable age at onset, first to second decades | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:variable features present ---
r_associated #0: 34 -->
en:stillbirth
n1=en:variable features present | n2=en:stillbirth | rel=r_associated | relid=0 | w=34
- en:abnormal sensitivity to therapeutic radiation ---
r_associated #0: 32 -->
en:stillbirth
n1=en:abnormal sensitivity to therapeutic radiation | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:accidental death ---
r_associated #0: 32 -->
en:stillbirth
n1=en:accidental death | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:age of onset/diagnosis 12-35 years ---
r_associated #0: 32 -->
en:stillbirth
n1=en:age of onset/diagnosis 12-35 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:all features are unilateral ---
r_associated #0: 32 -->
en:stillbirth
n1=en:all features are unilateral | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:allelic disorder to potassium-aggravated myotonia (608390) ---
r_associated #0: 32 -->
en:stillbirth
n1=en:allelic disorder to potassium-aggravated myotonia (608390) | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:approximately 40% of cases are inherited or new germline mutations ---
r_associated #0: 32 -->
en:stillbirth
n1=en:approximately 40% of cases are inherited or new germline mutations | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:asymptomatic patients may show changes on sd-oct ---
r_associated #0: 32 -->
en:stillbirth
n1=en:asymptomatic patients may show changes on sd-oct | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:based on a report of 4 patients from 2 consanguineous families (last curated august 2015) ---
r_associated #0: 32 -->
en:stillbirth
n1=en:based on a report of 4 patients from 2 consanguineous families (last curated august 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:blistering may worsen during the summer ---
r_associated #0: 32 -->
en:stillbirth
n1=en:blistering may worsen during the summer | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:carneous mole ---
r_associated #0: 32 -->
en:stillbirth
n1=en:carneous mole | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:clonidine can alleviate hyperhidrosis ---
r_associated #0: 32 -->
en:stillbirth
n1=en:clonidine can alleviate hyperhidrosis | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:coloboma is associated with larger microdeletion (490kb) of 11q13 ---
r_associated #0: 32 -->
en:stillbirth
n1=en:coloboma is associated with larger microdeletion (490kb) of 11q13 | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:dead fetus ---
r_associated #0: 32 -->
en:stillbirth
n1=en:dead fetus | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:death before age 40 ---
r_associated #0: 32 -->
en:stillbirth
n1=en:death before age 40 | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:death usually in first year of life ---
r_associated #0: 32 -->
en:stillbirth
n1=en:death usually in first year of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:diagnosis made when at least 2/3 features present (optic nerve hypoplasia, hypopituitarism with pituitary hypoplasia, midline forebrain defects) ---
r_associated #0: 32 -->
en:stillbirth
n1=en:diagnosis made when at least 2/3 features present (optic nerve hypoplasia, hypopituitarism with pituitary hypoplasia, midline forebrain defects) | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:discordant phenotype among monozygotic twins has been reported ---
r_associated #0: 32 -->
en:stillbirth
n1=en:discordant phenotype among monozygotic twins has been reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:divided into isolated cases (75-80%), familial (10-15%), and syndromal (1-5%) ---
r_associated #0: 32 -->
en:stillbirth
n1=en:divided into isolated cases (75-80%), familial (10-15%), and syndromal (1-5%) | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:early death due to sepsis ---
r_associated #0: 32 -->
en:stillbirth
n1=en:early death due to sepsis | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:estimated frequency 1/2000-1/4000 individuals ---
r_associated #0: 32 -->
en:stillbirth
n1=en:estimated frequency 1/2000-1/4000 individuals | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:fatal before age 2 years ---
r_associated #0: 32 -->
en:stillbirth
n1=en:fatal before age 2 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:features are variable ---
r_associated #0: 32 -->
en:stillbirth
n1=en:features are variable | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:fetal health and development ---
r_associated #0: 32 -->
en:stillbirth
n1=en:fetal health and development | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:four clinically indistinguishable biochemically distinct forms (see 252900, 252920, 252930) ---
r_associated #0: 32 -->
en:stillbirth
n1=en:four clinically indistinguishable biochemically distinct forms (see 252900, 252920, 252930) | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:fractures and dental caries and premature secondary tooth loss occur in adulthood ---
r_associated #0: 32 -->
en:stillbirth
n1=en:fractures and dental caries and premature secondary tooth loss occur in adulthood | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:frequency and severity of symptoms do not worsen with age ---
r_associated #0: 32 -->
en:stillbirth
n1=en:frequency and severity of symptoms do not worsen with age | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:genetic heterogeneity (see 605407) ---
r_associated #0: 32 -->
en:stillbirth
n1=en:genetic heterogeneity (see 605407) | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:heterozygotes exhibit blue sclerae and soft velvety skin ---
r_associated #0: 32 -->
en:stillbirth
n1=en:heterozygotes exhibit blue sclerae and soft velvety skin | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:highly variable organ involvement and severity ---
r_associated #0: 32 -->
en:stillbirth
n1=en:highly variable organ involvement and severity | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:highly variable phenotype and severity ---
r_associated #0: 32 -->
en:stillbirth
n1=en:highly variable phenotype and severity | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:hydrops fetalis is associated with death in utero (90%) or within 2 days of birth ---
r_associated #0: 32 -->
en:stillbirth
n1=en:hydrops fetalis is associated with death in utero (90%) or within 2 days of birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:incidence 1-1.5/1,000 live births ---
r_associated #0: 32 -->
en:stillbirth
n1=en:incidence 1-1.5/1,000 live births | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:incidence is estimated to be between 1 in 2,000 and 1 in 7,000 live births ---
r_associated #0: 32 -->
en:stillbirth
n1=en:incidence is estimated to be between 1 in 2,000 and 1 in 7,000 live births | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:incomplete penetrance in carrier females ---
r_associated #0: 32 -->
en:stillbirth
n1=en:incomplete penetrance in carrier females | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:increased susceptibility to malignant hyperthermia ---
r_associated #0: 32 -->
en:stillbirth
n1=en:increased susceptibility to malignant hyperthermia | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:increased susceptibility to multiple carcinomas ---
r_associated #0: 32 -->
en:stillbirth
n1=en:increased susceptibility to multiple carcinomas | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:initial hearing loss is mild progressing to severe or profound by the seventh decade ---
r_associated #0: 32 -->
en:stillbirth
n1=en:initial hearing loss is mild progressing to severe or profound by the seventh decade | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:intellectual regression and loss of speech precede the onset of motor retardation by more than 10 years ---
r_associated #0: 32 -->
en:stillbirth
n1=en:intellectual regression and loss of speech precede the onset of motor retardation by more than 10 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:intrafamilial phenotypic variability ranging from transient or permanent neonatal diabetes (610582) to mody (616329) to impaired fasting glucose or impaired glucose tolerance ---
r_associated #0: 32 -->
en:stillbirth
n1=en:intrafamilial phenotypic variability ranging from transient or permanent neonatal diabetes (610582) to mody (616329) to impaired fasting glucose or impaired glucose tolerance | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:intrafamilial variability in degree of hypotrichosis ---
r_associated #0: 32 -->
en:stillbirth
n1=en:intrafamilial variability in degree of hypotrichosis | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:juvenile rigid early-onset form more often paternally inherited ---
r_associated #0: 32 -->
en:stillbirth
n1=en:juvenile rigid early-onset form more often paternally inherited | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:late-adult onset has been reported ---
r_associated #0: 32 -->
en:stillbirth
n1=en:late-adult onset has been reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:levodopa-induced dyskinesias ---
r_associated #0: 32 -->
en:stillbirth
n1=en:levodopa-induced dyskinesias | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:liver symptoms improve with age and disappear after puberty ---
r_associated #0: 32 -->
en:stillbirth
n1=en:liver symptoms improve with age and disappear after puberty | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:major cause of death is heart failure ---
r_associated #0: 32 -->
en:stillbirth
n1=en:major cause of death is heart failure | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:majority of cases (95%) are sporadic ---
r_associated #0: 32 -->
en:stillbirth
n1=en:majority of cases (95%) are sporadic | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:majority of patients are stillborn or die before 5 months of age ---
r_associated #0: 32 -->
en:stillbirth
n1=en:majority of patients are stillborn or die before 5 months of age | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:male patients have more severe disease than female patients ---
r_associated #0: 32 -->
en:stillbirth
n1=en:male patients have more severe disease than female patients | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:male predominance of 3:1 to 5:1 ---
r_associated #0: 32 -->
en:stillbirth
n1=en:male predominance of 3:1 to 5:1 | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:male to female ratio is greater than 3:1 ---
r_associated #0: 32 -->
en:stillbirth
n1=en:male to female ratio is greater than 3:1 | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:many adults with typical form remain ambulatory ---
r_associated #0: 32 -->
en:stillbirth
n1=en:many adults with typical form remain ambulatory | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:many patients require cardiac pacemakers ---
r_associated #0: 32 -->
en:stillbirth
n1=en:many patients require cardiac pacemakers | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:marked heterogeneity ---
r_associated #0: 32 -->
en:stillbirth
n1=en:marked heterogeneity | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:may fade with age ---
r_associated #0: 32 -->
en:stillbirth
n1=en:may fade with age | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:mean age at onset 22 years (range 7 to 50 years) ---
r_associated #0: 32 -->
en:stillbirth
n1=en:mean age at onset 22 years (range 7 to 50 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:mean age at onset of hypoglycemia may be delayed (median, 9 months, diagnosis sometimes made in adulthood) ---
r_associated #0: 32 -->
en:stillbirth
n1=en:mean age at onset of hypoglycemia may be delayed (median, 9 months, diagnosis sometimes made in adulthood) | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:mean age of onset 20.6 years ---
r_associated #0: 32 -->
en:stillbirth
n1=en:mean age of onset 20.6 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:mean age of onset about 62 years (45-79 years) ---
r_associated #0: 32 -->
en:stillbirth
n1=en:mean age of onset about 62 years (45-79 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:mean age of onset in third decade ---
r_associated #0: 32 -->
en:stillbirth
n1=en:mean age of onset in third decade | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:median age at onset of puberty is 5.75 years in affected girls and 8.1 years in affected boys ---
r_associated #0: 32 -->
en:stillbirth
n1=en:median age at onset of puberty is 5.75 years in affected girls and 8.1 years in affected boys | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:multiple prenatal fractures ---
r_associated #0: 32 -->
en:stillbirth
n1=en:multiple prenatal fractures | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:onset of lymphedema around puberty ---
r_associated #0: 32 -->
en:stillbirth
n1=en:onset of lymphedema around puberty | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:pelvic pain ---
r_associated #0: 32 -->
en:stillbirth
n1=en:pelvic pain | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:poor response to l-dopa ---
r_associated #0: 32 -->
en:stillbirth
n1=en:poor response to l-dopa | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:possible x-linked dominant inheritance ---
r_associated #0: 32 -->
en:stillbirth
n1=en:possible x-linked dominant inheritance | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:prenatal nutritional deficiency ---
r_associated #0: 32 -->
en:stillbirth
n1=en:prenatal nutritional deficiency | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:pyogenic arthritis, pyoderma gangrenosum and acne ---
r_associated #0: 32 -->
en:stillbirth
n1=en:pyogenic arthritis, pyoderma gangrenosum and acne | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:three unrelated patients have been reported (last curated december 2015) ---
r_associated #0: 32 -->
en:stillbirth
n1=en:three unrelated patients have been reported (last curated december 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:twenty-five percent of affected babies are stillborn ---
r_associated #0: 32 -->
en:stillbirth
n1=en:twenty-five percent of affected babies are stillborn | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:two unrelated families have been reported (last curated may 2013) ---
r_associated #0: 32 -->
en:stillbirth
n1=en:two unrelated families have been reported (last curated may 2013) | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- en:weakness during pregnancy in some affected females has been reported ---
r_associated #0: 32 -->
en:stillbirth
n1=en:weakness during pregnancy in some affected females has been reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- mortalité foetale tardive ---
r_associated #0: 32 -->
en:stillbirth
n1=mortalité foetale tardive | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- épidémiologique ---
r_associated #0: 32 -->
en:stillbirth
n1=épidémiologique | n2=en:stillbirth | rel=r_associated | relid=0 | w=32
- décès accidentel ---
r_associated #0: 31 -->
en:stillbirth
n1=décès accidentel | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:adult onset has been reported ---
r_associated #0: 31 -->
en:stillbirth
n1=en:adult onset has been reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:approximately one-third of patients eventually lose outer hair cell function and have profound sensorineural deafness (after 10 to 20 years) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:approximately one-third of patients eventually lose outer hair cell function and have profound sensorineural deafness (after 10 to 20 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:autosomal recessive disorder tends to be more severe ---
r_associated #0: 31 -->
en:stillbirth
n1=en:autosomal recessive disorder tends to be more severe | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:average age at diagnosis 17.8 years (range 2-35 years) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:average age at diagnosis 17.8 years (range 2-35 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:based on report of 2 individuals (last curated november 2013) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:based on report of 2 individuals (last curated november 2013) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:bleeding is usually delayed-onset after challenge ---
r_associated #0: 31 -->
en:stillbirth
n1=en:bleeding is usually delayed-onset after challenge | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:both mutations occurred de novo ---
r_associated #0: 31 -->
en:stillbirth
n1=en:both mutations occurred de novo | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:brow delivery ---
r_associated #0: 31 -->
en:stillbirth
n1=en:brow delivery | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:carrier females may have mild intellectual disability ---
r_associated #0: 31 -->
en:stillbirth
n1=en:carrier females may have mild intellectual disability | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:childhood onset ---
r_associated #0: 31 -->
en:stillbirth
n1=en:childhood onset | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:clinical spectrum in males ranges from lethal neonatal onset to milder forms with first recognized episode in late childhood or even in adulthood ---
r_associated #0: 31 -->
en:stillbirth
n1=en:clinical spectrum in males ranges from lethal neonatal onset to milder forms with first recognized episode in late childhood or even in adulthood | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:clinically 'silent' nystagmus evident on eye movement recording in carrier females ---
r_associated #0: 31 -->
en:stillbirth
n1=en:clinically 'silent' nystagmus evident on eye movement recording in carrier females | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:contractures other than plantar are less common and less severe ---
r_associated #0: 31 -->
en:stillbirth
n1=en:contractures other than plantar are less common and less severe | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:death in childhood may occur due to end-stage renal disease ---
r_associated #0: 31 -->
en:stillbirth
n1=en:death in childhood may occur due to end-stage renal disease | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:death in the first years of life ---
r_associated #0: 31 -->
en:stillbirth
n1=en:death in the first years of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:drug-induced dyskinesias occur in a subset of patients ---
r_associated #0: 31 -->
en:stillbirth
n1=en:drug-induced dyskinesias occur in a subset of patients | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:early adult onset has been reported ---
r_associated #0: 31 -->
en:stillbirth
n1=en:early adult onset has been reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:early death occurs in affected infants (days to months after disease onset) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:early death occurs in affected infants (days to months after disease onset) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:early death often occurs from cardiac failure or infection ---
r_associated #0: 31 -->
en:stillbirth
n1=en:early death often occurs from cardiac failure or infection | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:early onset (9-48 years, but reported up to 68 years) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:early onset (9-48 years, but reported up to 68 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:episodes are triggered by cold exposure ---
r_associated #0: 31 -->
en:stillbirth
n1=en:episodes are triggered by cold exposure | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:eye involvement begins at birth, neurologic involvement begins later ---
r_associated #0: 31 -->
en:stillbirth
n1=en:eye involvement begins at birth, neurologic involvement begins later | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:familial occurrence is rare ---
r_associated #0: 31 -->
en:stillbirth
n1=en:familial occurrence is rare | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:favorable response to ephedrine treatment ---
r_associated #0: 31 -->
en:stillbirth
n1=en:favorable response to ephedrine treatment | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:female carriers may be mildly affected ---
r_associated #0: 31 -->
en:stillbirth
n1=en:female carriers may be mildly affected | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:female reproductive system disorder ---
r_associated #0: 31 -->
en:stillbirth
n1=en:female reproductive system disorder | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:found dead ---
r_associated #0: 31 -->
en:stillbirth
n1=en:found dead | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:four unrelated families have been reported (last curated september 2015) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:four unrelated families have been reported (last curated september 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:genetic heterogeneity (see 161800) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:genetic heterogeneity (see 161800) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:gonadal and somatic mosaicism reported in parent ---
r_associated #0: 31 -->
en:stillbirth
n1=en:gonadal and somatic mosaicism reported in parent | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:hearing loss occurs later if at all ---
r_associated #0: 31 -->
en:stillbirth
n1=en:hearing loss occurs later if at all | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:hearing loss progresses to profound deafness ---
r_associated #0: 31 -->
en:stillbirth
n1=en:hearing loss progresses to profound deafness | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:herpes simplex infections ---
r_associated #0: 31 -->
en:stillbirth
n1=en:herpes simplex infections | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:highly variable phenotype with respect to facial dysmorphism and neurologic features ---
r_associated #0: 31 -->
en:stillbirth
n1=en:highly variable phenotype with respect to facial dysmorphism and neurologic features | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:hyperlipidemia may be partially responsive to fat-restricted diet ---
r_associated #0: 31 -->
en:stillbirth
n1=en:hyperlipidemia may be partially responsive to fat-restricted diet | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:hyperpigmented patches increased in size and number with age ---
r_associated #0: 31 -->
en:stillbirth
n1=en:hyperpigmented patches increased in size and number with age | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:incidence - 1/16,000 live births ---
r_associated #0: 31 -->
en:stillbirth
n1=en:incidence - 1/16,000 live births | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:incidence of 1 in 100,000 to 125,000 at birth ---
r_associated #0: 31 -->
en:stillbirth
n1=en:incidence of 1 in 100,000 to 125,000 at birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:incidence of 1 in 25,000 livebirths ---
r_associated #0: 31 -->
en:stillbirth
n1=en:incidence of 1 in 25,000 livebirths | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:incidence of 1 in 3,500 boys ---
r_associated #0: 31 -->
en:stillbirth
n1=en:incidence of 1 in 3,500 boys | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:incidence of 1 in 50,000 to 1 in 100,000 ---
r_associated #0: 31 -->
en:stillbirth
n1=en:incidence of 1 in 50,000 to 1 in 100,000 | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:incidence worldwide of 1 in 30,000 to 50,000 ---
r_associated #0: 31 -->
en:stillbirth
n1=en:incidence worldwide of 1 in 30,000 to 50,000 | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:increased incidence in asian countries (e.g., 1.46 per 10,000 live births in taiwan) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:increased incidence in asian countries (e.g., 1.46 per 10,000 live births in taiwan) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:increased risk of myeloproliferative disorders in those with somatic mutations ---
r_associated #0: 31 -->
en:stillbirth
n1=en:increased risk of myeloproliferative disorders in those with somatic mutations | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:infantile, late-infantile, juvenile, and adult onset have been reported ---
r_associated #0: 31 -->
en:stillbirth
n1=en:infantile, late-infantile, juvenile, and adult onset have been reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:intracellular accumulation of material can occur in neuronal and nonneuronal cells ---
r_associated #0: 31 -->
en:stillbirth
n1=en:intracellular accumulation of material can occur in neuronal and nonneuronal cells | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:intrafamilial variability in nail changes ---
r_associated #0: 31 -->
en:stillbirth
n1=en:intrafamilial variability in nail changes | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:intrafamilial variability in severity of hypothyroidism ---
r_associated #0: 31 -->
en:stillbirth
n1=en:intrafamilial variability in severity of hypothyroidism | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:late fetal mortality ---
r_associated #0: 31 -->
en:stillbirth
n1=en:late fetal mortality | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:length of attack, 3 to 7 days ---
r_associated #0: 31 -->
en:stillbirth
n1=en:length of attack, 3 to 7 days | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:limb malformations are variable ---
r_associated #0: 31 -->
en:stillbirth
n1=en:limb malformations are variable | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:liveborn often die within first week of life ---
r_associated #0: 31 -->
en:stillbirth
n1=en:liveborn often die within first week of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:madelung deformity more frequent and more severe in females ---
r_associated #0: 31 -->
en:stillbirth
n1=en:madelung deformity more frequent and more severe in females | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:majority of cases are sporadic, often in tall, thin men ---
r_associated #0: 31 -->
en:stillbirth
n1=en:majority of cases are sporadic, often in tall, thin men | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:majority of cases diagnosed at age 10-15 years ---
r_associated #0: 31 -->
en:stillbirth
n1=en:majority of cases diagnosed at age 10-15 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:majority of children die before age 2 ---
r_associated #0: 31 -->
en:stillbirth
n1=en:majority of children die before age 2 | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:majority of patients die in neonatal period secondary to respiratory insufficiency ---
r_associated #0: 31 -->
en:stillbirth
n1=en:majority of patients die in neonatal period secondary to respiratory insufficiency | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:male to female ratio 4:1 ---
r_associated #0: 31 -->
en:stillbirth
n1=en:male to female ratio 4:1 | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:male-to-female ratio, 1.8 to 1 ---
r_associated #0: 31 -->
en:stillbirth
n1=en:male-to-female ratio, 1.8 to 1 | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:males are more severely affected ---
r_associated #0: 31 -->
en:stillbirth
n1=en:males are more severely affected | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:males are most severely affected, but females can also be affected ---
r_associated #0: 31 -->
en:stillbirth
n1=en:males are most severely affected, but females can also be affected | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:many cases due to de novo mutation ---
r_associated #0: 31 -->
en:stillbirth
n1=en:many cases due to de novo mutation | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:many patients become wheelchair-bound ---
r_associated #0: 31 -->
en:stillbirth
n1=en:many patients become wheelchair-bound | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:maternal imprinting ---
r_associated #0: 31 -->
en:stillbirth
n1=en:maternal imprinting | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:may occur in adults (also in pregnancy) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:may occur in adults (also in pregnancy) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:mean age at onset 10.6 years ---
r_associated #0: 31 -->
en:stillbirth
n1=en:mean age at onset 10.6 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:mean age at onset 33 years (range 20-60) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:mean age at onset 33 years (range 20-60) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:mean age at onset is 13 years (range 6 to 43) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:mean age at onset is 13 years (range 6 to 43) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:mean age at onset of cerebellar ataxia is 52.8 years ---
r_associated #0: 31 -->
en:stillbirth
n1=en:mean age at onset of cerebellar ataxia is 52.8 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:mean age of onset 22 years (range 5-54) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:mean age of onset 22 years (range 5-54) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:mean age of presentation of renal cancer is 50 years, but earlier onset has been reported ---
r_associated #0: 31 -->
en:stillbirth
n1=en:mean age of presentation of renal cancer is 50 years, but earlier onset has been reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:mean survival 5 months ---
r_associated #0: 31 -->
en:stillbirth
n1=en:mean survival 5 months | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:mesomelia becomes more evident with age ---
r_associated #0: 31 -->
en:stillbirth
n1=en:mesomelia becomes more evident with age | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:mild asymmetric regional disease (e.g. 180380.0029) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:mild asymmetric regional disease (e.g. 180380.0029) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy ---
r_associated #0: 31 -->
en:stillbirth
n1=en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:occurs in a southern maryland tri-racial inbred population known as the brandywine isolate ---
r_associated #0: 31 -->
en:stillbirth
n1=en:occurs in a southern maryland tri-racial inbred population known as the brandywine isolate | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:penetrance estimated to be 80% ---
r_associated #0: 31 -->
en:stillbirth
n1=en:penetrance estimated to be 80% | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:precipitated by fatigue or alcohol ---
r_associated #0: 31 -->
en:stillbirth
n1=en:precipitated by fatigue or alcohol | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:prenatal disorder ---
r_associated #0: 31 -->
en:stillbirth
n1=en:prenatal disorder | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:preterm birth ---
r_associated #0: 31 -->
en:stillbirth
n1=en:preterm birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:preterm infant ---
r_associated #0: 31 -->
en:stillbirth
n1=en:preterm infant | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:prevalence estimated at 1 in 50,000 ---
r_associated #0: 31 -->
en:stillbirth
n1=en:prevalence estimated at 1 in 50,000 | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:reactions and intoxications due to drugs administered to newborn ---
r_associated #0: 31 -->
en:stillbirth
n1=en:reactions and intoxications due to drugs administered to newborn | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:slight male predominance (3:2) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:slight male predominance (3:2) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:some patients may show normal early development before seizure onset ---
r_associated #0: 31 -->
en:stillbirth
n1=en:some patients may show normal early development before seizure onset | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:tumor suppressor gene ---
r_associated #0: 31 -->
en:stillbirth
n1=en:tumor suppressor gene | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:twin preg with fetal loss and retention of one fetus,delivered, with or w/o mention of antepart cond ---
r_associated #0: 31 -->
en:stillbirth
n1=en:twin preg with fetal loss and retention of one fetus,delivered, with or w/o mention of antepart cond | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:two sibs have been reported (last curated november 2015) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:two sibs have been reported (last curated november 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:two unrelated consanguineous families have been reported (last curated july 2015) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:two unrelated consanguineous families have been reported (last curated july 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:variable age of onset (7-59 years) ---
r_associated #0: 31 -->
en:stillbirth
n1=en:variable age of onset (7-59 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:virtually all patients with this condition are female ---
r_associated #0: 31 -->
en:stillbirth
n1=en:virtually all patients with this condition are female | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- en:visual impairment is present at birth and is progressive ---
r_associated #0: 31 -->
en:stillbirth
n1=en:visual impairment is present at birth and is progressive | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- gonorrhée ---
r_associated #0: 31 -->
en:stillbirth
n1=gonorrhée | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- hydramnios ---
r_associated #0: 31 -->
en:stillbirth
n1=hydramnios | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- indisposition ---
r_associated #0: 31 -->
en:stillbirth
n1=indisposition | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- ménopausé ---
r_associated #0: 31 -->
en:stillbirth
n1=ménopausé | n2=en:stillbirth | rel=r_associated | relid=0 | w=31
- IST
(infection sexuellement transmissible) ---
r_associated #0: 30 -->
en:stillbirth
n1=IST (infection sexuellement transmissible) | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- Signes et symptômes ---
r_associated #0: 30 -->
en:stillbirth
n1=Signes et symptômes | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- blennorragie ---
r_associated #0: 30 -->
en:stillbirth
n1=blennorragie | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- cas de décès ---
r_associated #0: 30 -->
en:stillbirth
n1=cas de décès | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:age of onset between 5 and 10 years of age ---
r_associated #0: 30 -->
en:stillbirth
n1=en:age of onset between 5 and 10 years of age | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:associated with iron deficiency anemia ---
r_associated #0: 30 -->
en:stillbirth
n1=en:associated with iron deficiency anemia | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:autoimmune features are variable ---
r_associated #0: 30 -->
en:stillbirth
n1=en:autoimmune features are variable | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:blisters are precipitated by minor skin trauma ---
r_associated #0: 30 -->
en:stillbirth
n1=en:blisters are precipitated by minor skin trauma | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:boys are more often affected than girls (3:2) ---
r_associated #0: 30 -->
en:stillbirth
n1=en:boys are more often affected than girls (3:2) | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:condyloma acuminatum ---
r_associated #0: 30 -->
en:stillbirth
n1=en:condyloma acuminatum | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:congenital onset ---
r_associated #0: 30 -->
en:stillbirth
n1=en:congenital onset | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:dead - sudden death ---
r_associated #0: 30 -->
en:stillbirth
n1=en:dead - sudden death | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:death due to respiratory insufficiency within minutes to hours after birth ---
r_associated #0: 30 -->
en:stillbirth
n1=en:death due to respiratory insufficiency within minutes to hours after birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:death in fourth to fifth decade ---
r_associated #0: 30 -->
en:stillbirth
n1=en:death in fourth to fifth decade | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:developmental fault ---
r_associated #0: 30 -->
en:stillbirth
n1=en:developmental fault | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:dramatic improvement with proper treatment ---
r_associated #0: 30 -->
en:stillbirth
n1=en:dramatic improvement with proper treatment | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:endometriosis ---
r_associated #0: 30 -->
en:stillbirth
n1=en:endometriosis | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:episodes may be triggered by exercise, emotional stress, head trauma, angiography, lack of sleep, heat ---
r_associated #0: 30 -->
en:stillbirth
n1=en:episodes may be triggered by exercise, emotional stress, head trauma, angiography, lack of sleep, heat | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:episodes tend to decrease with age ---
r_associated #0: 30 -->
en:stillbirth
n1=en:episodes tend to decrease with age | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:exacerbated by stress ---
r_associated #0: 30 -->
en:stillbirth
n1=en:exacerbated by stress | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:excessive skin picking of sores ---
r_associated #0: 30 -->
en:stillbirth
n1=en:excessive skin picking of sores | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:genetic heterogeneity (see 116800 for summary) ---
r_associated #0: 30 -->
en:stillbirth
n1=en:genetic heterogeneity (see 116800 for summary) | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:hearing loss ma be fluctuating or progressive ---
r_associated #0: 30 -->
en:stillbirth
n1=en:hearing loss ma be fluctuating or progressive | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:heterozygous female carriers may manifest symptoms ---
r_associated #0: 30 -->
en:stillbirth
n1=en:heterozygous female carriers may manifest symptoms | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:high pain threshold ---
r_associated #0: 30 -->
en:stillbirth
n1=en:high pain threshold | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:highly variable age at onset (range 9 to 69 years) ---
r_associated #0: 30 -->
en:stillbirth
n1=en:highly variable age at onset (range 9 to 69 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:in general, men have more severe disease than women ---
r_associated #0: 30 -->
en:stillbirth
n1=en:in general, men have more severe disease than women | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:incidence 1 in 30,000 male births ---
r_associated #0: 30 -->
en:stillbirth
n1=en:incidence 1 in 30,000 male births | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:incidence 8/1,000 newborns ---
r_associated #0: 30 -->
en:stillbirth
n1=en:incidence 8/1,000 newborns | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:incomplete penetrance (range 13% to 77% by 50 years of age) ---
r_associated #0: 30 -->
en:stillbirth
n1=en:incomplete penetrance (range 13% to 77% by 50 years of age) | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:increased risk of early death ---
r_associated #0: 30 -->
en:stillbirth
n1=en:increased risk of early death | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:infantile onset ---
r_associated #0: 30 -->
en:stillbirth
n1=en:infantile onset | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:infants are stillborn or die shortly after birth ---
r_associated #0: 30 -->
en:stillbirth
n1=en:infants are stillborn or die shortly after birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:infants may have acute life-threatening crises ---
r_associated #0: 30 -->
en:stillbirth
n1=en:infants may have acute life-threatening crises | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:isolated finding ---
r_associated #0: 30 -->
en:stillbirth
n1=en:isolated finding | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:itch, pain, and body malodor often ---
r_associated #0: 30 -->
en:stillbirth
n1=en:itch, pain, and body malodor often | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:l-dopa-induced dyskinesias ---
r_associated #0: 30 -->
en:stillbirth
n1=en:l-dopa-induced dyskinesias | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:later onset can also occur (up to age 17 years) ---
r_associated #0: 30 -->
en:stillbirth
n1=en:later onset can also occur (up to age 17 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:later onset in females ---
r_associated #0: 30 -->
en:stillbirth
n1=en:later onset in females | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:lifetime risk of ovarian cancer in mutation carriers is 10 to 20% ---
r_associated #0: 30 -->
en:stillbirth
n1=en:lifetime risk of ovarian cancer in mutation carriers is 10 to 20% | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:lipodystrophic appearance may be mild or not present ---
r_associated #0: 30 -->
en:stillbirth
n1=en:lipodystrophic appearance may be mild or not present | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:live birth ---
r_associated #0: 30 -->
en:stillbirth
n1=en:live birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:major fluid shifts may occur in severe cases ---
r_associated #0: 30 -->
en:stillbirth
n1=en:major fluid shifts may occur in severe cases | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:majority of cases sporadic ---
r_associated #0: 30 -->
en:stillbirth
n1=en:majority of cases sporadic | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:males tend to have earlier onset than females ---
r_associated #0: 30 -->
en:stillbirth
n1=en:males tend to have earlier onset than females | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:mammiplasty ---
r_associated #0: 30 -->
en:stillbirth
n1=en:mammiplasty | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:management of homocystinuria includes low methionine, cystine supplemented diet for pyridoxine nonresponders and pyridoxine supplementation for pyridoxine responders ---
r_associated #0: 30 -->
en:stillbirth
n1=en:management of homocystinuria includes low methionine, cystine supplemented diet for pyridoxine nonresponders and pyridoxine supplementation for pyridoxine responders | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:manifestations continue to appear until 5th decade ---
r_associated #0: 30 -->
en:stillbirth
n1=en:manifestations continue to appear until 5th decade | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:many cases are asymptomatic ---
r_associated #0: 30 -->
en:stillbirth
n1=en:many cases are asymptomatic | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:marked intrafamilial and interfamilial variability ---
r_associated #0: 30 -->
en:stillbirth
n1=en:marked intrafamilial and interfamilial variability | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:maternal oligohydramnios ---
r_associated #0: 30 -->
en:stillbirth
n1=en:maternal oligohydramnios | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:may be due to imprinting defect ---
r_associated #0: 30 -->
en:stillbirth
n1=en:may be due to imprinting defect | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:may be triggered by medications, including antineoplastic agents, immunotherapeutic agents, and antiplatelet agents ---
r_associated #0: 30 -->
en:stillbirth
n1=en:may be triggered by medications, including antineoplastic agents, immunotherapeutic agents, and antiplatelet agents | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:may not be clinically manifest until middle life ---
r_associated #0: 30 -->
en:stillbirth
n1=en:may not be clinically manifest until middle life | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:may result in sudden death ---
r_associated #0: 30 -->
en:stillbirth
n1=en:may result in sudden death | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:mean age at onset 32 years ---
r_associated #0: 30 -->
en:stillbirth
n1=en:mean age at onset 32 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:mean age at onset 66.8 years (range 47-77) ---
r_associated #0: 30 -->
en:stillbirth
n1=en:mean age at onset 66.8 years (range 47-77) | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:mean age at onset of proximal muscle weakness, 31 years ---
r_associated #0: 30 -->
en:stillbirth
n1=en:mean age at onset of proximal muscle weakness, 31 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:medial onset of end stage renal disease 13 years ---
r_associated #0: 30 -->
en:stillbirth
n1=en:medial onset of end stage renal disease 13 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:menstrual period ---
r_associated #0: 30 -->
en:stillbirth
n1=en:menstrual period | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:most patients become wheelchair-bound in the second or third decades ---
r_associated #0: 30 -->
en:stillbirth
n1=en:most patients become wheelchair-bound in the second or third decades | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:one patient has been reported (last curated august 2015) ---
r_associated #0: 30 -->
en:stillbirth
n1=en:one patient has been reported (last curated august 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:onset of night blindness varies among patients from early childhood to mid thirties ---
r_associated #0: 30 -->
en:stillbirth
n1=en:onset of night blindness varies among patients from early childhood to mid thirties | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:paralysis ---
r_associated #0: 30 -->
en:stillbirth
n1=en:paralysis | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:patient died during operation ---
r_associated #0: 30 -->
en:stillbirth
n1=en:patient died during operation | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:phenotype is due to hypomorphic nonmosaic mutation in the ebp gene ---
r_associated #0: 30 -->
en:stillbirth
n1=en:phenotype is due to hypomorphic nonmosaic mutation in the ebp gene | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:recurrent bacterial infection ---
r_associated #0: 30 -->
en:stillbirth
n1=en:recurrent bacterial infection | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:recurrent fetal loss ---
r_associated #0: 30 -->
en:stillbirth
n1=en:recurrent fetal loss | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:sids ---
r_associated #0: 30 -->
en:stillbirth
n1=en:sids | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:some patients have onset in second decade of life ---
r_associated #0: 30 -->
en:stillbirth
n1=en:some patients have onset in second decade of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:some patients may lose independent ambulation ---
r_associated #0: 30 -->
en:stillbirth
n1=en:some patients may lose independent ambulation | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:some patients may present with myopathic features ---
r_associated #0: 30 -->
en:stillbirth
n1=en:some patients may present with myopathic features | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:some patients never gain ambulation or become wheelchair-bound ---
r_associated #0: 30 -->
en:stillbirth
n1=en:some patients never gain ambulation or become wheelchair-bound | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:suffocation ---
r_associated #0: 30 -->
en:stillbirth
n1=en:suffocation | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:surviving males are postzygotic mosaic for ebp mutations ---
r_associated #0: 30 -->
en:stillbirth
n1=en:surviving males are postzygotic mosaic for ebp mutations | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:thanatopsy ---
r_associated #0: 30 -->
en:stillbirth
n1=en:thanatopsy | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:uterine rupture ---
r_associated #0: 30 -->
en:stillbirth
n1=en:uterine rupture | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:uterine tube ---
r_associated #0: 30 -->
en:stillbirth
n1=en:uterine tube | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- en:variable age at onset (late childhood to adult) ---
r_associated #0: 30 -->
en:stillbirth
n1=en:variable age at onset (late childhood to adult) | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- endométriose ---
r_associated #0: 30 -->
en:stillbirth
n1=endométriose | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- la ménopause ---
r_associated #0: 30 -->
en:stillbirth
n1=la ménopause | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- léthal ---
r_associated #0: 30 -->
en:stillbirth
n1=léthal | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- naissance d'un enfant vivant ---
r_associated #0: 30 -->
en:stillbirth
n1=naissance d'un enfant vivant | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- rétinite pigmentaire ---
r_associated #0: 30 -->
en:stillbirth
n1=rétinite pigmentaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- rétinite pigmentaire, surdité, retard mental, et hypogonadisme ---
r_associated #0: 30 -->
en:stillbirth
n1=rétinite pigmentaire, surdité, retard mental, et hypogonadisme | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- sein maternel ---
r_associated #0: 30 -->
en:stillbirth
n1=sein maternel | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- une anomalie congénitale ---
r_associated #0: 30 -->
en:stillbirth
n1=une anomalie congénitale | n2=en:stillbirth | rel=r_associated | relid=0 | w=30
- Maladie congénitale ---
r_associated #0: 29 -->
en:stillbirth
n1=Maladie congénitale | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- circulaire du cordon ---
r_associated #0: 29 -->
en:stillbirth
n1=circulaire du cordon | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:Stein-Leventhal syndrome ---
r_associated #0: 29 -->
en:stillbirth
n1=en:Stein-Leventhal syndrome | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:a milder form has also been reported ---
r_associated #0: 29 -->
en:stillbirth
n1=en:a milder form has also been reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:adult onset ---
r_associated #0: 29 -->
en:stillbirth
n1=en:adult onset | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:age of onset varies ranging from 3 weeks to 22 years ---
r_associated #0: 29 -->
en:stillbirth
n1=en:age of onset varies ranging from 3 weeks to 22 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:agonal death struggle ---
r_associated #0: 29 -->
en:stillbirth
n1=en:agonal death struggle | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:all reported mutations have occurred de novo ---
r_associated #0: 29 -->
en:stillbirth
n1=en:all reported mutations have occurred de novo | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:allelic to diastrophic dysplasia (222600), achondrogenesis, type 1b (600972), and multiple epiphyseal dysplasia, type 4 (226900) ---
r_associated #0: 29 -->
en:stillbirth
n1=en:allelic to diastrophic dysplasia (222600), achondrogenesis, type 1b (600972), and multiple epiphyseal dysplasia, type 4 (226900) | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:aortic dissection may occur in second decade of life ---
r_associated #0: 29 -->
en:stillbirth
n1=en:aortic dissection may occur in second decade of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:associated with advanced paternal age ---
r_associated #0: 29 -->
en:stillbirth
n1=en:associated with advanced paternal age | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:associated with hemodialysis ---
r_associated #0: 29 -->
en:stillbirth
n1=en:associated with hemodialysis | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:attacks more common in women ---
r_associated #0: 29 -->
en:stillbirth
n1=en:attacks more common in women | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:autosomal recessive form (277720) has also been described ---
r_associated #0: 29 -->
en:stillbirth
n1=en:autosomal recessive form (277720) has also been described | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:average onset of seizures 6 months (range 3-12) ---
r_associated #0: 29 -->
en:stillbirth
n1=en:average onset of seizures 6 months (range 3-12) | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:cardiac examination is usually unremarkable ---
r_associated #0: 29 -->
en:stillbirth
n1=en:cardiac examination is usually unremarkable | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:clinically resembles essential tremor, but not responsive to beta-adrenergic blockers ---
r_associated #0: 29 -->
en:stillbirth
n1=en:clinically resembles essential tremor, but not responsive to beta-adrenergic blockers | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:death by natural cause ---
r_associated #0: 29 -->
en:stillbirth
n1=en:death by natural cause | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:death may occur in infancy ---
r_associated #0: 29 -->
en:stillbirth
n1=en:death may occur in infancy | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:death usually in newborn period or infancy ---
r_associated #0: 29 -->
en:stillbirth
n1=en:death usually in newborn period or infancy | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:dentists, women ---
r_associated #0: 29 -->
en:stillbirth
n1=en:dentists, women | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:disease shows slow progression ---
r_associated #0: 29 -->
en:stillbirth
n1=en:disease shows slow progression | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:diurnal fluctuation of neurologic symptoms ---
r_associated #0: 29 -->
en:stillbirth
n1=en:diurnal fluctuation of neurologic symptoms | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:earlier onset is associated with more rapid progression ---
r_associated #0: 29 -->
en:stillbirth
n1=en:earlier onset is associated with more rapid progression | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:episode frequency is monthly to yearly, and decreases with age ---
r_associated #0: 29 -->
en:stillbirth
n1=en:episode frequency is monthly to yearly, and decreases with age | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:estimated frequence 1/3000 to 1/5000 ---
r_associated #0: 29 -->
en:stillbirth
n1=en:estimated frequence 1/3000 to 1/5000 | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:favorable response to 3,4-diaminopyridine ---
r_associated #0: 29 -->
en:stillbirth
n1=en:favorable response to 3,4-diaminopyridine | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:female carriers may show intermittent hematuria ---
r_associated #0: 29 -->
en:stillbirth
n1=en:female carriers may show intermittent hematuria | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:first fracture in early childhood ---
r_associated #0: 29 -->
en:stillbirth
n1=en:first fracture in early childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:foot deformities are present in infancy or childhood ---
r_associated #0: 29 -->
en:stillbirth
n1=en:foot deformities are present in infancy or childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:four separate types - (1) severe perinatal ('lethal') form, (2) severe infantile form, (3) childhood form, and (4) adult form ---
r_associated #0: 29 -->
en:stillbirth
n1=en:four separate types - (1) severe perinatal ('lethal') form, (2) severe infantile form, (3) childhood form, and (4) adult form | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:genetic heterogeneity (may be caused by mutation in nuclear-encoded or mitochondrial-encoded genes) ---
r_associated #0: 29 -->
en:stillbirth
n1=en:genetic heterogeneity (may be caused by mutation in nuclear-encoded or mitochondrial-encoded genes) | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:hearing loss is usually severe by age 20 years ---
r_associated #0: 29 -->
en:stillbirth
n1=en:hearing loss is usually severe by age 20 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:hearing loss occurs in late childhood ---
r_associated #0: 29 -->
en:stillbirth
n1=en:hearing loss occurs in late childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:heterozygous mutation carriers may have late-onset of mild symptoms ---
r_associated #0: 29 -->
en:stillbirth
n1=en:heterozygous mutation carriers may have late-onset of mild symptoms | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:highly variable expression ---
r_associated #0: 29 -->
en:stillbirth
n1=en:highly variable expression | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:immunologic defects are variable ---
r_associated #0: 29 -->
en:stillbirth
n1=en:immunologic defects are variable | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:in severe attacks, hemiplegia or coma may last days to weeks ---
r_associated #0: 29 -->
en:stillbirth
n1=en:in severe attacks, hemiplegia or coma may last days to weeks | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:incidence 1 in 15,000-28,000 births ---
r_associated #0: 29 -->
en:stillbirth
n1=en:incidence 1 in 15,000-28,000 births | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:incidence of 1 in 10,000 to 1 in 20,000 ---
r_associated #0: 29 -->
en:stillbirth
n1=en:incidence of 1 in 10,000 to 1 in 20,000 | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:incidence of 1 in 300,000 ---
r_associated #0: 29 -->
en:stillbirth
n1=en:incidence of 1 in 300,000 | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:increased aneuploidy in offspring ---
r_associated #0: 29 -->
en:stillbirth
n1=en:increased aneuploidy in offspring | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:individuals do not develop erythrocytosis under hypoxic conditions ---
r_associated #0: 29 -->
en:stillbirth
n1=en:individuals do not develop erythrocytosis under hypoxic conditions | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:infectious intrauterine disorder ---
r_associated #0: 29 -->
en:stillbirth
n1=en:infectious intrauterine disorder | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:intrauterine death, affecting management of mother, antepartum condition or complication ---
r_associated #0: 29 -->
en:stillbirth
n1=en:intrauterine death, affecting management of mother, antepartum condition or complication | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:ketogenic diet may be effective ---
r_associated #0: 29 -->
en:stillbirth
n1=en:ketogenic diet may be effective | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:later onset of hearing loss in some patients ---
r_associated #0: 29 -->
en:stillbirth
n1=en:later onset of hearing loss in some patients | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:later onset of neurologic features ---
r_associated #0: 29 -->
en:stillbirth
n1=en:later onset of neurologic features | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:life-threatening infections ---
r_associated #0: 29 -->
en:stillbirth
n1=en:life-threatening infections | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:liver size returns to normal after 3 months to 3 years ---
r_associated #0: 29 -->
en:stillbirth
n1=en:liver size returns to normal after 3 months to 3 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:loss of independent ambulation (in 2 of 3 patients) ---
r_associated #0: 29 -->
en:stillbirth
n1=en:loss of independent ambulation (in 2 of 3 patients) | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:lower limb weakness is presenting feature ---
r_associated #0: 29 -->
en:stillbirth
n1=en:lower limb weakness is presenting feature | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:majority die in neonatal period secondary to respiratory insufficiency ---
r_associated #0: 29 -->
en:stillbirth
n1=en:majority die in neonatal period secondary to respiratory insufficiency | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:majority of children die between 6 months and 5 yrs ---
r_associated #0: 29 -->
en:stillbirth
n1=en:majority of children die between 6 months and 5 yrs | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:males may be more affected than females ---
r_associated #0: 29 -->
en:stillbirth
n1=en:males may be more affected than females | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:may be precipitated by minor illness (e.g., viral infection, fever) ---
r_associated #0: 29 -->
en:stillbirth
n1=en:may be precipitated by minor illness (e.g., viral infection, fever) | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:midline defects ---
r_associated #0: 29 -->
en:stillbirth
n1=en:midline defects | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:perinatal terminology ---
r_associated #0: 29 -->
en:stillbirth
n1=en:perinatal terminology | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:placenta ---
r_associated #0: 29 -->
en:stillbirth
n1=en:placenta | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:premature labor ---
r_associated #0: 29 -->
en:stillbirth
n1=en:premature labor | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:presence of severe midfacial and limb defects and birth length less than 37cm associated with stillborn or early infant death ---
r_associated #0: 29 -->
en:stillbirth
n1=en:presence of severe midfacial and limb defects and birth length less than 37cm associated with stillborn or early infant death | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:quadruplet pregnancy with fetal loss and retention of one or more fetus(es), delivered, with or without mention of antepartum condition ---
r_associated #0: 29 -->
en:stillbirth
n1=en:quadruplet pregnancy with fetal loss and retention of one or more fetus(es), delivered, with or without mention of antepartum condition | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:quadruplet pregnancy with fetal loss and retention of one or more fetus(es), unspecified as to episode of care or not applicable ---
r_associated #0: 29 -->
en:stillbirth
n1=en:quadruplet pregnancy with fetal loss and retention of one or more fetus(es), unspecified as to episode of care or not applicable | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:severe ambulatory restriction ---
r_associated #0: 29 -->
en:stillbirth
n1=en:severe ambulatory restriction | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:some patients show a favorable response to sulfonylurea treatment ---
r_associated #0: 29 -->
en:stillbirth
n1=en:some patients show a favorable response to sulfonylurea treatment | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:symptoms precipitated by alcohol, caffeine, fatigue, stress, exertion, ovulation, menstruation ---
r_associated #0: 29 -->
en:stillbirth
n1=en:symptoms precipitated by alcohol, caffeine, fatigue, stress, exertion, ovulation, menstruation | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:therapeutic abortion ---
r_associated #0: 29 -->
en:stillbirth
n1=en:therapeutic abortion | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:three unrelated consanguineous families (libyan, egyptian, and pakistani origin) have been reported (last curated july 2015) ---
r_associated #0: 29 -->
en:stillbirth
n1=en:three unrelated consanguineous families (libyan, egyptian, and pakistani origin) have been reported (last curated july 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:trichomonas infection ---
r_associated #0: 29 -->
en:stillbirth
n1=en:trichomonas infection | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:triplet pregnancy with fetal loss and retention of one or more fetus(es), antepartum condition or complication ---
r_associated #0: 29 -->
en:stillbirth
n1=en:triplet pregnancy with fetal loss and retention of one or more fetus(es), antepartum condition or complication | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:tuba uterina ---
r_associated #0: 29 -->
en:stillbirth
n1=en:tuba uterina | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:tumors and pregnancy ---
r_associated #0: 29 -->
en:stillbirth
n1=en:tumors and pregnancy | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:two unrelated families have been reported (last curated october 2015) ---
r_associated #0: 29 -->
en:stillbirth
n1=en:two unrelated families have been reported (last curated october 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:vaginal disorder ---
r_associated #0: 29 -->
en:stillbirth
n1=en:vaginal disorder | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- en:vaginal hemorrhage ---
r_associated #0: 29 -->
en:stillbirth
n1=en:vaginal hemorrhage | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- hypotonie utérine ---
r_associated #0: 29 -->
en:stillbirth
n1=hypotonie utérine | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- mort-né ---
r_associated #0: 29 -->
en:stillbirth
n1=mort-né | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- un décès accidentel ---
r_associated #0: 29 -->
en:stillbirth
n1=un décès accidentel | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- vies perdues ---
r_associated #0: 29 -->
en:stillbirth
n1=vies perdues | n2=en:stillbirth | rel=r_associated | relid=0 | w=29
- FATXIX ---
r_associated #0: 28 -->
en:stillbirth
n1=FATXIX | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- Hydramnios ---
r_associated #0: 28 -->
en:stillbirth
n1=Hydramnios | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- accouchement par voies naturelles ---
r_associated #0: 28 -->
en:stillbirth
n1=accouchement par voies naturelles | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:(3) adult nonnephropathic (219750) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:(3) adult nonnephropathic (219750) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:20% die before age one (usually secondary to renal or laryngeal defects) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:20% die before age one (usually secondary to renal or laryngeal defects) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:adult onset (wide range of age) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:adult onset (wide range of age) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:age at onset 8 to 55 years (mean 40 years) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:age at onset 8 to 55 years (mean 40 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:age of onset of distal lower limb weakness 8-16 years ---
r_associated #0: 28 -->
en:stillbirth
n1=en:age of onset of distal lower limb weakness 8-16 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:approximately half of the mutations are de novo ---
r_associated #0: 28 -->
en:stillbirth
n1=en:approximately half of the mutations are de novo | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:both autosomal dominant and autosomal recessive inheritance has been described ---
r_associated #0: 28 -->
en:stillbirth
n1=en:both autosomal dominant and autosomal recessive inheritance has been described | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:breech extraction - delivered ---
r_associated #0: 28 -->
en:stillbirth
n1=en:breech extraction - delivered | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:caused by somatic mutations ---
r_associated #0: 28 -->
en:stillbirth
n1=en:caused by somatic mutations | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:cephalohematoma ---
r_associated #0: 28 -->
en:stillbirth
n1=en:cephalohematoma | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:cone-shaped epiphyses appear in early childhood and disappear with premature fusion of growth plate before puberty ---
r_associated #0: 28 -->
en:stillbirth
n1=en:cone-shaped epiphyses appear in early childhood and disappear with premature fusion of growth plate before puberty | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:death in infancy in 2 patients ---
r_associated #0: 28 -->
en:stillbirth
n1=en:death in infancy in 2 patients | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:death in third or fourth decades, usually due to respiratory infection ---
r_associated #0: 28 -->
en:stillbirth
n1=en:death in third or fourth decades, usually due to respiratory infection | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:death in utero or in early infancy is common ---
r_associated #0: 28 -->
en:stillbirth
n1=en:death in utero or in early infancy is common | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:death often in the teenage years ---
r_associated #0: 28 -->
en:stillbirth
n1=en:death often in the teenage years | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:death usually in infancy due to respiratory failure ---
r_associated #0: 28 -->
en:stillbirth
n1=en:death usually in infancy due to respiratory failure | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:decapitation ---
r_associated #0: 28 -->
en:stillbirth
n1=en:decapitation | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:deposits may recur in graft after corneal transplantation ---
r_associated #0: 28 -->
en:stillbirth
n1=en:deposits may recur in graft after corneal transplantation | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:disorder of muscle tone of newborn, unspecified ---
r_associated #0: 28 -->
en:stillbirth
n1=en:disorder of muscle tone of newborn, unspecified | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:drowning ---
r_associated #0: 28 -->
en:stillbirth
n1=en:drowning | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:end-stage renal failure may occur ---
r_associated #0: 28 -->
en:stillbirth
n1=en:end-stage renal failure may occur | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:facial dysmorphic features are mild ---
r_associated #0: 28 -->
en:stillbirth
n1=en:facial dysmorphic features are mild | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:family a had a severe multisystem disorder resulting in death before age 2 years ---
r_associated #0: 28 -->
en:stillbirth
n1=en:family a had a severe multisystem disorder resulting in death before age 2 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:female carriers may be affected ---
r_associated #0: 28 -->
en:stillbirth
n1=en:female carriers may be affected | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:female carriers may have asymptomatic hypercalciuria or hypophosphatemia only ---
r_associated #0: 28 -->
en:stillbirth
n1=en:female carriers may have asymptomatic hypercalciuria or hypophosphatemia only | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:female internal genitalia structure ---
r_associated #0: 28 -->
en:stillbirth
n1=en:female internal genitalia structure | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:fetal death from asphyxia and/or anoxia, not clear if noted before or after onset of labor ---
r_associated #0: 28 -->
en:stillbirth
n1=en:fetal death from asphyxia and/or anoxia, not clear if noted before or after onset of labor | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:fetal resorption ---
r_associated #0: 28 -->
en:stillbirth
n1=en:fetal resorption | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:genetic heterogeneity (see 609192) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:genetic heterogeneity (see 609192) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:glucocorticoid deficiency occurs in mid-childhood ---
r_associated #0: 28 -->
en:stillbirth
n1=en:glucocorticoid deficiency occurs in mid-childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:hand and foot lesions can severely limit dexterity (due to flexion contractures) and mobility (due to painful fissures) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:hand and foot lesions can severely limit dexterity (due to flexion contractures) and mobility (due to painful fissures) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:high recurrence rate ---
r_associated #0: 28 -->
en:stillbirth
n1=en:high recurrence rate | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:highly variable severity, ranging from death in utero to survival to adulthood with normal intelligence ---
r_associated #0: 28 -->
en:stillbirth
n1=en:highly variable severity, ranging from death in utero to survival to adulthood with normal intelligence | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:hip joint replacement often necessary ---
r_associated #0: 28 -->
en:stillbirth
n1=en:hip joint replacement often necessary | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:hypothyroidism is less severe in individuals with high dietary iodine intake ---
r_associated #0: 28 -->
en:stillbirth
n1=en:hypothyroidism is less severe in individuals with high dietary iodine intake | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:icelandic families ---
r_associated #0: 28 -->
en:stillbirth
n1=en:icelandic families | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:incidence ranges from 1 in 40,000 to 1 in 350,000 births ---
r_associated #0: 28 -->
en:stillbirth
n1=en:incidence ranges from 1 in 40,000 to 1 in 350,000 births | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:increased male to female ratio (7.5:1) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:increased male to female ratio (7.5:1) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:inheritance pattern is unclear ---
r_associated #0: 28 -->
en:stillbirth
n1=en:inheritance pattern is unclear | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:initial development may appear normal ---
r_associated #0: 28 -->
en:stillbirth
n1=en:initial development may appear normal | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:insidious onset ---
r_associated #0: 28 -->
en:stillbirth
n1=en:insidious onset | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:intermediate expression in females ---
r_associated #0: 28 -->
en:stillbirth
n1=en:intermediate expression in females | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:intrafamilial variability in number of missing teeth ---
r_associated #0: 28 -->
en:stillbirth
n1=en:intrafamilial variability in number of missing teeth | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:late adult onset (after age 55 years) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:late adult onset (after age 55 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:leg pain during childhood ---
r_associated #0: 28 -->
en:stillbirth
n1=en:leg pain during childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:less than 20% have onset at 18 years of age or less (dominant and recessive) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:less than 20% have onset at 18 years of age or less (dominant and recessive) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:lethal in utero or perinatal lethal ---
r_associated #0: 28 -->
en:stillbirth
n1=en:lethal in utero or perinatal lethal | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:macerated stillbirth ---
r_associated #0: 28 -->
en:stillbirth
n1=en:macerated stillbirth | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:majority are stillborn or die in early neonatal period ---
r_associated #0: 28 -->
en:stillbirth
n1=en:majority are stillborn or die in early neonatal period | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:majority of patients are ambulatory ---
r_associated #0: 28 -->
en:stillbirth
n1=en:majority of patients are ambulatory | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:malignant breast neoplasm ---
r_associated #0: 28 -->
en:stillbirth
n1=en:malignant breast neoplasm | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:many features are present only in an untreated patient ---
r_associated #0: 28 -->
en:stillbirth
n1=en:many features are present only in an untreated patient | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:may be triggered by minor head trauma ---
r_associated #0: 28 -->
en:stillbirth
n1=en:may be triggered by minor head trauma | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:may have seasonal variance in severity ---
r_associated #0: 28 -->
en:stillbirth
n1=en:may have seasonal variance in severity | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:mean age of onset 31 years (range 5-60) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:mean age of onset 31 years (range 5-60) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:mean age of onset 50 to 52 years ---
r_associated #0: 28 -->
en:stillbirth
n1=en:mean age of onset 50 to 52 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:median age of onset of nail dystrophy - 7 years (range 1-6 years) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:median age of onset of nail dystrophy - 7 years (range 1-6 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:menstrual periods ---
r_associated #0: 28 -->
en:stillbirth
n1=en:menstrual periods | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:menstruating ---
r_associated #0: 28 -->
en:stillbirth
n1=en:menstruating | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:necrotic process ---
r_associated #0: 28 -->
en:stillbirth
n1=en:necrotic process | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:no consistent dysmorphic facial phenotype ---
r_associated #0: 28 -->
en:stillbirth
n1=en:no consistent dysmorphic facial phenotype | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:osteoglophonic, derived from greek meaning hollowed out ---
r_associated #0: 28 -->
en:stillbirth
n1=en:osteoglophonic, derived from greek meaning hollowed out | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:other abnormal products of conception ---
r_associated #0: 28 -->
en:stillbirth
n1=en:other abnormal products of conception | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:other conditions originating in the perinatal period ---
r_associated #0: 28 -->
en:stillbirth
n1=en:other conditions originating in the perinatal period | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:postmortem examination ---
r_associated #0: 28 -->
en:stillbirth
n1=en:postmortem examination | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:precipitation by pregnancy ---
r_associated #0: 28 -->
en:stillbirth
n1=en:precipitation by pregnancy | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:pregnancy test false positive ---
r_associated #0: 28 -->
en:stillbirth
n1=en:pregnancy test false positive | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:presentation in children - diarrhea, constipation (rarely), short stature, pubertal delay, rickets, iron and folate deficiency with anemia ---
r_associated #0: 28 -->
en:stillbirth
n1=en:presentation in children - diarrhea, constipation (rarely), short stature, pubertal delay, rickets, iron and folate deficiency with anemia | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:prevalence of true hypoprothrombinemia is 1 in 2 million ---
r_associated #0: 28 -->
en:stillbirth
n1=en:prevalence of true hypoprothrombinemia is 1 in 2 million | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:some patients have resolution of symptoms in first year of life ---
r_associated #0: 28 -->
en:stillbirth
n1=en:some patients have resolution of symptoms in first year of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:therapy is placement of implantable cardioverter defibrillator (icd) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:therapy is placement of implantable cardioverter defibrillator (icd) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:triplet pregnancy with fetal loss and retention of one or more fetus(es), unspecified as to episode of care or not applicable ---
r_associated #0: 28 -->
en:stillbirth
n1=en:triplet pregnancy with fetal loss and retention of one or more fetus(es), unspecified as to episode of care or not applicable | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:two families with confirmed adra2b mutations have been reported (last curated june 2015) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:two families with confirmed adra2b mutations have been reported (last curated june 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:two sibs from a consanguineous syrian family have been reported (last curated july 2015) ---
r_associated #0: 28 -->
en:stillbirth
n1=en:two sibs from a consanguineous syrian family have been reported (last curated july 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:variable phenotype, particularly with regard to cortical malformations ---
r_associated #0: 28 -->
en:stillbirth
n1=en:variable phenotype, particularly with regard to cortical malformations | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- rétinite pigmentaire liée au sexe récessive 3 ---
r_associated #0: 28 -->
en:stillbirth
n1=rétinite pigmentaire liée au sexe récessive 3 | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- rétinite pigmentaire liée à la rhodopsine ---
r_associated #0: 28 -->
en:stillbirth
n1=rétinite pigmentaire liée à la rhodopsine | n2=en:stillbirth | rel=r_associated | relid=0 | w=28
- en:about 20% of female mutation carriers may show mild muscle weakness ---
r_associated #0: 27 -->
en:stillbirth
n1=en:about 20% of female mutation carriers may show mild muscle weakness | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:acyesis ---
r_associated #0: 27 -->
en:stillbirth
n1=en:acyesis | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:adult onset (20 to 50 years) ---
r_associated #0: 27 -->
en:stillbirth
n1=en:adult onset (20 to 50 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:affected individuals are born with normal-appearing skin and develop scaling a few days after birth ---
r_associated #0: 27 -->
en:stillbirth
n1=en:affected individuals are born with normal-appearing skin and develop scaling a few days after birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:affected individuals have a relatively mild ichthyosis phenotype ---
r_associated #0: 27 -->
en:stillbirth
n1=en:affected individuals have a relatively mild ichthyosis phenotype | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:affected individuals may have more than 1 cardiac structural defect, or none at all ---
r_associated #0: 27 -->
en:stillbirth
n1=en:affected individuals may have more than 1 cardiac structural defect, or none at all | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:age at onset 14 to 44 years ---
r_associated #0: 27 -->
en:stillbirth
n1=en:age at onset 14 to 44 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:anatomic structures ---
r_associated #0: 27 -->
en:stillbirth
n1=en:anatomic structures | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:brittle-bone disease ---
r_associated #0: 27 -->
en:stillbirth
n1=en:brittle-bone disease | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:can also be caused by contiguous gene deletion on chromosome 22q11.2 ---
r_associated #0: 27 -->
en:stillbirth
n1=en:can also be caused by contiguous gene deletion on chromosome 22q11.2 | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:chemical intrauterine disorder ---
r_associated #0: 27 -->
en:stillbirth
n1=en:chemical intrauterine disorder | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:childhood or adolescent onset (usually less than 25 years) ---
r_associated #0: 27 -->
en:stillbirth
n1=en:childhood or adolescent onset (usually less than 25 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:classic severe form shows onset at 2 to 3 months of age ---
r_associated #0: 27 -->
en:stillbirth
n1=en:classic severe form shows onset at 2 to 3 months of age | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:clinical and biochemical abnormalities disappear with age ---
r_associated #0: 27 -->
en:stillbirth
n1=en:clinical and biochemical abnormalities disappear with age | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:clinical variability, both pure and complicated forms ---
r_associated #0: 27 -->
en:stillbirth
n1=en:clinical variability, both pure and complicated forms | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:death from pneumonia ---
r_associated #0: 27 -->
en:stillbirth
n1=en:death from pneumonia | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:death in early childhood may occur ---
r_associated #0: 27 -->
en:stillbirth
n1=en:death in early childhood may occur | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:death often occurs in childhood ---
r_associated #0: 27 -->
en:stillbirth
n1=en:death often occurs in childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:diurnal fluctuation ---
r_associated #0: 27 -->
en:stillbirth
n1=en:diurnal fluctuation | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:dwarfism not detectable at birth ---
r_associated #0: 27 -->
en:stillbirth
n1=en:dwarfism not detectable at birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:early death in males ---
r_associated #0: 27 -->
en:stillbirth
n1=en:early death in males | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:episodes last from several hours to days ---
r_associated #0: 27 -->
en:stillbirth
n1=en:episodes last from several hours to days | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:estimated incidence of 1-2 in 10,000 ---
r_associated #0: 27 -->
en:stillbirth
n1=en:estimated incidence of 1-2 in 10,000 | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:ethnologic ---
r_associated #0: 27 -->
en:stillbirth
n1=en:ethnologic | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:excessive postsurgical blood loss ---
r_associated #0: 27 -->
en:stillbirth
n1=en:excessive postsurgical blood loss | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:fishy body odor ---
r_associated #0: 27 -->
en:stillbirth
n1=en:fishy body odor | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:gonococcia ---
r_associated #0: 27 -->
en:stillbirth
n1=en:gonococcia | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:great variation in extent of hypertrophy in mutation-positive individuals ---
r_associated #0: 27 -->
en:stillbirth
n1=en:great variation in extent of hypertrophy in mutation-positive individuals | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:hearing loss may be congenital or rapidly progressive leading to severe hearing loss by age 3 years ---
r_associated #0: 27 -->
en:stillbirth
n1=en:hearing loss may be congenital or rapidly progressive leading to severe hearing loss by age 3 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:hematuria may become apparent after respiratory infections (synpharyngitic) ---
r_associated #0: 27 -->
en:stillbirth
n1=en:hematuria may become apparent after respiratory infections (synpharyngitic) | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:hemorrhagic complication of pregnancy ---
r_associated #0: 27 -->
en:stillbirth
n1=en:hemorrhagic complication of pregnancy | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:heterozygote may have elevated serum phosphate and elevated serum 1,25-dihydroxycholecalciferol ---
r_associated #0: 27 -->
en:stillbirth
n1=en:heterozygote may have elevated serum phosphate and elevated serum 1,25-dihydroxycholecalciferol | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:heterozygotes may exhibit syndromic manifestations ---
r_associated #0: 27 -->
en:stillbirth
n1=en:heterozygotes may exhibit syndromic manifestations | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:heterozygous carriers exhibit palmoplantar hyperkeratosis (see 148700) ---
r_associated #0: 27 -->
en:stillbirth
n1=en:heterozygous carriers exhibit palmoplantar hyperkeratosis (see 148700) | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:high frequency of levodopa-induced dyskinesias ---
r_associated #0: 27 -->
en:stillbirth
n1=en:high frequency of levodopa-induced dyskinesias | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:high mortality in infancy and early childhood (in some patients) ---
r_associated #0: 27 -->
en:stillbirth
n1=en:high mortality in infancy and early childhood (in some patients) | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:highly variable frequency and severity of attacks ---
r_associated #0: 27 -->
en:stillbirth
n1=en:highly variable frequency and severity of attacks | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:homozygotes have more severe disease with earlier onset of thrombosis ---
r_associated #0: 27 -->
en:stillbirth
n1=en:homozygotes have more severe disease with earlier onset of thrombosis | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:however, neonatal seizures, severe mental retardation, distinct dysmorphic features, and mitochondrial dysfunction are unique to 2p21 deletion syndrome (2p21del) ---
r_associated #0: 27 -->
en:stillbirth
n1=en:however, neonatal seizures, severe mental retardation, distinct dysmorphic features, and mitochondrial dysfunction are unique to 2p21 deletion syndrome (2p21del) | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:improvement with age ---
r_associated #0: 27 -->
en:stillbirth
n1=en:improvement with age | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:incidence of 1 in 1.5 million births ---
r_associated #0: 27 -->
en:stillbirth
n1=en:incidence of 1 in 1.5 million births | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:incidence of 1 in 39,000 ---
r_associated #0: 27 -->
en:stillbirth
n1=en:incidence of 1 in 39,000 | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:incomplete penetrance in some families ---
r_associated #0: 27 -->
en:stillbirth
n1=en:incomplete penetrance in some families | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:independent ambulation is maintained ---
r_associated #0: 27 -->
en:stillbirth
n1=en:independent ambulation is maintained | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:induced vaginal delivery ---
r_associated #0: 27 -->
en:stillbirth
n1=en:induced vaginal delivery | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:infant loss ---
r_associated #0: 27 -->
en:stillbirth
n1=en:infant loss | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:infantile onset with hepatic involvement ---
r_associated #0: 27 -->
en:stillbirth
n1=en:infantile onset with hepatic involvement | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:initially normal rod responses may become significantly reduced at older age ---
r_associated #0: 27 -->
en:stillbirth
n1=en:initially normal rod responses may become significantly reduced at older age | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:interfamilial and intrafamilial clinical heterogeneity ---
r_associated #0: 27 -->
en:stillbirth
n1=en:interfamilial and intrafamilial clinical heterogeneity | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:intermittent exacerbations ---
r_associated #0: 27 -->
en:stillbirth
n1=en:intermittent exacerbations | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:joint laxity decreases with age ---
r_associated #0: 27 -->
en:stillbirth
n1=en:joint laxity decreases with age | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:late-adult onset (fifth to sixth decade) ---
r_associated #0: 27 -->
en:stillbirth
n1=en:late-adult onset (fifth to sixth decade) | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:leiomyoma ---
r_associated #0: 27 -->
en:stillbirth
n1=en:leiomyoma | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:lesions increase in size and number with age ---
r_associated #0: 27 -->
en:stillbirth
n1=en:lesions increase in size and number with age | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:lethal in males ---
r_associated #0: 27 -->
en:stillbirth
n1=en:lethal in males | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:lifelong occurrence ---
r_associated #0: 27 -->
en:stillbirth
n1=en:lifelong occurrence | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:lifetime risk of breast cancer in mutation carriers is 60 to 85% ---
r_associated #0: 27 -->
en:stillbirth
n1=en:lifetime risk of breast cancer in mutation carriers is 60 to 85% | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:likely allelic to sc phocomelia syndrome (269000) ---
r_associated #0: 27 -->
en:stillbirth
n1=en:likely allelic to sc phocomelia syndrome (269000) | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:majority are isolated cases ---
r_associated #0: 27 -->
en:stillbirth
n1=en:majority are isolated cases | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:majority of cases have been sporadic ---
r_associated #0: 27 -->
en:stillbirth
n1=en:majority of cases have been sporadic | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:males more affected than females (2 to 2.5:1) ---
r_associated #0: 27 -->
en:stillbirth
n1=en:males more affected than females (2 to 2.5:1) | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:marked intrafamilial variability of clinical features ---
r_associated #0: 27 -->
en:stillbirth
n1=en:marked intrafamilial variability of clinical features | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:may be lethal in the neonatal period ---
r_associated #0: 27 -->
en:stillbirth
n1=en:may be lethal in the neonatal period | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:may regress ---
r_associated #0: 27 -->
en:stillbirth
n1=en:may regress | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:may result in death in neonatal period or early childhood ---
r_associated #0: 27 -->
en:stillbirth
n1=en:may result in death in neonatal period or early childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:mean age of diagnosis 40 years ---
r_associated #0: 27 -->
en:stillbirth
n1=en:mean age of diagnosis 40 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:mean age of onset 35-40 years ---
r_associated #0: 27 -->
en:stillbirth
n1=en:mean age of onset 35-40 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:mean age of onset, 5 years ---
r_associated #0: 27 -->
en:stillbirth
n1=en:mean age of onset, 5 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:median age of diagnosis is 28 years ---
r_associated #0: 27 -->
en:stillbirth
n1=en:median age of diagnosis is 28 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:median age of onset of pigmentation - 8 years (range 1-15 years) ---
r_associated #0: 27 -->
en:stillbirth
n1=en:median age of onset of pigmentation - 8 years (range 1-15 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:patient b presented with asymptomatic increased serum creatine kinase and no clinical muscle symptoms ---
r_associated #0: 27 -->
en:stillbirth
n1=en:patient b presented with asymptomatic increased serum creatine kinase and no clinical muscle symptoms | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:pigmentation not always butterfly-shaped ---
r_associated #0: 27 -->
en:stillbirth
n1=en:pigmentation not always butterfly-shaped | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:premature aging syndrome ---
r_associated #0: 27 -->
en:stillbirth
n1=en:premature aging syndrome | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:presence of additional features is variable ---
r_associated #0: 27 -->
en:stillbirth
n1=en:presence of additional features is variable | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:prevalent among the amish ---
r_associated #0: 27 -->
en:stillbirth
n1=en:prevalent among the amish | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:progressive clinical course with onset in childhood ---
r_associated #0: 27 -->
en:stillbirth
n1=en:progressive clinical course with onset in childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:some patients may not present until adulthood ---
r_associated #0: 27 -->
en:stillbirth
n1=en:some patients may not present until adulthood | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:some patients show improvement during summer or with fever ---
r_associated #0: 27 -->
en:stillbirth
n1=en:some patients show improvement during summer or with fever | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:some patients with advanced loss of vision have normal eog ---
r_associated #0: 27 -->
en:stillbirth
n1=en:some patients with advanced loss of vision have normal eog | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:subtype 3a comprises myoclonus and dementia ---
r_associated #0: 27 -->
en:stillbirth
n1=en:subtype 3a comprises myoclonus and dementia | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:sudden death within first days of life ---
r_associated #0: 27 -->
en:stillbirth
n1=en:sudden death within first days of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:symptoms precipitated by stress, exertion, fatigue, alcohol ---
r_associated #0: 27 -->
en:stillbirth
n1=en:symptoms precipitated by stress, exertion, fatigue, alcohol | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:triplet pregnancy with fetal loss and retention of one or more fetus(es), delivered, with or without mention of antepartum condition ---
r_associated #0: 27 -->
en:stillbirth
n1=en:triplet pregnancy with fetal loss and retention of one or more fetus(es), delivered, with or without mention of antepartum condition | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:two unrelated families have been reported (last curated june 2015) ---
r_associated #0: 27 -->
en:stillbirth
n1=en:two unrelated families have been reported (last curated june 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:usually symptomatic in adulthood with history of weakness since infancy or childhood ---
r_associated #0: 27 -->
en:stillbirth
n1=en:usually symptomatic in adulthood with history of weakness since infancy or childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:variable severity of clinical and radiologic manifestations ---
r_associated #0: 27 -->
en:stillbirth
n1=en:variable severity of clinical and radiologic manifestations | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- en:woman ---
r_associated #0: 27 -->
en:stillbirth
n1=en:woman | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- ethnologique ---
r_associated #0: 27 -->
en:stillbirth
n1=ethnologique | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- mort à la naissance ---
r_associated #0: 27 -->
en:stillbirth
n1=mort à la naissance | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- naissance d'un enfant mort-né ---
r_associated #0: 27 -->
en:stillbirth
n1=naissance d'un enfant mort-né | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- naissance sans vie ---
r_associated #0: 27 -->
en:stillbirth
n1=naissance sans vie | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- paralysis ---
r_associated #0: 27 -->
en:stillbirth
n1=paralysis | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- périodes ---
r_associated #0: 27 -->
en:stillbirth
n1=périodes | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- rétinite pigmentaire liée à la périphérine (pro219leu) ---
r_associated #0: 27 -->
en:stillbirth
n1=rétinite pigmentaire liée à la périphérine (pro219leu) | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- rétinopathie pigmentaire ---
r_associated #0: 27 -->
en:stillbirth
n1=rétinopathie pigmentaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- suffocation ---
r_associated #0: 27 -->
en:stillbirth
n1=suffocation | n2=en:stillbirth | rel=r_associated | relid=0 | w=27
- accouchement d'un enfant mort-né ---
r_associated #0: 26 -->
en:stillbirth
n1=accouchement d'un enfant mort-né | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- avortement accidentel ---
r_associated #0: 26 -->
en:stillbirth
n1=avortement accidentel | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- dépistage des lésions du col de l'utérus ---
r_associated #0: 26 -->
en:stillbirth
n1=dépistage des lésions du col de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:50% of cases represent new mutations associated with advanced paternal age ---
r_associated #0: 26 -->
en:stillbirth
n1=en:50% of cases represent new mutations associated with advanced paternal age | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:age at diagnosis 24 +/- 18 years for dominant disease ---
r_associated #0: 26 -->
en:stillbirth
n1=en:age at diagnosis 24 +/- 18 years for dominant disease | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:all cases sporadic (18 males, 7 females) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:all cases sporadic (18 males, 7 females) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:allelic disorder to early-onset sarcoidosis (609464) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:allelic disorder to early-onset sarcoidosis (609464) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:allelic to hypoparathyroidism-retardation-dysmorphism syndrome (241410) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:allelic to hypoparathyroidism-retardation-dysmorphism syndrome (241410) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:allelic to metaphyseal dysplasia without hypotrichosis (250460) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:allelic to metaphyseal dysplasia without hypotrichosis (250460) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:approximately 70-80% of cases are de novo and sporadic ---
r_associated #0: 26 -->
en:stillbirth
n1=en:approximately 70-80% of cases are de novo and sporadic | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:associated with smoking ---
r_associated #0: 26 -->
en:stillbirth
n1=en:associated with smoking | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:ataxia is nonprogressive ---
r_associated #0: 26 -->
en:stillbirth
n1=en:ataxia is nonprogressive | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise ---
r_associated #0: 26 -->
en:stillbirth
n1=en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:autosomal recessive inheritance with earlier onset has been reported in 3 patients ---
r_associated #0: 26 -->
en:stillbirth
n1=en:autosomal recessive inheritance with earlier onset has been reported in 3 patients | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:based on report of 2 sibs in 2008 ---
r_associated #0: 26 -->
en:stillbirth
n1=en:based on report of 2 sibs in 2008 | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:caused by inheritance of the mutation on the paternal allele (imprinting) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:caused by inheritance of the mutation on the paternal allele (imprinting) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:cervical cancer screening ---
r_associated #0: 26 -->
en:stillbirth
n1=en:cervical cancer screening | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:chronic course with exacerbations and remissions ---
r_associated #0: 26 -->
en:stillbirth
n1=en:chronic course with exacerbations and remissions | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:death and sudden death ---
r_associated #0: 26 -->
en:stillbirth
n1=en:death and sudden death | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:death in adolescence ---
r_associated #0: 26 -->
en:stillbirth
n1=en:death in adolescence | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:death in infancy secondary to respiratory insufficiency/pneumonia ---
r_associated #0: 26 -->
en:stillbirth
n1=en:death in infancy secondary to respiratory insufficiency/pneumonia | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:death in majority of infants soon after birth ---
r_associated #0: 26 -->
en:stillbirth
n1=en:death in majority of infants soon after birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:diagnosis within the first 3 months of life ---
r_associated #0: 26 -->
en:stillbirth
n1=en:diagnosis within the first 3 months of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:diarrhea worsens in parallel with increases in severity of skin disease ---
r_associated #0: 26 -->
en:stillbirth
n1=en:diarrhea worsens in parallel with increases in severity of skin disease | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:few familial (parent offspring) cases reported ---
r_associated #0: 26 -->
en:stillbirth
n1=en:few familial (parent offspring) cases reported | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:four patients from 3 families have been reported (last curated march 2016) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:four patients from 3 families have been reported (last curated march 2016) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:four unrelated patients have been reported (last curated june 2014) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:four unrelated patients have been reported (last curated june 2014) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:fractures decrease after puberty but increase after menopause ---
r_associated #0: 26 -->
en:stillbirth
n1=en:fractures decrease after puberty but increase after menopause | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:frequency of infections decreases after 3 years of age ---
r_associated #0: 26 -->
en:stillbirth
n1=en:frequency of infections decreases after 3 years of age | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:gaia stillbirth level of diagnostic certainty terminology ---
r_associated #0: 26 -->
en:stillbirth
n1=en:gaia stillbirth level of diagnostic certainty terminology | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:gonococcis ---
r_associated #0: 26 -->
en:stillbirth
n1=en:gonococcis | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:hairy elbows become apparent in infancy and regress during adolescence ---
r_associated #0: 26 -->
en:stillbirth
n1=en:hairy elbows become apparent in infancy and regress during adolescence | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:hepatic failure develops in first months of life ---
r_associated #0: 26 -->
en:stillbirth
n1=en:hepatic failure develops in first months of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:heterozygous females may have situs inversus or other midline defects ---
r_associated #0: 26 -->
en:stillbirth
n1=en:heterozygous females may have situs inversus or other midline defects | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:heterozygous females more mildly affected than hemizygous males ---
r_associated #0: 26 -->
en:stillbirth
n1=en:heterozygous females more mildly affected than hemizygous males | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:high frequency hearing loss progresses to include all frequencies ---
r_associated #0: 26 -->
en:stillbirth
n1=en:high frequency hearing loss progresses to include all frequencies | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:highly variable clinical phenotype ---
r_associated #0: 26 -->
en:stillbirth
n1=en:highly variable clinical phenotype | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:highly variable phenotype that includes several subtypes (see, e.g., 607485, 601104) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:highly variable phenotype that includes several subtypes (see, e.g., 607485, 601104) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:highly variable severity and features ---
r_associated #0: 26 -->
en:stillbirth
n1=en:highly variable severity and features | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:incidence 1 in 8,000 live births ---
r_associated #0: 26 -->
en:stillbirth
n1=en:incidence 1 in 8,000 live births | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:incidence of 1 in 250,000 births ---
r_associated #0: 26 -->
en:stillbirth
n1=en:incidence of 1 in 250,000 births | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:incidence of 1 in 57,000 ---
r_associated #0: 26 -->
en:stillbirth
n1=en:incidence of 1 in 57,000 | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:incomplete penetrance with 45 to 51 repeats ---
r_associated #0: 26 -->
en:stillbirth
n1=en:incomplete penetrance with 45 to 51 repeats | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:increased sensitivity to valproic acid toxicity ---
r_associated #0: 26 -->
en:stillbirth
n1=en:increased sensitivity to valproic acid toxicity | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:infantile form has onset within first 6 months of life ---
r_associated #0: 26 -->
en:stillbirth
n1=en:infantile form has onset within first 6 months of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:infections may precipitate ketotic episodes ---
r_associated #0: 26 -->
en:stillbirth
n1=en:infections may precipitate ketotic episodes | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:infertilitas feminis ---
r_associated #0: 26 -->
en:stillbirth
n1=en:infertilitas feminis | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:late-adult onset (usually after age 50 years) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:late-adult onset (usually after age 50 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:later onset of optic atrophy (mean 19 years, range 5 to 50 years) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:later onset of optic atrophy (mean 19 years, range 5 to 50 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:lesions provoked by friction, sun exposure, heat, and injury ---
r_associated #0: 26 -->
en:stillbirth
n1=en:lesions provoked by friction, sun exposure, heat, and injury | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:liver disease may be the most predominant finding ---
r_associated #0: 26 -->
en:stillbirth
n1=en:liver disease may be the most predominant finding | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:long headache duration (greater than 12 hours) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:long headache duration (greater than 12 hours) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:loss of tumor suppressor gene ---
r_associated #0: 26 -->
en:stillbirth
n1=en:loss of tumor suppressor gene | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:majority of cases are male ---
r_associated #0: 26 -->
en:stillbirth
n1=en:majority of cases are male | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:marked phenotypic variability, even within an individual ---
r_associated #0: 26 -->
en:stillbirth
n1=en:marked phenotypic variability, even within an individual | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:marked variation in severity - severe early onset disease (neonatal period) and milder juvenile disease (onset 8-13 years) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:marked variation in severity - severe early onset disease (neonatal period) and milder juvenile disease (onset 8-13 years) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:maternal anticipation bias ---
r_associated #0: 26 -->
en:stillbirth
n1=en:maternal anticipation bias | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:mean age at onset 28 years ---
r_associated #0: 26 -->
en:stillbirth
n1=en:mean age at onset 28 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:mean age at onset 57-60 years ---
r_associated #0: 26 -->
en:stillbirth
n1=en:mean age at onset 57-60 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:mean age at termination 3 to 4 years ---
r_associated #0: 26 -->
en:stillbirth
n1=en:mean age at termination 3 to 4 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:mean age of onset 30 years (range 25-42) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:mean age of onset 30 years (range 25-42) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:median age at onset 23 years ---
r_associated #0: 26 -->
en:stillbirth
n1=en:median age at onset 23 years | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:non-cancer related death ---
r_associated #0: 26 -->
en:stillbirth
n1=en:non-cancer related death | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:onset in first decade (as early as infancy in some) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:onset in first decade (as early as infancy in some) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:onset of visual dysfunction in early childhood ---
r_associated #0: 26 -->
en:stillbirth
n1=en:onset of visual dysfunction in early childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:patient b is 1 child born of unrelated scandinavian parents with a more severe phenotype with onset in the neonatal period ---
r_associated #0: 26 -->
en:stillbirth
n1=en:patient b is 1 child born of unrelated scandinavian parents with a more severe phenotype with onset in the neonatal period | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:patients may die in infancy or childhood due to respiratory failure ---
r_associated #0: 26 -->
en:stillbirth
n1=en:patients may die in infancy or childhood due to respiratory failure | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:pediatric terminology ---
r_associated #0: 26 -->
en:stillbirth
n1=en:pediatric terminology | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:post mortem examination ---
r_associated #0: 26 -->
en:stillbirth
n1=en:post mortem examination | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:premature birth of newborn ---
r_associated #0: 26 -->
en:stillbirth
n1=en:premature birth of newborn | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:quinidine therapy may be effective ---
r_associated #0: 26 -->
en:stillbirth
n1=en:quinidine therapy may be effective | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:relatively mild phenotype ---
r_associated #0: 26 -->
en:stillbirth
n1=en:relatively mild phenotype | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:sexually transmitted diseases ---
r_associated #0: 26 -->
en:stillbirth
n1=en:sexually transmitted diseases | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:short umbilical cord ---
r_associated #0: 26 -->
en:stillbirth
n1=en:short umbilical cord | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:single umbilical artery ---
r_associated #0: 26 -->
en:stillbirth
n1=en:single umbilical artery | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:skewed x-inactivation, with complete skewing in some individuals ---
r_associated #0: 26 -->
en:stillbirth
n1=en:skewed x-inactivation, with complete skewing in some individuals | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:stillbirth and foetal death ---
r_associated #0: 26 -->
en:stillbirth
n1=en:stillbirth and foetal death | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:symptoms present from infancy or early childhood ---
r_associated #0: 26 -->
en:stillbirth
n1=en:symptoms present from infancy or early childhood | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:three fetuses from 1 family have been reported (last curated august 2015) ---
r_associated #0: 26 -->
en:stillbirth
n1=en:three fetuses from 1 family have been reported (last curated august 2015) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:treatment with sulfonylurea can be effective ---
r_associated #0: 26 -->
en:stillbirth
n1=en:treatment with sulfonylurea can be effective | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- liomyome ---
r_associated #0: 26 -->
en:stillbirth
n1=liomyome | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- maladie opportuniste ---
r_associated #0: 26 -->
en:stillbirth
n1=maladie opportuniste | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- maladies sexuellement transmises ---
r_associated #0: 26 -->
en:stillbirth
n1=maladies sexuellement transmises | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- maladies sexuellement transmissibles ---
r_associated #0: 26 -->
en:stillbirth
n1=maladies sexuellement transmissibles | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- maladies vénériennes ---
r_associated #0: 26 -->
en:stillbirth
n1=maladies vénériennes | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- mise au monde d'un enfant mort-né ---
r_associated #0: 26 -->
en:stillbirth
n1=mise au monde d'un enfant mort-né | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- mort in utéro ---
r_associated #0: 26 -->
en:stillbirth
n1=mort in utéro | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- mort intra-utérine ---
r_associated #0: 26 -->
en:stillbirth
n1=mort intra-utérine | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- mort prénatale ---
r_associated #0: 26 -->
en:stillbirth
n1=mort prénatale | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- naissance vivante ---
r_associated #0: 26 -->
en:stillbirth
n1=naissance vivante | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- rétinite pigmentaire liée à la PDEB (1-bp del, his557-to-tyr) ---
r_associated #0: 26 -->
en:stillbirth
n1=rétinite pigmentaire liée à la PDEB (1-bp del, his557-to-tyr) | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- rétinite pigmentaire sénile ---
r_associated #0: 26 -->
en:stillbirth
n1=rétinite pigmentaire sénile | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- à la vie à la mort ---
r_associated #0: 26 -->
en:stillbirth
n1=à la vie à la mort | n2=en:stillbirth | rel=r_associated | relid=0 | w=26
- en:autopsia ---
r_associated #0: 25 -->
en:stillbirth
n1=en:autopsia | n2=en:stillbirth | rel=r_associated | relid=0 | w=25
- en:catamenia ---
r_associated #0: 25 -->
en:stillbirth
n1=en:catamenia | n2=en:stillbirth | rel=r_associated | relid=0 | w=25
- en:delivery of brow presentation ---
r_associated #0: 25 -->
en:stillbirth
n1=en:delivery of brow presentation | n2=en:stillbirth | rel=r_associated | relid=0 | w=25
- en:developmental anomaly ---
r_associated #0: 25 -->
en:stillbirth
n1=en:developmental anomaly | n2=en:stillbirth | rel=r_associated | relid=0 | w=25
- en:metrofibroma ---
r_associated #0: 25 -->
en:stillbirth
n1=en:metrofibroma | n2=en:stillbirth | rel=r_associated | relid=0 | w=25
- en:oviduct ---
r_associated #0: 25 -->
en:stillbirth
n1=en:oviduct | n2=en:stillbirth | rel=r_associated | relid=0 | w=25
- en:polyhydramnion ---
r_associated #0: 25 -->
en:stillbirth
n1=en:polyhydramnion | n2=en:stillbirth | rel=r_associated | relid=0 | w=25
- en:prenatal nutritional physiological phenomena ---
r_associated #0: 25 -->
en:stillbirth
n1=en:prenatal nutritional physiological phenomena | n2=en:stillbirth | rel=r_associated | relid=0 | w=25
- en:vulvar cancer ---
r_associated #0: 25 -->
en:stillbirth
n1=en:vulvar cancer | n2=en:stillbirth | rel=r_associated | relid=0 | w=25
- goniodysgénésie-retard mental-petite taille (syndrome) ---
r_associated #0: 25 -->
en:stillbirth
n1=goniodysgénésie-retard mental-petite taille (syndrome) | n2=en:stillbirth | rel=r_associated | relid=0 | w=25
- rétinite pigmentaire liée à la périphérine ---
r_associated #0: 25 -->
en:stillbirth
n1=rétinite pigmentaire liée à la périphérine | n2=en:stillbirth | rel=r_associated | relid=0 | w=25
- algie pelvienne ---
r_associated #0: 24 -->
en:stillbirth
n1=algie pelvienne | n2=en:stillbirth | rel=r_associated | relid=0 | w=24
- dépistage du cancer du col de l'utérus ---
r_associated #0: 24 -->
en:stillbirth
n1=dépistage du cancer du col de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=24
- en:until dead dead dead ---
r_associated #0: 24 -->
en:stillbirth
n1=en:until dead dead dead | n2=en:stillbirth | rel=r_associated | relid=0 | w=24
- Fausse couche ---
r_associated #0: 23 -->
en:stillbirth
n1=Fausse couche | n2=en:stillbirth | rel=r_associated | relid=0 | w=23
- en:caput succedanum ---
r_associated #0: 23 -->
en:stillbirth
n1=en:caput succedanum | n2=en:stillbirth | rel=r_associated | relid=0 | w=23
- en:epidemiological ---
r_associated #0: 23 -->
en:stillbirth
n1=en:epidemiological | n2=en:stillbirth | rel=r_associated | relid=0 | w=23
- en:necropsy ---
r_associated #0: 23 -->
en:stillbirth
n1=en:necropsy | n2=en:stillbirth | rel=r_associated | relid=0 | w=23
- en:sudden infant death ---
r_associated #0: 23 -->
en:stillbirth
n1=en:sudden infant death | n2=en:stillbirth | rel=r_associated | relid=0 | w=23
- létale ---
r_associated #0: 23 -->
en:stillbirth
n1=létale | n2=en:stillbirth | rel=r_associated | relid=0 | w=23
- malformation ---
r_associated #0: 23 -->
en:stillbirth
n1=malformation | n2=en:stillbirth | rel=r_associated | relid=0 | w=23
- USUV ---
r_associated #0: 22 -->
en:stillbirth
n1=USUV | n2=en:stillbirth | rel=r_associated | relid=0 | w=22
- en:infant wastage ---
r_associated #0: 22 -->
en:stillbirth
n1=en:infant wastage | n2=en:stillbirth | rel=r_associated | relid=0 | w=22
- en:leiomyoma uteri ---
r_associated #0: 22 -->
en:stillbirth
n1=en:leiomyoma uteri | n2=en:stillbirth | rel=r_associated | relid=0 | w=22
- en:necroscopy ---
r_associated #0: 22 -->
en:stillbirth
n1=en:necroscopy | n2=en:stillbirth | rel=r_associated | relid=0 | w=22
- en:postmenopausal ---
r_associated #0: 22 -->
en:stillbirth
n1=en:postmenopausal | n2=en:stillbirth | rel=r_associated | relid=0 | w=22
- en:postmortem ---
r_associated #0: 22 -->
en:stillbirth
n1=en:postmortem | n2=en:stillbirth | rel=r_associated | relid=0 | w=22
- en:the menopause ---
r_associated #0: 22 -->
en:stillbirth
n1=en:the menopause | n2=en:stillbirth | rel=r_associated | relid=0 | w=22
- en:uteri ---
r_associated #0: 22 -->
en:stillbirth
n1=en:uteri | n2=en:stillbirth | rel=r_associated | relid=0 | w=22
- condylome acuminé ---
r_associated #0: 21 -->
en:stillbirth
n1=condylome acuminé | n2=en:stillbirth | rel=r_associated | relid=0 | w=21
- céphalhématocèle ---
r_associated #0: 21 -->
en:stillbirth
n1=céphalhématocèle | n2=en:stillbirth | rel=r_associated | relid=0 | w=21
- céphalhématome ---
r_associated #0: 21 -->
en:stillbirth
n1=céphalhématome | n2=en:stillbirth | rel=r_associated | relid=0 | w=21
- en:metra ---
r_associated #0: 21 -->
en:stillbirth
n1=en:metra | n2=en:stillbirth | rel=r_associated | relid=0 | w=21
- en:salpinx uterina ---
r_associated #0: 21 -->
en:stillbirth
n1=en:salpinx uterina | n2=en:stillbirth | rel=r_associated | relid=0 | w=21
- en:std ---
r_associated #0: 21 -->
en:stillbirth
n1=en:std | n2=en:stillbirth | rel=r_associated | relid=0 | w=21
- immobilité ---
r_associated #0: 21 -->
en:stillbirth
n1=immobilité | n2=en:stillbirth | rel=r_associated | relid=0 | w=21
- interruption médicale de grossesse ---
r_associated #0: 21 -->
en:stillbirth
n1=interruption médicale de grossesse | n2=en:stillbirth | rel=r_associated | relid=0 | w=21
- oviducte ---
r_associated #0: 21 -->
en:stillbirth
n1=oviducte | n2=en:stillbirth | rel=r_associated | relid=0 | w=21
- pertes humaines ---
r_associated #0: 21 -->
en:stillbirth
n1=pertes humaines | n2=en:stillbirth | rel=r_associated | relid=0 | w=21
- rétinite pigmentaire et retard mental ---
r_associated #0: 21 -->
en:stillbirth
n1=rétinite pigmentaire et retard mental | n2=en:stillbirth | rel=r_associated | relid=0 | w=21
- 22 semaines de gestation ---
r_associated #0: 20 -->
en:stillbirth
n1=22 semaines de gestation | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- Avortement spontané ---
r_associated #0: 20 -->
en:stillbirth
n1=Avortement spontané | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- accouchement ---
r_associated #0: 20 -->
en:stillbirth
n1=accouchement | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- bébé mort à la naissance ---
r_associated #0: 20 -->
en:stillbirth
n1=bébé mort à la naissance | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- décès ---
r_associated #0: 20 -->
en:stillbirth
n1=décès | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- enfant ---
r_associated #0: 20 -->
en:stillbirth
n1=enfant | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- expulsion ---
r_associated #0: 20 -->
en:stillbirth
n1=expulsion | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- expulsion du fœtus ---
r_associated #0: 20 -->
en:stillbirth
n1=expulsion du fœtus | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- expulsion du foetus ---
r_associated #0: 20 -->
en:stillbirth
n1=expulsion du foetus | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- fœtus ---
r_associated #0: 20 -->
en:stillbirth
n1=fœtus | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- foetus ---
r_associated #0: 20 -->
en:stillbirth
n1=foetus | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- fœtus ---
r_associated #0: 20 -->
en:stillbirth
n1=fœtus | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- maladies ---
r_associated #0: 20 -->
en:stillbirth
n1=maladies | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- mise ---
r_associated #0: 20 -->
en:stillbirth
n1=mise | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- mort ---
r_associated #0: 20 -->
en:stillbirth
n1=mort | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- mort-nés ---
r_associated #0: 20 -->
en:stillbirth
n1=mort-nés | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- mortalité ---
r_associated #0: 20 -->
en:stillbirth
n1=mortalité | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- mortalité néonatale ---
r_associated #0: 20 -->
en:stillbirth
n1=mortalité néonatale | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- médecine ---
r_associated #0: 20 -->
en:stillbirth
n1=médecine | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- médecine spécialisée ---
r_associated #0: 20 -->
en:stillbirth
n1=médecine spécialisée | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- médecine
(science) ---
r_associated #0: 20 -->
en:stillbirth
n1=médecine (science) | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- naissance ---
r_associated #0: 20 -->
en:stillbirth
n1=naissance | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- obstétrique ---
r_associated #0: 20 -->
en:stillbirth
n1=obstétrique | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- processus pathologique ---
r_associated #0: 20 -->
en:stillbirth
n1=processus pathologique | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- pédiatrie ---
r_associated #0: 20 -->
en:stillbirth
n1=pédiatrie | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- sociologie ---
r_associated #0: 20 -->
en:stillbirth
n1=sociologie | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- spécialités médicales ---
r_associated #0: 20 -->
en:stillbirth
n1=spécialités médicales | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- taux ---
r_associated #0: 20 -->
en:stillbirth
n1=taux | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- épidémiologie ---
r_associated #0: 20 -->
en:stillbirth
n1=épidémiologie | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- état d'un enfant mort-né ---
r_associated #0: 20 -->
en:stillbirth
n1=état d'un enfant mort-né | n2=en:stillbirth | rel=r_associated | relid=0 | w=20
- blennorrhagie ---
r_associated #0: 16 -->
en:stillbirth
n1=blennorrhagie | n2=en:stillbirth | rel=r_associated | relid=0 | w=16
- fibromyome ---
r_associated #0: 16 -->
en:stillbirth
n1=fibromyome | n2=en:stillbirth | rel=r_associated | relid=0 | w=16
- Accouchement par voie vaginale ---
r_associated #0: 15 -->
en:stillbirth
n1=Accouchement par voie vaginale | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Arthralgie ---
r_associated #0: 15 -->
en:stillbirth
n1=Arthralgie | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Asphyxie ---
r_associated #0: 15 -->
en:stillbirth
n1=Asphyxie | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Avortement thérapeutique ---
r_associated #0: 15 -->
en:stillbirth
n1=Avortement thérapeutique | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Cancer de l'utérus ---
r_associated #0: 15 -->
en:stillbirth
n1=Cancer de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Cancer du col de l'utérus ---
r_associated #0: 15 -->
en:stillbirth
n1=Cancer du col de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Douleur articulaire ---
r_associated #0: 15 -->
en:stillbirth
n1=Douleur articulaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Endométriose ---
r_associated #0: 15 -->
en:stillbirth
n1=Endométriose | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Faucher (tube de) ---
r_associated #0: 15 -->
en:stillbirth
n1=Faucher (tube de) | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Gonorrhée ---
r_associated #0: 15 -->
en:stillbirth
n1=Gonorrhée | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Hyde (prurigo nodulaire de) ---
r_associated #0: 15 -->
en:stillbirth
n1=Hyde (prurigo nodulaire de) | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Infection sexuellement transmissible ---
r_associated #0: 15 -->
en:stillbirth
n1=Infection sexuellement transmissible | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Infertilité féminine ---
r_associated #0: 15 -->
en:stillbirth
n1=Infertilité féminine | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Jusqu'à la Mort ---
r_associated #0: 15 -->
en:stillbirth
n1=Jusqu'à la Mort | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Kyste ovarien ---
r_associated #0: 15 -->
en:stillbirth
n1=Kyste ovarien | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Léiomyome ---
r_associated #0: 15 -->
en:stillbirth
n1=Léiomyome | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Léiomyome utérin ---
r_associated #0: 15 -->
en:stillbirth
n1=Léiomyome utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Maladie Sexuellement Transmissible ---
r_associated #0: 15 -->
en:stillbirth
n1=Maladie Sexuellement Transmissible | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Malformation congénitale ---
r_associated #0: 15 -->
en:stillbirth
n1=Malformation congénitale | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Mortinatalité ---
r_associated #0: 15 -->
en:stillbirth
n1=Mortinatalité | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Pertes humaines ---
r_associated #0: 15 -->
en:stillbirth
n1=Pertes humaines | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Tube utérin ---
r_associated #0: 15 -->
en:stillbirth
n1=Tube utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Usutu (virus) ---
r_associated #0: 15 -->
en:stillbirth
n1=Usutu (virus) | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Utérus ---
r_associated #0: 15 -->
en:stillbirth
n1=Utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- aspergillose pulmonaire chronique nécrosante (ou semi-invasive) ---
r_associated #0: 15 -->
en:stillbirth
n1=aspergillose pulmonaire chronique nécrosante (ou semi-invasive) | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- automatisme médullaire (réflexe d') ---
r_associated #0: 15 -->
en:stillbirth
n1=automatisme médullaire (réflexe d') | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- en:hydramnion ---
r_associated #0: 15 -->
en:stillbirth
n1=en:hydramnion | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- en:mass reflex ---
r_associated #0: 15 -->
en:stillbirth
n1=en:mass reflex | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- en:medullary automatic defence reflex ---
r_associated #0: 15 -->
en:stillbirth
n1=en:medullary automatic defence reflex | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- fibromyalgie (critères de l' American College of Rheumatology ) ---
r_associated #0: 15 -->
en:stillbirth
n1=fibromyalgie (critères de l' American College of Rheumatology ) | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- gonorrhoee ---
r_associated #0: 15 -->
en:stillbirth
n1=gonorrhoee | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- gonorrhœe ---
r_associated #0: 15 -->
en:stillbirth
n1=gonorrhœe | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- malentendant (enfant) ---
r_associated #0: 15 -->
en:stillbirth
n1=malentendant (enfant) | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- mortalité (taux de) ---
r_associated #0: 15 -->
en:stillbirth
n1=mortalité (taux de) | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- utérus cloisonné cervical ---
r_associated #0: 15 -->
en:stillbirth
n1=utérus cloisonné cervical | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
- Autopsie ---
r_associated #0: 10 -->
en:stillbirth
n1=Autopsie | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Bleier (clip de) ---
r_associated #0: 10 -->
en:stillbirth
n1=Bleier (clip de) | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Fibromes utérins ---
r_associated #0: 10 -->
en:stillbirth
n1=Fibromes utérins | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Herpès génital ---
r_associated #0: 10 -->
en:stillbirth
n1=Herpès génital | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- IST ---
r_associated #0: 10 -->
en:stillbirth
n1=IST | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Leiner-Moussous (syndrome de) ---
r_associated #0: 10 -->
en:stillbirth
n1=Leiner-Moussous (syndrome de) | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Maladies sexuellement transmissibles ---
r_associated #0: 10 -->
en:stillbirth
n1=Maladies sexuellement transmissibles | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Malformation ---
r_associated #0: 10 -->
en:stillbirth
n1=Malformation | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Mammoplastie ---
r_associated #0: 10 -->
en:stillbirth
n1=Mammoplastie | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Menstruation ---
r_associated #0: 10 -->
en:stillbirth
n1=Menstruation | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Menstrues ---
r_associated #0: 10 -->
en:stillbirth
n1=Menstrues | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Mort cérébrale ---
r_associated #0: 10 -->
en:stillbirth
n1=Mort cérébrale | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Mort subite du nourrisson ---
r_associated #0: 10 -->
en:stillbirth
n1=Mort subite du nourrisson | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Mortinaissance ---
r_associated #0: 10 -->
en:stillbirth
n1=Mortinaissance | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Ménopause ---
r_associated #0: 10 -->
en:stillbirth
n1=Ménopause | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Naissance multiple ---
r_associated #0: 10 -->
en:stillbirth
n1=Naissance multiple | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Ostéoporose ---
r_associated #0: 10 -->
en:stillbirth
n1=Ostéoporose | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Oviducte ---
r_associated #0: 10 -->
en:stillbirth
n1=Oviducte | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Paralysis ---
r_associated #0: 10 -->
en:stillbirth
n1=Paralysis | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Polyhydramnios ---
r_associated #0: 10 -->
en:stillbirth
n1=Polyhydramnios | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- VACTERL (syndrome) ---
r_associated #0: 10 -->
en:stillbirth
n1=VACTERL (syndrome) | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Vagin ---
r_associated #0: 10 -->
en:stillbirth
n1=Vagin | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- atrophie musculaire, ataxie, rétinite pigmentaire et diabète sucré ---
r_associated #0: 10 -->
en:stillbirth
n1=atrophie musculaire, ataxie, rétinite pigmentaire et diabète sucré | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- coquelicots ---
r_associated #0: 10 -->
en:stillbirth
n1=coquelicots | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- durée de fonctionnement ---
r_associated #0: 10 -->
en:stillbirth
n1=durée de fonctionnement | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- dépendance environnementale (syndrome de) ---
r_associated #0: 10 -->
en:stillbirth
n1=dépendance environnementale (syndrome de) | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- dépistage des lésions du col de l?utérus ---
r_associated #0: 10 -->
en:stillbirth
n1=dépistage des lésions du col de l?utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:ailment ---
r_associated #0: 10 -->
en:stillbirth
n1=en:ailment | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:blennorhea ---
r_associated #0: 10 -->
en:stillbirth
n1=en:blennorhea | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:blennorragia ---
r_associated #0: 10 -->
en:stillbirth
n1=en:blennorragia | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:blennorrhagia ---
r_associated #0: 10 -->
en:stillbirth
n1=en:blennorrhagia | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:boob job ---
r_associated #0: 10 -->
en:stillbirth
n1=en:boob job | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:cacomorphosis ---
r_associated #0: 10 -->
en:stillbirth
n1=en:cacomorphosis | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:cephalematoma ---
r_associated #0: 10 -->
en:stillbirth
n1=en:cephalematoma | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:cephalhematoma ---
r_associated #0: 10 -->
en:stillbirth
n1=en:cephalhematoma | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:change of life ---
r_associated #0: 10 -->
en:stillbirth
n1=en:change of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:chronic necrotizing pulmonary aspergillosis ---
r_associated #0: 10 -->
en:stillbirth
n1=en:chronic necrotizing pulmonary aspergillosis | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:ethnological ---
r_associated #0: 10 -->
en:stillbirth
n1=en:ethnological | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:goniodysgenesis-mental retardation-short stature syndrome ---
r_associated #0: 10 -->
en:stillbirth
n1=en:goniodysgenesis-mental retardation-short stature syndrome | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:gonococal urethritis ---
r_associated #0: 10 -->
en:stillbirth
n1=en:gonococal urethritis | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:gonorrhoea ---
r_associated #0: 10 -->
en:stillbirth
n1=en:gonorrhoea | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:gonorrhoeae ---
r_associated #0: 10 -->
en:stillbirth
n1=en:gonorrhoeae | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:hypoacousic child ---
r_associated #0: 10 -->
en:stillbirth
n1=en:hypoacousic child | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:illness ---
r_associated #0: 10 -->
en:stillbirth
n1=en:illness | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:immobility ---
r_associated #0: 10 -->
en:stillbirth
n1=en:immobility | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:indisposition ---
r_associated #0: 10 -->
en:stillbirth
n1=en:indisposition | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:inertness ---
r_associated #0: 10 -->
en:stillbirth
n1=en:inertness | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:life-long ---
r_associated #0: 10 -->
en:stillbirth
n1=en:life-long | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:mammaplasty ---
r_associated #0: 10 -->
en:stillbirth
n1=en:mammaplasty | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:menopaused ---
r_associated #0: 10 -->
en:stillbirth
n1=en:menopaused | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:metrocarcinoma ---
r_associated #0: 10 -->
en:stillbirth
n1=en:metrocarcinoma | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:monthlies ---
r_associated #0: 10 -->
en:stillbirth
n1=en:monthlies | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:mortality rate ---
r_associated #0: 10 -->
en:stillbirth
n1=en:mortality rate | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:post-mortem ---
r_associated #0: 10 -->
en:stillbirth
n1=en:post-mortem | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:postmenopausal woman ---
r_associated #0: 10 -->
en:stillbirth
n1=en:postmenopausal woman | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:rules ---
r_associated #0: 10 -->
en:stillbirth
n1=en:rules | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:sexual involution ---
r_associated #0: 10 -->
en:stillbirth
n1=en:sexual involution | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:stillbirth rate ---
r_associated #0: 10 -->
en:stillbirth
n1=en:stillbirth rate | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:the change ---
r_associated #0: 10 -->
en:stillbirth
n1=en:the change | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:the change of life ---
r_associated #0: 10 -->
en:stillbirth
n1=en:the change of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:turn of life ---
r_associated #0: 10 -->
en:stillbirth
n1=en:turn of life | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:uterine atonia ---
r_associated #0: 10 -->
en:stillbirth
n1=en:uterine atonia | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:uterine hypotonia ---
r_associated #0: 10 -->
en:stillbirth
n1=en:uterine hypotonia | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:uterus subseptus unicorporeus ---
r_associated #0: 10 -->
en:stillbirth
n1=en:uterus subseptus unicorporeus | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:venereal wart ---
r_associated #0: 10 -->
en:stillbirth
n1=en:venereal wart | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- en:viable birth ---
r_associated #0: 10 -->
en:stillbirth
n1=en:viable birth | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- fausse corde vocale ---
r_associated #0: 10 -->
en:stillbirth
n1=fausse corde vocale | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- goniome ---
r_associated #0: 10 -->
en:stillbirth
n1=goniome | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- goniomètre ---
r_associated #0: 10 -->
en:stillbirth
n1=goniomètre | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- gonion ---
r_associated #0: 10 -->
en:stillbirth
n1=gonion | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- gonioscopie ---
r_associated #0: 10 -->
en:stillbirth
n1=gonioscopie | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- goniosynéchies ---
r_associated #0: 10 -->
en:stillbirth
n1=goniosynéchies | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- goniotomie endoscopique ---
r_associated #0: 10 -->
en:stillbirth
n1=goniotomie endoscopique | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- gonochorisme ---
r_associated #0: 10 -->
en:stillbirth
n1=gonochorisme | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- hypothyroïdie (manifestations neuromusculaires dans l') ---
r_associated #0: 10 -->
en:stillbirth
n1=hypothyroïdie (manifestations neuromusculaires dans l') | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- indisposée ---
r_associated #0: 10 -->
en:stillbirth
n1=indisposée | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- maladie des os de verre ---
r_associated #0: 10 -->
en:stillbirth
n1=maladie des os de verre | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- mort cellulaire (après irradiation) ---
r_associated #0: 10 -->
en:stillbirth
n1=mort cellulaire (après irradiation) | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- mort imminente (expérience de la) ---
r_associated #0: 10 -->
en:stillbirth
n1=mort imminente (expérience de la) | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- mortalité périnatale (taux de) ---
r_associated #0: 10 -->
en:stillbirth
n1=mortalité périnatale (taux de) | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- pertes menstruelles ---
r_associated #0: 10 -->
en:stillbirth
n1=pertes menstruelles | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- polyglucosanes (neuropathie à ) ---
r_associated #0: 10 -->
en:stillbirth
n1=polyglucosanes (neuropathie à ) | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- postmortem ---
r_associated #0: 10 -->
en:stillbirth
n1=postmortem | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- quadriplégie spastique, rétinite pigmentaire et retard mental ---
r_associated #0: 10 -->
en:stillbirth
n1=quadriplégie spastique, rétinite pigmentaire et retard mental | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- regles ---
r_associated #0: 10 -->
en:stillbirth
n1=regles | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- réflexe en masse ---
r_associated #0: 10 -->
en:stillbirth
n1=réflexe en masse | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire (classification de Fishman) ---
r_associated #0: 10 -->
en:stillbirth
n1=rétinite pigmentaire (classification de Fishman) | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- submersion ---
r_associated #0: 10 -->
en:stillbirth
n1=submersion | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- syndrome de Stein-Leventhal-Cohen ---
r_associated #0: 10 -->
en:stillbirth
n1=syndrome de Stein-Leventhal-Cohen | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- trompe de fallope ---
r_associated #0: 10 -->
en:stillbirth
n1=trompe de fallope | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- utéro-ovarien ---
r_associated #0: 10 -->
en:stillbirth
n1=utéro-ovarien | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- utéroplacentaire ---
r_associated #0: 10 -->
en:stillbirth
n1=utéroplacentaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- utérus bicorne unicervical ---
r_associated #0: 10 -->
en:stillbirth
n1=utérus bicorne unicervical | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- utérus biforis ---
r_associated #0: 10 -->
en:stillbirth
n1=utérus biforis | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- utérus biloculaire ---
r_associated #0: 10 -->
en:stillbirth
n1=utérus biloculaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- utérus bipartitus ---
r_associated #0: 10 -->
en:stillbirth
n1=utérus bipartitus | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- utérus cicatriciel ---
r_associated #0: 10 -->
en:stillbirth
n1=utérus cicatriciel | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- utérus cloisonné ---
r_associated #0: 10 -->
en:stillbirth
n1=utérus cloisonné | n2=en:stillbirth | rel=r_associated | relid=0 | w=10
- Aspergillus flavus ---
r_associated #0: 5 -->
en:stillbirth
n1=Aspergillus flavus | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Aspergillus fumigatus ---
r_associated #0: 5 -->
en:stillbirth
n1=Aspergillus fumigatus | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Aspergillus nidulans ---
r_associated #0: 5 -->
en:stillbirth
n1=Aspergillus nidulans | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Aspergillus niger ---
r_associated #0: 5 -->
en:stillbirth
n1=Aspergillus niger | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Aspergillus terreus ---
r_associated #0: 5 -->
en:stillbirth
n1=Aspergillus terreus | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Fibrome utérin ---
r_associated #0: 5 -->
en:stillbirth
n1=Fibrome utérin | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Interruption médicale de grossesse ---
r_associated #0: 5 -->
en:stillbirth
n1=Interruption médicale de grossesse | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Lester (signe de) ---
r_associated #0: 5 -->
en:stillbirth
n1=Lester (signe de) | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Létal ---
r_associated #0: 5 -->
en:stillbirth
n1=Létal | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Maladie opportuniste ---
r_associated #0: 5 -->
en:stillbirth
n1=Maladie opportuniste | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Maladies vénériennes ---
r_associated #0: 5 -->
en:stillbirth
n1=Maladies vénériennes | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Mort cardiaque subite ---
r_associated #0: 5 -->
en:stillbirth
n1=Mort cardiaque subite | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Mort clinique ---
r_associated #0: 5 -->
en:stillbirth
n1=Mort clinique | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Mts ---
r_associated #0: 5 -->
en:stillbirth
n1=Mts | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Médecine ---
r_associated #0: 5 -->
en:stillbirth
n1=Médecine | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Rétinite pigmentaire ---
r_associated #0: 5 -->
en:stillbirth
n1=Rétinite pigmentaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- SOCIOLOGIE ---
r_associated #0: 5 -->
en:stillbirth
n1=SOCIOLOGIE | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Sociologie ---
r_associated #0: 5 -->
en:stillbirth
n1=Sociologie | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- Spécialités médicales ---
r_associated #0: 5 -->
en:stillbirth
n1=Spécialités médicales | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- aspergillose pulmonaire diffuse ---
r_associated #0: 5 -->
en:stillbirth
n1=aspergillose pulmonaire diffuse | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- aspergillose pulmonaire invasive ---
r_associated #0: 5 -->
en:stillbirth
n1=aspergillose pulmonaire invasive | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- aspergillose sinusienne ---
r_associated #0: 5 -->
en:stillbirth
n1=aspergillose sinusienne | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- automatisme mental ---
r_associated #0: 5 -->
en:stillbirth
n1=automatisme mental | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- automatisme psychique ---
r_associated #0: 5 -->
en:stillbirth
n1=automatisme psychique | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- automutilation ---
r_associated #0: 5 -->
en:stillbirth
n1=automutilation | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- automédication ---
r_associated #0: 5 -->
en:stillbirth
n1=automédication | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- autonomisation de la pointe du nez ---
r_associated #0: 5 -->
en:stillbirth
n1=autonomisation de la pointe du nez | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- autonomisation du patient ---
r_associated #0: 5 -->
en:stillbirth
n1=autonomisation du patient | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- autophagique ---
r_associated #0: 5 -->
en:stillbirth
n1=autophagique | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- autophagocytose ---
r_associated #0: 5 -->
en:stillbirth
n1=autophagocytose | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- autophagosome ---
r_associated #0: 5 -->
en:stillbirth
n1=autophagosome | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- autophonie ---
r_associated #0: 5 -->
en:stillbirth
n1=autophonie | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- autopoagnosie ---
r_associated #0: 5 -->
en:stillbirth
n1=autopoagnosie | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- en:stillborn baby ---
r_associated #0: 5 -->
en:stillbirth
n1=en:stillborn baby | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- en:stillborns ---
r_associated #0: 5 -->
en:stillbirth
n1=en:stillborns | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- en:vector canal ---
r_associated #0: 5 -->
en:stillbirth
n1=en:vector canal | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- fibromyalgie associée ---
r_associated #0: 5 -->
en:stillbirth
n1=fibromyalgie associée | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- fibromyalgie primitive ---
r_associated #0: 5 -->
en:stillbirth
n1=fibromyalgie primitive | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- fibromyalgie secondaire ---
r_associated #0: 5 -->
en:stillbirth
n1=fibromyalgie secondaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- fibromyoadénome prostatique ---
r_associated #0: 5 -->
en:stillbirth
n1=fibromyoadénome prostatique | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- fibroplastique ---
r_associated #0: 5 -->
en:stillbirth
n1=fibroplastique | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- fibrosarcome ---
r_associated #0: 5 -->
en:stillbirth
n1=fibrosarcome | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- fibrosarcome cutané ---
r_associated #0: 5 -->
en:stillbirth
n1=fibrosarcome cutané | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- fibrosarcome de l'utérus ---
r_associated #0: 5 -->
en:stillbirth
n1=fibrosarcome de l'utérus | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- fibrosarcome du sein ---
r_associated #0: 5 -->
en:stillbirth
n1=fibrosarcome du sein | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- fibrosarcome du système musculosquelettique extraosseux ---
r_associated #0: 5 -->
en:stillbirth
n1=fibrosarcome du système musculosquelettique extraosseux | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- gonocoque ---
r_associated #0: 5 -->
en:stillbirth
n1=gonocoque | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- gonocyte ---
r_associated #0: 5 -->
en:stillbirth
n1=gonocyte | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- gonocytome ---
r_associated #0: 5 -->
en:stillbirth
n1=gonocytome | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- gonométrie ---
r_associated #0: 5 -->
en:stillbirth
n1=gonométrie | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- gonosome ---
r_associated #0: 5 -->
en:stillbirth
n1=gonosome | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- gonosomique ---
r_associated #0: 5 -->
en:stillbirth
n1=gonosomique | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydramnios aigu ---
r_associated #0: 5 -->
en:stillbirth
n1=hydramnios aigu | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydramnios chronique ---
r_associated #0: 5 -->
en:stillbirth
n1=hydramnios chronique | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydranencéphalie ---
r_associated #0: 5 -->
en:stillbirth
n1=hydranencéphalie | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydrargirose ---
r_associated #0: 5 -->
en:stillbirth
n1=hydrargirose | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydrargyrie ---
r_associated #0: 5 -->
en:stillbirth
n1=hydrargyrie | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydrargyrisme ---
r_associated #0: 5 -->
en:stillbirth
n1=hydrargyrisme | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydratase ---
r_associated #0: 5 -->
en:stillbirth
n1=hydratase | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydratation cutanée ---
r_associated #0: 5 -->
en:stillbirth
n1=hydratation cutanée | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydrate de carbone ---
r_associated #0: 5 -->
en:stillbirth
n1=hydrate de carbone | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydrencéphalie ---
r_associated #0: 5 -->
en:stillbirth
n1=hydrencéphalie | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydrencéphalocèle ---
r_associated #0: 5 -->
en:stillbirth
n1=hydrencéphalocèle | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydrine ---
r_associated #0: 5 -->
en:stillbirth
n1=hydrine | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydroa ---
r_associated #0: 5 -->
en:stillbirth
n1=hydroa | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydroa aestivalis ---
r_associated #0: 5 -->
en:stillbirth
n1=hydroa aestivalis | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydroa vacciniforme de Bazin ---
r_associated #0: 5 -->
en:stillbirth
n1=hydroa vacciniforme de Bazin | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydroadénome ---
r_associated #0: 5 -->
en:stillbirth
n1=hydroadénome | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydrocalice ---
r_associated #0: 5 -->
en:stillbirth
n1=hydrocalice | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydrocarboné ---
r_associated #0: 5 -->
en:stillbirth
n1=hydrocarboné | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- hydrocarbure ---
r_associated #0: 5 -->
en:stillbirth
n1=hydrocarbure | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- maladie de Fauchard ---
r_associated #0: 5 -->
en:stillbirth
n1=maladie de Fauchard | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- malf ormation dysraphique ---
r_associated #0: 5 -->
en:stillbirth
n1=malf ormation dysraphique | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- malformation kystique adénomatoïde du poumon ---
r_associated #0: 5 -->
en:stillbirth
n1=malformation kystique adénomatoïde du poumon | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- malformation luxante de la hanche ---
r_associated #0: 5 -->
en:stillbirth
n1=malformation luxante de la hanche | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- malformation mamelonnaire ---
r_associated #0: 5 -->
en:stillbirth
n1=malformation mamelonnaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- malformation mammaire ---
r_associated #0: 5 -->
en:stillbirth
n1=malformation mammaire | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- malformation ombilicale ---
r_associated #0: 5 -->
en:stillbirth
n1=malformation ombilicale | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- malformation utérine ---
r_associated #0: 5 -->
en:stillbirth
n1=malformation utérine | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- malformation vaginale ---
r_associated #0: 5 -->
en:stillbirth
n1=malformation vaginale | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- malformation vasculaire cérébrale du nourrisson ---
r_associated #0: 5 -->
en:stillbirth
n1=malformation vasculaire cérébrale du nourrisson | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- malformations de la charnière occipitocervicale ---
r_associated #0: 5 -->
en:stillbirth
n1=malformations de la charnière occipitocervicale | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- mamelon (adénomatose érosive du) ---
r_associated #0: 5 -->
en:stillbirth
n1=mamelon (adénomatose érosive du) | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- mortalité foetale intrapartum ---
r_associated #0: 5 -->
en:stillbirth
n1=mortalité foetale intrapartum | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- mortalité foetale précoce ---
r_associated #0: 5 -->
en:stillbirth
n1=mortalité foetale précoce | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- ménisque (signe du) ---
r_associated #0: 5 -->
en:stillbirth
n1=ménisque (signe du) | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- naissance (déclaration de) ---
r_associated #0: 5 -->
en:stillbirth
n1=naissance (déclaration de) | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- pædiatrie ---
r_associated #0: 5 -->
en:stillbirth
n1=pædiatrie | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- utérorelaxant, ante ---
r_associated #0: 5 -->
en:stillbirth
n1=utérorelaxant, ante | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- utérotomie ---
r_associated #0: 5 -->
en:stillbirth
n1=utérotomie | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- utérotonique ---
r_associated #0: 5 -->
en:stillbirth
n1=utérotonique | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- utérus acollis ---
r_associated #0: 5 -->
en:stillbirth
n1=utérus acollis | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- utérus bicorne ---
r_associated #0: 5 -->
en:stillbirth
n1=utérus bicorne | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- utérus bicorne bicervical ---
r_associated #0: 5 -->
en:stillbirth
n1=utérus bicorne bicervical | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- utérus à éperon ---
r_associated #0: 5 -->
en:stillbirth
n1=utérus à éperon | n2=en:stillbirth | rel=r_associated | relid=0 | w=5
- menace d'avortement ---
r_associated #0: 1 -->
en:stillbirth
n1=menace d'avortement | n2=en:stillbirth | rel=r_associated | relid=0 | w=1
|